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Riassunto 
Obiettivo: Le microalghe (compresi i cianobatteri) rivestono un grande 
potenziale come fonte di composti naturali, da utilizzare come ingredienti 
funzionali in preparazioni alimentari. Fino ad oggi, diverse specie di microalghe 
e cianobatteri sono stati identificati, ma solo pochi di loro sono stati approvati e 
applicati nella produzione alimentare. Per aumentare il numero di ceppi idonei 
allo sfruttamento nell'industria alimentare, si rende necessaria un’approfondita 
indagine sulla loro sicurezza e sulla loro qualità nutrizionale. 
L'obiettivo generale del progetto di tesi è stato quello di valutare l'idoneità di 
alcune biomasse microalgali e cianobatteriche che potrebbero essere proposte 
per la produzione di alimenti innovativi e nutraceutici. Per perseguire questo 
obiettivo, numerose biomasse di microalghe e di cianobatteri sono state prodotte 
e testate per valutarne: i) composizione biochimica, ii) tossicità in vitro, iii) 
digeribilità in vitro, iv) sicurezza e potenziali effetti salutistici in vivo, v) effetti 
sulle qualità organolettiche e sulle potenzialità antiossidanti dopo addizione in 
alimenti convenzionali, vi) idoneità alla fermentazione. 
Metodi e Risultati: Il Capitolo 3 riporta i test utilizzati per indagare la 
possibile tossicità in vitro di ceppi selezionati di microalghe e cianobatteri. Gli 
estratti metanolici e acquosi delle biomasse microalgali e cianobatteriche sono 
stati testati su fibroblasti dermici di origine umana e su Artemia salina. Sebbene 
in alcuni casi i due modelli abbiano fornito risultati contrastanti, questo lavoro 
ha confermato la validità dei pre-screenings di tossicità. Questi modelli in vitro, 
specialmente nel caso dell’estratto metanolico dopo 48 ore di incubazione, sono 
stati in grado di rilevare la potenziale tossicità di substrati microalgali e 
potrebbero servire come linee guida per prove in vivo su mammiferi, necessarie 
per richiedere l’applicazione per novel food nell'Unione Europea. 
L’analisi della composizione biochimica e la valutazione della digeribilità sono 
analisi fondamentali per fornire informazioni sulla qualità e sulla 
biodisponibilità degli elementi nutritivi nelle biomasse algali. Nel Capitolo 4, 
vengono studiate la composizione biochimica e la digeribilità in vitro di alcune 
biomasse di microalghe e cianobatteri. La composizione biochimica equilibrata 
e la buona digeribilità, in particolare per i cianobatteri, evidenziano il potenziale 
di questi microrganismi come alimenti funzionali. Per migliorare la digeribilità 
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in vitro, è stato anche valutato un pretrattamento di sonicazione su due biomasse 
liofilizzate appartenenti al phylum delle Chlorophyta. I dati ottenuti in questo 
studio confermano l'effetto positivo della sonicazione sulla dispersione cellulare 
e quindi sull'efficienza dell'azione enzimatica durante il processo di digestione. 
I risultati ottenuti dai modelli in vitro sono preliminari e devono essere 
confermati da studi in vivo sui mammiferi effettuati sull’intera biomassa algale. 
I Capitoli 5 e 6 si focalizzano sulla valutazione della sicurezza in vivo su ratti 
alimentati con biomasse di Arthrospira platensis F&M-C256 e Tisochrysis lutea 
F&M-M36. Le diete integrate (al 20%) con le due biomasse sono state ben 
tollerate. Le osservazioni cliniche e dei pesi corporei non hanno evidenziato 
effetti negativi e non sono stati osservati aumenti della pressione sanguigna o 
danni ossidativi renali. Il colesterolo LDL è risultato invariato, ed è stato 
osservato un aumento significativo del colesterolo HDL in entrambi i gruppi 
alimentati con A. platensis F&M-C256 e T. lutea F&M-M36. Queste due 
biomasse sarebbero probabilmente sicure anche a più alti dosaggi e potrebbero 
rappresentare una fonte promettente di alimenti funzionali per la prevenzione di 
diverse malattie. 
Nel Capitolo 7 al fine di esplorare la potenziale applicazione di microalghe e 
cianobatteri come ingredienti alimentari, sono stati analizzati biscotti contenenti 
A. platensis F&M-C256, Chlorella vulgaris Allma, Tetraselmis suecica F&M-
M33 e Phaeodactylum tricornutum F&M-M40 in termini di parametri fisico-
chimici, bioattività e digeribilità in vitro. Le proprietà fisiche dei biscotti sono 
state valutate per 8 settimane e non state trovate differenze significative in 
termini  di stabilità nella struttura. Inoltre, non sono state trovate differenze 
significative nella digeribilità in vitro tra i biscotti a base di microalghe ed il 
controllo. I biscotti a base di microalghe hanno invece presentato maggior 
potere antiossidante e contenuto fenolico totale rispetto al controllo. 
Nel Capitolo 8, al fine di migliorare l'accettabilità delle microalghe da parte del 
consumatore in termini di qualità organolettica e digeribilità, e per valutare la 
potenziale applicazione per la produzione di alimenti funzionali, le biomasse di 
A. platensis F&M-C256 e T. suecica F&M-M33 sono state fermentate con 
Lactobacillus plantarum. Oltre a migliorare la digeribilità, la fermentazione 
acido-lattica ha incrementato anche l'attività antiossidante. Questo studio ha 
evidenziato il potenziale di specie microalgali per la produzione di alimenti 
funzionali e probiotici.     
 
 vii 
Nel Capitolo 9, sono riportate le discussioni generali, dove i risultati dei diversi 
capitoli vengono discussi approfonditamente rispetto ai dati di letteratura. 
Conclusioni: I risultati dell'analisi della composizione biochimica e dei test in 
vitro ed in vivo dimostrano il potenziale delle microalghe e dei cianobatteri 
come candidati per la produzione di alimenti funzionali e nutraceutici. Inoltre, 
le biomasse di A. platensis F&M-C256, C. vulgaris Allma, T. suecica F&M-
M33 e P. tricornutum F&M-M46 si sono dimostrate idonee per lo sviluppo di 
prodotti funzionali a base di microalghe (ad esempio biscotti). Il processo di 
fermentazione ha poi migliorato la qualità delle biomasse di A. platensis F&M-
C256 e T. suecica F&M-M33 in termini di qualità organolettiche e digeribilità. 
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Summary 
Aim: Microalgae (including cyanobacteria) have great potential as a source of 
natural compounds, to be used as functional ingredients in food preparations. 
Up to date, several species of microalgae and cyanobacteria were classified but 
only few of them are approved and applied in food production. To increase the 
number of suitable strains for the food industry, a deep investigation about their 
safety and quality is fundamental. 
The general aim of the thesis project was to evaluate the suitability of some 
microalgal and cyanobacterial biomasses that might be proposed for the 
production of innovative foods and nutraceuticals. To pursue this aim, i) 
chemical composition, ii) in vitro toxicity, iii) in vitro digestibility, iv) in vivo 
safety evaluation and potential health effects, v) the effects on organoleptic and 
antioxidant quality after the inclusion of microalgal and cyanobacterial biomass 
in conventional foods, and vi) suitability to fermentation were investigated. 
Methods and Results: Chapter 3 reports the tests which investigated the 
possible in vitro toxicity of selected microalgal and cyanobacterial strains. 
Methanolic and aqueous extracts of the microalgal biomasses were tested on 
human dermal fibroblasts and on Artemia salina models. Although in some 
cases the two models provided contrasting results, this work confirmed their 
validity for preliminary screening of toxicity. These in vitro models, especially 
in the case of methanolic extract after 48 hours of incubation, were able to 
detect the potential toxicity of microalgal substrates and may well serve as 
guidelines for in vivo tests on mammals, which are necessary to apply for novel 
food in the European Union. 
The biochemical composition and the evaluation of digestibility are 
fundamental analyses to provide information about the quality and 
bioavailability of nutritional components of microalgal biomasses. In Chapter 
4, the biochemical composition and the in vitro digestibility of some selected 
microalgal and cyanobacterial biomasses are reported. A balanced biochemical 
composition and a good digestibility, in particular for cyanobacteria, indicated 
these microorganisms as promising functional foods. To enhance the in vitro 
digestibility, a sonication pre-treatment on two lyophilised biomasses belonging 
to Chlorophyta phylum was also evaluated. The data obtained in this study 
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confirm the positive effect of sonication on cellular dispersion and consequently 
on the efficiency of the enzymes action during the digestion process. 
Results obtained from in vitro models are preliminary and must be confirmed by 
in vivo studies on mammals performed on the whole algal biomass. Chapters 5 
and 6 focused on a safety evaluation of one month feeding of Arthrospira 
platensis F&M-C256 and Tisochrysis lutea F&M-M36 in rats. The microalgae 
supplemented diets (20%) were well-tolerated. Clinical observations and body 
weights did not reveal negative effects and no increase in blood pressure or 
renal oxidative damage were observed. LDL cholesterol levels were unchanged, 
but a significant increase in HDL was found in the A. platensis F&M-C256 and 
T. lutea F&M-M36 fed groups. Microalgae as A. platensis F&M-C256 and T. 
lutea F&M-M36 are probably safe even at higher dosage and they may 
represent a promising source of functional foods for the prevention of several 
diseases. 
To explore the potential food application of microalgae and cyanobacteria, A. 
platensis F&M-C256, Chlorella vulgaris Allma, Tetraselmis suecica F&M-
M33 and Phaeodactylum tricornutum F&M-M40-based cookies were analysed 
in terms of physicochemical parameters, bioactivity and in vitro digestibility 
(Chapter 7). The cookies physical properties were evaluated along 8 weeks and 
no significant differences were found in terms of texture stability. No significant 
difference in in vitro digestibility between microalgae cookies and the control 
was found. On the other hand, microalgae cookies presented significantly higher 
in vitro antioxidant capacity and total phenolic content than the control.  
In Chapter 8, in order to improve the acceptability of microalgae by the 
consumer in terms of organoleptic quality and digestibility, and to evaluate the 
potential application for the production of functional foods, Lactobacillus 
plantarum was used to ferment A. platensis F&M-C256 and T. suecica F&M-
M33 biomasses. In addition to enhancing digestibility, lactic acid fermentation 
also increased antioxidant activity. This study highlighted the potential of 
microalgae species for the production of economically valuable functional food 
and probiotics. 
Chapter 9 reports the general discussion in which the findings of the different 
chapters are discussed together with a deepened comparison with literature 
results. 
Conclusions: The results of the analysis of biochemical composition and in 
vitro and in vivo tests demonstrate the potential of microalgae and cyanobacteria 
as candidates for the production of functional foods and nutraceuticals.                      
Summary 
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A. platensis F&M-C256, C. vulgaris Allma, T. suecica F&M-M33 and P. 
tricornutum F&M-M46 have been also found suitable for the development of 
functional microalgae-based products (e.g. cookies). Fermentation process also 
enhanced the quality of A. platensis F&M-C256 and T. suecica F&M-M33 
biomasses in terms of organoleptic quality and digestibility. 
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1. Introduction 
The pressure on natural resources is becoming increasingly unsustainable, as the 
food supply problem continues to grow in many parts of the world, therefore, in 
addition to the financial and energy crises, it is necessary to shift the focus on 
food security. Indeed, the global energy crisis that is increasing by almost 50 
years suggests that we should consider new alternatives for solving these 
problems (Goswami and Kreith, 2015). Increasing population also increases the 
global demand for energy and, due to the exhaustion of conventional energy 
sources, notably petroleum, it also increases the price, thus decreasing the 
capacity of people to purchase primary goods (Sorrell, 2015). 
To live a healthy and balanced life, people must have food of good quality and 
in quantities needed to meet their energy and nutrients requirements. Without 
adequate nutrition, adults and children will encounter difficulty in maintaining 
optimal physical condition, making them more susceptible to disease (Stipanuk, 
2013). Nowadays, not all people have access to sufficient quantities of food 
(Fig. 1). About 795 million people are chronically undernourished and are not 
able to have enough food to meet their energy needs (Fig. 1) (FAO, 2015). 
Malnutrition in the form of deficiency of vitamins, minerals and essential fatty 
acids continues to be, on a global scale, the leading cause of serious illnesses 
and death of millions of people per year (McGuire, 2015). 
 
 
Figure 1 The changing distribution of hunger in the world: numbers and shares 
of undernourished people by region, 1990–92 and 2014–16 
Source: FAO, 2015 
General introduction 
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It is expected that in 2050 the world population will reach 9 billion with a 
particularly high concentration in urban areas (Fig. 2) (Antal and Van Den 
Bergh, 2016), and that the demand for food and raw materials is not directly 
proportional to the increase of the population.  
 
 
Figure 2 Word population expected in 2050 
Adapted from Website Population Reference Bureau, 2013 
 
The economic development that some emerging countries are experiencing, 
allowing for richest diets, especially in animal protein, leads to an increase in 
the demand for food. To meet future demands, the global production of food 
and raw materials should highly increase over the next 40 years (Antal and Van 
Den Bergh, 2016). Such production could be reached thanks to the 
intensification of agricultural programs implemented in recent years in most 
industrialized countries (Antal and Van Den Bergh, 2016), but we have to 
consider some factors that might counteract the achievement of this objective. 
For the first time in history, the demand for freshwater in the urban areas has 
exceeded that used for agriculture (Cosgrove and Loucks, 2015). It is expected 
that in 2050, the cities will consume about half of the available freshwater, 
reducing by one-third that available for agricultural production, and increasing 
the areas of the planet where there is not a safe source of drinking water for 
human consumption (Cosgrove and Loucks, 2015). 
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It is estimated that freshwater shortage will have a negative impact on 
agricultural production, calculating a loss in terms of food of around 350 
million tons per year, an equal amount to the current global rice production 
(Cribb, 2010). The challenge for the next generation of farmers will be to 
double the productivity of the fields using only two-thirds of the water available 
today. This implies an increase of about 200% efficiency of water use (Cribb, 
2010). 
From all these issues then a question arises, from which the next challenge 
comes: “how to increase the production of biomass with a minimal increase in 
terrestrial area and with a limited use of water and fossil energy and at the same 
time reduce or avoid adverse effects on natural resources and ecosystems?”. It is 
clear that to rely on molecular biology or the introduction of new types of 
fertilizers or pesticides, as was done in the second half of the last Century to 
face food needs from emerging countries is not enough. Rather, it is necessary 
to find new sources of energy, and reduce to a minimum the impact on 
ecosystems. Microalgae should be part of the solution towards a new economy 
based on new biological sources (Tredici, 2014). Indeed, microalgae cultivation 
has several advantages compare to traditional crops, especially in terms of 
sustainability: i) they do not need fertile soil and pesticides or herbicides for 
their cultivation, limiting the water pollution by these products; ii) many 
microalgae can be cultivated in saline, sea or brackish water, avoiding the 
competition for freshwater resources; iii) they can grow on wastewaters iv) they 
require CO2 sources for their growth, thus they can absorb this gas from flue 
gases (Tredici, 2016; Chini Zittelli et al., 2013a,b; Rodolfi et al., 2009).  
 
1.1 Microalgae and biotechnology: photosynthesis, taxa, and cultivation 
1.1.1 Photosynthesis of microalgae 
Microalgae, as well as cyanobacteria, are usually phototrophic microorganisms, 
which obtain the energy directly from sunlight, using inorganic elements as a 
source of nutrients for growth. These microorganisms are present in all aquatic 
ecosystems, both marine and freshwater, where are the starting point of the food 
chains. They can be found, also in the surface layers of many lands, organized 
in colonies, in filaments or solitary (Tredici, 2010). 
Microalgae (including cyanobacteria) are directly responsible for about half of 
the photosynthetic activity on Earth (Tredici, 2010). The capacity of these 
organisms to grow in extreme environments, including deserts, hypersaline 
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lakes and glaciers is related to their particular abilities to produce reserve 
substances, in their high biodiversity, which makes them suitable also for 
extreme climates (Varshney et al., 2015). Generally, large filamentous 
cyanobacteria colonize first, most probably because of their possession of thick 
extracellular sheaths or mucus layers, which improve the water retention 
properties (Tomaselli and Giovannetti, 1993). Some microalgal and 
cyanobacterial species can also grow on organic substrates (sugars, alcohols or 
organic acids) in the presence or absence of light, which makes them even more 
adaptable to the different environmental conditions (Varshney et al., 2015).  
The photoautotrophic organisms, through photosynthesis, convert inorganic 
compounds (H2O, CO2, N, and P) into organic compounds as carbohydrates 
(sugars), proteins and lipids (oils) by using solar energy. This process is divided 
into two phases: light phase, which occurs in thylakoids, and leads to the 
formation of ATP and NADPH2 in addition to the release of O2; and, dark 
phase, which takes place in the stroma, in which NADPH2 and ATP are used to 
reduce carbon dioxide into carbohydrates in the Calvin-Benson cycle. The 
spectrum of visible light, between 350 (violet) and 750 (far red) nm corresponds 
to that of Photosynthetically Active Radiation (PAR), which is the radiation 
used in photosynthesis. Chloroplasts are the seat of the photosynthetic apparatus 
and are constituted by a series of said thylakoid vesicles and by a matrix or 
stroma. Prokaryotic cells, such as those of cyanobacteria, have a more simple 
structure. Chlorophyll a is present in all oxygenic photoautotrophic organisms 
mainly in the reaction center, while chlorophyll b or c and some carotenoids act 
as antenna pigments (Tredici, 2010). 
1.1.2 Microalgal taxa 
Microalgae commercially exploited and their products represent a very small 
number of species compared to the high number present in nature, from 30,000 
to 1 million species according to different sources (Guiry, 2012). 
The main microalgae classification system was based on morphological 
characteristics, type of reserve substance, nature of pigments and constituents of 
the cell wall (Christensen, 1964; Tomaselli, 2008). In recent years molecular 
analyses are providing new characters well beyond the morphology-based 
systematics of the past, leading to a much better understanding of what may 
constitute a species, as well as the phylogenetic and evolutionary relationships 
between species. In the future developments of proteomics and metabolomics 
will impact on our understanding of what constitutes a species (Borowitzka, 
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2016). However, thanks to several taxonomic databases, especially AlgaeBase 
(http://www.algaebase.org/) it is now relatively easy for a researcher to check 
the current as well as the past names (synonyms) of a particular species. 
The main algal groups are shown below: 
 Cyanobacteria: they are the unique group of prokaryotes with oxygenic 
photosynthesis, they have glycogen as main reserve substance, their cell 
wall is of Gram-negative type, they synthesize chlorophyll and 
phycobiliproteins and, in the case of Prochlorales, also chlorophyll b. They 
include Microcystis, Arthrospira (commonly called spirulina), Nostoc and 
nitrogen-fixing cyanobacteria, such as Anabaena azollae (symbiont of 
Azolla fern), which are a valuable source of nitrogen in the rice fields 
(Stanier and Bazine, 1977; Balloni et al., 1980); 
 Rhodophyta (red algae): they have chlorophyll a and d and 
phycobiliproteins, they synthesize starch of Floridee and amorphous 
polysaccharides. They may contain high amounts of polyunsaturated fatty 
acids (as Porphyridium) (Dixon, 1973); 
 Chlorophyta (green algae): they include a large variety of organisms with 
considerable morphological differences. They all have chlorophyll a and b 
and synthesize starch. Some species can synthesize and accumulate 
carotenoids outside of the chloroplast in the case of stress (Huss et al., 
1999). Chlorella, Dunaliella, Haematococcus and Tetraselmis are 
cultivated at large-scale for aquaculture, or for the production of pigments 
and dietary supplements (Chini Zittelli et al., 2006); 
 Dinophyta (dinoflagellates): they synthesize chlorophyll a and c, and 
peridinin, accumulate starch and are a potential source of polyunsaturated 
fatty acids (such as n-3). They can generate extended blooms and are 
producers of algal toxins. In addition to the environmental impact, these 
toxins can also create problems in aquaculture (Lee, 1999a); 
 Prymnesiophyta: their cells contain chlorophyll a and c and fucoxanthin, 
can produce chrysolaminarin as a reserve substance and their cells can be 
coated with calcium carbonate flakes (coccolithophorids) (Lee, 1999b). To 
this group belong important microalgae commonly used in aquaculture 
(Isochrysis, Pavlova) (Chini Zittelli et al., 2004) and others which can 
produce ichthyotoxins, such Prymnesium (Lee, 1999b); 
 Bacillariopyhta (diatoms): they are the group with the largest number of 
known species, they can have unicellular organization, form colonies or 
short chains. Their characteristic brown colour is due to the combination of 
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chlorophyll a, c, and fucoxanthin. Their principal stock product is 
chrysolaminarin, although lipids can be present in considerable amounts. 
Diatoms are divided into pennate, with bilateral symmetry, and centric, 
with radial symmetry. They live in aquatic environments and in the surface 
layers of soil and play an important ecological role being responsible for 
40% of all primary production in the oceans (Falkowski and La Roche, 
1991). Commercial uses of the diatoms are mainly related to aquaculture 
(Phaeodactylum), and to the significant presence of polyunsaturated fatty 
acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA) (Lee, 1999c); 
 Eustigmatophyta: This class includes single-celled organisms that live in 
marine waters and on the surface of many soils. They contain only 
chlorophyll a (Lee, 1999d). Most of the Eustigmatophyceae are used in 
aquaculture (Nannochloropsis) and for the extraction of polyunsaturated 
fatty acids (EPA) (Chini Zittelli et al., 2003). 
1.1.3 Cultivation of microalgae 
Photobioreactors are reactors in which phototrophic microorganisms can grow 
or where they can perform photobiological reactions. The bioreactors can be 
open, if the surface of the culture is in direct contact with the atmosphere or 
closed, if the surface of the culture is not in direct contact with the atmosphere 
(Tredici, 2004). 
In this work, we tested strains/products belonging to species already approved 
as food in the EU (C. vulgaris, A. flos-aquae from Klamath Lake blooms, A. 
platensis), and species not approved at present (C. sorokiniana and Tetraselmis 
suecica), but belonging to genera of approved species. Other microalgae were 
also tested: Nostoc sphaeroides, an edible cyanobacterium consumed in China 
and other Asian countries (Han et al. 2013), Tisochrysis lutea, Nannochloropsis 
oceanica, and Phaeodactylum tricornutum, widely used (as well as Tetraselmis 
spp.) in aquaculture (Tredici et al. 2009; Muller-Feuga 2013), and 
Porphyridium purpureum, rich in EPA, but to date used only in cosmetics (Arad 
and Levy-Ontman 2010; Rajasulochana and Preethy 2015). The algae produced 
in this thesis were cultivated in closed photobioreactors (Tredici et al. 2011; 
Chini Zittelli et al. 2013a,b) in semi-batch mode. Closed photobioreactors can 
be defined as culture systems where most of the light has to across the reactor 
walls before arriving at the cells. In this way, it decrease the possibility of 
contamination by other organisms, it can ensure greater control of the culture 
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and it can optimize the production process. To obtain high performance it is 
necessary to optimize the constructive criteria such as the Is/V (Illuminated 
surface/Volume) ratio, which determines the amount of light that enters within 
the system per unit of volume (Tredici, 2004). These photobioreactors can 
produce biomass with natural and artificial light, making possible the 
production of biomass throughout the year, and at all latitudes even if they are 
characterized by a fairly high cost. Thanks to the production of a high-quality 
biomass, such as Nannochloropsis (Chini Zittelli et al., 2003; Rodolfi et al., 
2003; Freire et al., 2016) Tetraselmis (Moheimani, 2013) and Isochrysis (Thu et 
al., 2015) they are successfully used in aquaculture. Photobioreactors can be 
classified according to their design in: (i) flat or tubular; ii) horizontal, inclined, 
vertical or spiral; iii) manifold or serpentine; iv) hybrid; v) floating; vi) biofilm 
reactors.  
The reactors used for the cultivation of strains in the present thesis were of the 
flat panel type. The photobioreactor used is denominated "Green Wall Panel" 
(GWP
®
), characterized by a good scalability at the industrial level and by a low 
cost of realization and management. The first Green Wall Panel type (GWP
®
-I, 
Fig. 3 left, Tredici and Rodolfi, 2004) was followed by the second model, the 
GWP
®
-II (Fig. 3 center) (Tredici et al., 2011), characterized by a greater 
simplicity of construction and easiness of operation and by the third model the 
GWP
®
-III (Tredici, 2016) (Fig. 3 right). 
 
 
 
Figure 3 Green Wall Panel (GWP
®
) photobioreactors: GWP
®
-I (left), GWP
®
-II 
(center), GWP
®
-III (right) 
Source: Website Fotosintetica & Microbiologica S.r.l., 2016 
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1.2 Microalgae as new foods and nutraceuticals 
1.2.1 Definition of “food” and “nutraceutical”  
FAO defines “food” any substance consumed to provide nutritional support for 
the body (http://www.fao.org/home/en/). 
The term “nutraceutical” is derived from “nutrition” and “pharmaceutical”. 
Therefore, nutraceuticals may be defined as “natural bioactive, chemical 
compounds that have health promoting, disease preventing or medicinal 
properties” (Sawalha, 2014). Nutraceuticals products may include isolated 
nutrients, dietary supplements, nutritious biomass, herbal products, genetically 
modified food, fortified foods with essential vitamins, minerals, amino acids, 
antioxidants, essential fatty acids and high value-added bioactive molecules. A 
nutraceutical product is expected to possess specific health benefits, due to the 
presence of either antioxidant compounds, signalling-pathway modulators or 
other bioactive molecules (Saha et al., 2015). 
The term “dietary supplements” are defined as any product that can be taken by 
mouth that contains an ingredient intended to supplement a diet. Dietary 
ingredients in these products may include vitamins, minerals, herbs, amino 
acids, and substances such as enzymes, organ tissues, and metabolites (Website 
Frost and Sullivan, 2011). “Functional foods and beverages” are similar in 
appearance to, or may be a conventional food and beverages that are consumed 
as part of the usual diet, and is demonstrated to have physiological benefits 
and/or reduce the risk of chronic disease beyond basic nutritional functions. 
These products help to prevent a disease or compromised health condition 
and/or to improve physical or mental performance (Website Frost and Sullivan, 
2011). Moreover, terms such as “dietary supplements”, “food supplements”, 
“foods for special dietary use”, “foods for specific health use” and “health 
foods” differentially classify nutraceuticals in the United States, the European 
Union, India, Japan and China, respectively (Table 1) (Website Frost & 
Sullivan, 2011). 
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Table 1 Varying definitions and regulations for nutraceuticals around the world 
Country Given label Definition Regulating body 
United 
States                          
of America 
Dietary 
supplements 
Any of the following which have a 
beneficial nutritional effects 
- Vitamins 
- Minerals 
- Botanicals and their extracts 
- Aminoacids 
- Concentrates and extracts 
Food and Drug 
Authority  
(Website FDA, 
2016) 
European 
Union 
Food 
supplements 
- Concentrated sources of nutrients 
- Other substances with a 
beneficial nutritional effect 
Europe and Food 
Standard Safety 
Authority  
(Website EFSA, 
2016) 
India Food for 
special              
dietary use 
- Plants/botanicals: whole or 
extracts 
- Minerals, vitamins, aminoacids, 
enzymes 
- Substances of animal origin  
Food Safety and 
Standards Act 
(Website FSSAI, 
2015) 
Japan Foods for 
specific  
health use 
Any food that can provide and/or 
supplement any of the following 
- Nutrition 
- Sensory satisfaction  
- Beneficial physiological effect 
Japan Health and 
Nutrition Food 
Association 
(Website 
MHLWJ, 2016 ) 
China Health foods Any food that: 
- Should be suitable for specific 
group(s) of people 
- Should also be able to adjust 
body functions and 
- Should not aim at curing diseases  
State Food and 
Drug 
Administration 
(Website CFDA, 
2016) 
 
Adapted from Website Frost & Sullivan, 2011 
 
1.2.2 Microalgae as a source of food 
Microalgae are an enormous biological resource in terms of biodiversity, 
representing one of the most promising microbial groups for new products and 
applications (Pulz and Gross, 2004). They can be used to enhance the nutritional 
value of food and animal feed, due to their well-balanced chemical composition. 
Moreover, they are cultivated as a source of highly valuable molecules such as 
polyunsaturated fatty acids, pigments, antioxidants, pharmaceuticals and other 
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biologically active compounds. The application of microalgal biomass and/or 
metabolites is an interesting and innovative approach for the development of 
healthier food products (Gouveia et al., 2008b). 
The use of micro- and macroalgae as food is known since centuries (Powell et 
al., 1962; Mabeau and Fleurence, 1993) and even today they are used in a 
variety of commercial products with many more in development (Griffiths et 
al., 2016).  
Macroalgae, including Porphyra, Enteromorpha intestinalis, Laminaria 
japonica, Undaria pinnatifida and Monostroma nitidum, are common 
components in the diets of many people, especially from the Atlantic Europe 
and Asia (Becker, 2004). In Scandinavia and Scotland, Rhodymenia palmata is 
frequently collected and used for food purposes, while in India is prepared a 
soup made by Gracilaria (Krauss, 1962). 
Various indigenous people use cyanobacteria such as Arthrospira and Nostoc 
grown in nature, to integrate poor diets poor in proteins, vitamins and minerals. 
For example the Kanembou in Chad collect spirulina in natural lakes, where 
special conditions of pH and salinity create a monoalgal bloom (Abdulqader et 
al., 2000). In Myanmar, the natural blooms of Arthrospira occur in small 
volcanic basins in some periods of the year, are collected, subjected to simple 
processing and consumed as food (Potts, 2000). The Klamath Lake in Oregon 
(USA), is known for the exploitation of seasonal blooms of Aphanizomenon 
flos-aquae. From this cyanobacterium is obtained a dietary supplement 
consumed in the United States and since 15 years it is also known in Europe 
(Hu, 2004). In Asia Nostoc (a filamentous cyanobacterium) is collected from 
arid environments to be used as a ritual food (Potts, 2000). 
The microalgae cultivation at large-scale started in around 1940 thanks to new 
knowledge about biotechnology and the demand for microalgae from 
aquaculture world (Vonshak, 1996). Starting from 1950, microalgae have been 
investigated for the production of protein-rich biomass for supplying the 
overpopulated areas of the planet (Spoehr, 1951). Only with the first 
experiments aimed to evaluate the acceptability and the digestibility of the algae 
there were the first concerns about their use as the unique source of food. 
Powell et al. (1962) at the conclusion of their study carried out on men that had 
been fed with large amounts of Chlorella and Scenedesmus, verified that high 
quantities of microalgae in diets (> 100 g day
-1
) can give digestive and nutrient 
absorption problems. Therefore, microalgae for human consumption should be 
considered more as a food supplement and not as a food to be consumed as the 
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only portion of a diet. Gross et al. (1978) noted a considerable increase in 
weight in infants fed with small doses of Scenedesmus sp. (10 g day
-1
), 
integrated to the normal food ration, attributing this increase in weight to the 
higher protein intake than children fed without microalgae.  
Numerous combinations of microalgae or mixtures with other health foods can 
be found in the market in the form of tablets, powders, capsules and pastilles as 
nutritional supplements (Gouveia et al., 2008b) (Fig. 4).  
 
 
Figure 4 Tablets, powders, capsules, and pastilles from microalgae 
Adapted from Webiste e-sportshop.cz; Website Ankit Pulps & Boards Pvt. Ltd.; 
Website Spirulina Powder; Website GKwell 
 
They can also be incorporated into food products (e.g. pastas, biscuits, bread, 
snack foods, candies, yoghurts, soft drinks), providing health-promoting effects 
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that are associated with microalgal biomass, probably related to a general 
immune-modulating effect (Gouveia et al., 2008b) (Fig. 5).  
 
 
Figure 5 Products with different microalgal biomasses: biscuits (a), pasta (b), 
bread (c) 
Adapted from Gouveia et al., 2008b; Fradique et al., 2010; Webiste Culinary 
Pen; Website AlgiTect; Webiste Gourmetmom 
 
1.2.3 Microalgae as a source of nutraceuticals 
The potential of microalgae to offer a competitive commercial alternative 
source of nutraceuticals is a reality (Table 2).  
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Table 2 Nutraceutical products, divided into 11 categories with typical 
commercial products outlined 
Nutraceutical category Example 
Amino acid and              
(poly)-peptide 
Arginine, bioactive peptides, digestive enzymes, 
glutamate, immunoglobulins, isoleucine, 
lactoferrin, leucine, lysine, valine 
Fibres β-glucan, digestion resistant starch and 
maltodextrin, gum, insoluble fibre, inulin, pectin, 
polydextrose 
Mineral Calcium, iron, magnesium, potassium, selenium, 
sodium, zinc 
Phytochemical Isoflavone, isothiocyanate, lignan, phytosterol, 
polyphenol, tocotrienol 
Pigment and carotenoid Astaxanthin, β-carotene, lutein, lycopene, 
zeaxanthin 
Polyol Isomalt, lactitol, maltitol, xylitol 
Polyunsaturated fatty acid Arachidonic acid, conjugated linoleic acid, 
docosahexaenoic acid, eicosapentaenoic acid, γ-
linoleic acid 
Prebiotic Fructooligosaccharides, glucooligosaccharides, 
inulin, polydextrose, soya bean oligosaccharides, 
xylooligosaccharides 
Probiotic Living organisms and/or bacterial cultures 
Vitamin A, B1, B2, B6, B12, Biotin, C, D, E, Folic acid, 
K, niacin, pantothenic acid 
No set category Chondroitin, coenzyme Q10, glucosamin, inositol, 
lipoic acid 
Source: Saha et al., 2015 
 
Microalgae are used for different purposes in the field of human nutrition, the 
largest of which, in quantitative terms is probably the use as protein 
supplements (from Arthrospira, Aphanizomenon, Chlorella) and carotenoids (β-
carotene from Dunaliella and astaxanthin from Haematococcus) (Becker, 2004; 
Koller et al., 2014). 
Cyanobacteria contain β-carotene (80% of total carotenoids) as the major 
carotenoid, followed by zeaxanthin, while the richest commercial source of β-
carotene is the green microalga Dunaliella salina (Sajilata et al., 2008; Gateau 
General introduction 
15                                                                                                                                            
et al., 2016). Haematococcus pluvialis, a green microalga, is the richest known 
natural source of carotenoid astaxanthin, which has antioxidant activities much 
higher than β-carotene and vitamin E (Kang et al., 2007). From a commercial 
point of view, microalgal carotenoids have long been used as natural colouring 
materials. Aquatic feed containing β-carotene is known to enhance the flesh 
colour of salmon. Fowl feed enriched in β-carotene is also used to enhance the 
colour and appeal of egg yolks and, overall, enhance the nutritional and health 
benefit of the egg. β-carotene incorporated into feed has also been reported to 
contribute to the improved health and fertility of cattle (Thajuddin & 
Subramanian, 2005). Carotenoids have also been reported to be physiologically 
important to a variety of metabolic functions in humans. One molecule of β-
carotene can be enzymatically converted into two molecules of vitamin A 
within the body. This leads to all the health benefits of vitamin A being 
acquired, such as improved eyesight, enhanced immune response, and the 
protection against certain cancers through the vitamin’s ability to scavenge 
damaging free radicals (Paiva & Russell, 1999; Bowen et al., 2015). 
The lipid content of microalgae is variable among the species and in the same 
species according to the method of cultivation, and in special cases may also 
reach 60% of the dry weight of the cell (Rodolfi et al., 2009). The microalgal 
fatty acids are typically composed of carbon chains from C12 to C20 (saturated 
or with varying degrees of unsaturation) (Becker, 2004). The fatty acids that 
have more influence on the quality of microalgal biomass are eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA). It is recommended a daily 
assumption of EPA and DHA of approximately 100-150 mg day
-1
 for children 
of 2-4 years and 200-250 mg day
-1
 for children of 6-10 years. For pregnant and 
lactating women the daily assumption should be up to 0.3 g day
-1
 (FAO, 2010). 
Studies have determined that DHA is one of the major fatty acids of the brain 
and retina. DHA has been referred to as an IQ-associated fatty acid, due to its 
involvement with brain development and functioning throughout life, especially 
in relation to visual and cognitive development (Auestad et al., 2003). Studies 
have also shown that EPA and DHA assist in the prevention of coronary heart 
disease, stroke, hypertension, dementia, Alzheimer’s and depression (Kris-
Etherton et al., 2002; Ruxton et al., 2005; Swanson et al., 2012; Das, 2008; 
Ryckebosh et al., 2014). Recognized microalgal sources of essential fatty acids 
are: the cyanobacterium Arthrospira platensis for γ-linolenic acid (GLA); the 
red microalga Porphyridium sp. for arachidonic acid (ARA); the dinoflagellate 
microalga Crypthecodinium cohnii and the heterotrophic microalga 
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Schizochytrium sp. (Spolaore et al., 2006), and the microalga Isochrysis galbana 
for DHA (Alonso et al., 1992; Molino Grima et al., 1992); the green microalga 
Nannochloropsis spp. and the diatoms Phaeodactylum tricornutum and 
Nitzschia sp. for EPA (Spolaore et al., 2006). GLA is one of the essential ω-6 
fatty acids that help to lower low-density lipoprotein in hypocholesteromic 
patients. It relieves from symptoms of pre-menstrual syndrome and helps in 
treating atopic eczema. It has pro-inflammatory and anti-inflammatory 
properties (Gang-Guk et al., 2008). ARA is a biogenetic precursor of 
prostaglandin and leucotrienes, which play major roles in circulatory and central 
nervous systems. It is important for visual sharpness and valuable ingredient in 
baby food formulations (Pratoomyot et al., 2005). 
The high protein content (even >70%) of many microalgal biomasses is one of 
the main features that leads to consider these microorganisms as a promising 
unconventional source of proteins (Lupatini et al., 2016). Many algal biomasses 
have a high protein quality, especially in relation to the composition and 
digestibility of amino acids (Becker, 2004). Some microalgal species have a 
higher content of sulfur amino acids (methionine and cysteine), essential amino 
acids that must be integrated with the diet, compared to conventional vegetable 
protein sources (Giordano and Prioretti, 2016). Over five decades ago, 
Chlorella and Arthrospria were recommended for human and animal dietary 
consumption (Saha et al., 2015). Microalgal proteins favourably compare to 
conventional vegetable proteins in terms of their nutritional attributes and 
digestibility. In 1973, the WHO/FAO recommended microalgae consumption 
based on the balance of their essential amino acids (Becker, 2007). Ten amino 
acids: including arginine, histidine, isoleucine, leucine, lysine, methionine, 
phenylalanine, threonine, tryptophan, and valine are considered as essential for 
human and animal nutrition (Saha et al., 2015). Interestingly, all these ten 
essential amino acids can be sourced from microalgae protein derived from 
Chlorella vulgaris, Dunaliella bardawil, Scenedesmus obliquus, Arthrospira 
maxima and Arthrospira platensis. Of commercial interest is the fact that the 
market for algal protein has started to develop over the last five years, as 
scientific studies reporting on the nutritional, functional and nutraceutical 
properties of algal proteins have increased (Saha et al., 2015). 
Microalgae contain an array of vitamins including A, B1, B2, B3 (Niacin), B6, 
B12, C, E, folic acid and pantothenic acid, which have been reported to be 
present at high levels compared with most routine foods (Becker, 2004). The 
water soluble B-complex vitamins have wide-ranging functions that ultimately 
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facilitate the processes involved in yielding energy from carbohydrates. B-
complex vitamins are essential for healthy skin, hair, eyes, and the proper 
functioning of the liver and nervous systems. Arthrospira platensis, Chlorella 
pyrenoidoisa and Scenedesmus quadricauda are among the richest sources of A, 
E, B1, Vit B2, B3, B6, folic acid, B12, C and pantothenic acid vitamins 
(Becker, 2004). A diet or supplement containing biomass from a combination of 
carefully selected microalgal species could provide vitamins of high bio-
availability (Saha et al., 2015). 
Microalgae compounds are also recognised as hypotensive, immunomodulatory 
and antiproliferative (Saha et al., 2015). Hypertension is a controllable risk 
factor associated with cardiovascular disease, and the renin-angiotensin-
aldosterone system is a target for blood pressure control (FitzGerald et al., 
2004). Cleavage of angiotensinogen by renin produces angiotensin I, which is 
subsequently hydrolyzed by angiotensin-I-converting enzyme (ACE) to 
angiotensin II (a potent vasoconstrictor). Research has demonstrated that the 
ACE enzyme is subject to inhibition by peptides possessing the appropriate 
amino acid sequence. Several peptides from Chlorella vulgaris were reported to 
possess angiotensin I-converting enzyme (ACE) inhibitory activities (Suetsuna 
and Chen, 2001). Also, peptides from Arthrospira platensis were reported to 
show ACE-I inhibitory activities (Suetsuna and Chen, 2001). In some instances, 
ACE-I inhibitory compounds may also act as immunomodulators, as the 
inhibition of ACE results in the formation of bradykinin, which mediates the 
acute inflammatory process (FitzGerald et al., 2004). Chicken and mice fed 
Arthrospira biomass demonstrated increased phagocytic activity and increased 
natural killer cell-mediated antitumor activities (Singh et al., 2011). In vitro 
studies with human blood cells incubated with Arthrospira extracts showed 
elevated interferon (13.6-fold) and interleukin (IL)-1β and IL-4 (three-fold) 
levels (Singh et al., 2011). Other studies with cyanobacterial extracts containing 
microcystin demonstrated enhanced murine immunosuppressive activities and 
cytokine modulation in vivo (Singh et al., 2011). A murine in vivo study 
demonstrated that extracellular sulphated polysaccharides from Porphyridium 
cruentum showed both immune enhancing activity and the inhibition of S180 
tumour cell proliferation (Sun et al., 2012). The peptide VECYGPNRPQF, 
derived from protein hydrolysates of Chlorella vulgaris, was also found to 
possess anti-proliferative activities (Sheih et al., 2010). A recent review (Wu et 
al., 2016) investigated immunomodulatory, and anti-inflammatory activities of 
Arthrospira in both animals and humans, along with the underlying 
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mechanisms. Arthrospira activates cellular antioxidant enzymes, inhibits lipid 
peroxidation and DNA damage, scavenges free radicals, and increases the 
activity of superoxide dismutase and catalase. Clinical trials show that 
Arthrospira prevents skeletal muscle damage under conditions of exercise-
induced oxidative stress and can stimulate the production of antibodies and up- 
or downregulate the expression of cytokine-encoding genes to induce 
immunomodulatory and anti-inflammatory responses. The molecular 
mechanism(s) by which Arthrospira induces these activities is unclear, but 
phycocyanin and β-carotene are important molecules. Moreover, Spirulina 
effectively regulates the ERK1/2, JNK, p38, and IκB pathways (Wu et al., 
2016). 
Plant-based functional foods, containing sterols and fibres, are widely 
recommended as an alternative non-pharmacological approach to lower plasma 
cholesterol levels. A study with hypercholesterolemic patients showed a 
reduction in cholesterol and improved lipid profiles following a Arthrospira 
feeding trial (Ramamoorthy and Premakumari, 1996). A cholesterol-lowering 
activity was also reported in hamsters following a feeding trial with Chlorella 
pyrenoidosa biomass powder (Cherng and Shih, 2005). It was proposed that 
water-soluble fibres, vegetable protein, phospholipids, Vitamin C, Vitamin E 
and β-carotene were the possible active ingredients involved. Of note is that the 
ratio of arginine to lysine for Chlorella protein is deemed better than proteins 
from soya bean. Plant proteins with low lysine contents have been reported as 
advantageous towards lowering serum cholesterol levels (Cherng and Shih, 
2005). A hypothesis was also proposed from a separate study that the Advanced 
Glycation End product-inhibitory property of Chlorella prevents atherosclerosis 
in vivo (Yamagishi et al., 2005). 
The extraction of multiple high value-added biomolecules from microalgal 
biomass may promote a more sustainable, cost-effective process, leading to the 
better utilization of microalgae (Draaisma et al., 2013; Website Frost and 
Sullivan, 2011). 
1.2.4 Microalgae authorised as food and producing companies 
Arthrospira platensis, Chlorella luteoviridis, Chlorella pyrenoidosa, Chlorella 
vulgaris and Aphanizomenon flos-aquae from Klamath Lake (Oregon, USA) 
were used prior to May 1997 in Europe and thus are authorized as food in 
Europe (Website European Union, Novel Food catalogue). Odontella aurita 
was authorized successively (European Union, 2005) and, in 2014, also the 
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chlorophyta Tetraselmis chuii was approved as food, following the application 
by the Spanish company Fitoplancton Marino S.L. (AESAN, 2013; AECOSAN, 
2014). Astaxanthin from Haematococcus pluvialis was recently authorized 
(EFSA 2014). To be used as new food, with the exception of the microalgae 
already cited, microalgae and cyanobacteria have to follow the novel food 
regulation (European Union, 2015). In the United States, C. protothecoides, A. 
platensis, Dunaliella bardawil, and astaxanthin from Haematococcus are 
included in the GRAS list (FDA, GRAS Notices). In Australia, all Chlorella 
(including C. sorokiniana) and Arthrospira species and derivatives for which a 
novel food application was submitted have been so far considered as traditional 
food, whereas A. flos-aquae was considered as novel food and safety 
assessment was required due to the potential presence of cyanobacterial toxins 
such as microcystins and nodularin (FSANZ, 2016; Niccolai et al., 2016). 
In the field of human nutrition microalgae are marketed in different forms, 
principally tablets, capsules and liquids (Griffiths et al., 2016). They can also be 
incorporated into pastas, beverages, snacks, and candies (Gouveia et al., 2008a). 
Thanks to their different chemical properties, they can act as a nutritional 
supplement or represent a source of natural food colorants (de Jesus Raposo et 
al., 2013). The microalgae commercial production is dominated by four strains: 
Arthrospira, Chlorella, Dunaliella salina and Aphanizomenon flos-aquae 
(Table 3). 
 
Table 3 Present state of microalgae production 
 
Adapted from Spolaore et al., 2006; Gouveia et al., 2008b; and Norsker                  
et al., 2011 
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A significant amount of Arthrospira is produced in China and India. The 
world’s largest producer of algal powder (200 t/year) is Hainan Simai 
Enterprising Ltd. located in the Hainan province of China (Priyadarshani and 
Rath, 2012). The largest plant in the world is owned by Earthrise Farms (located 
at Calipatria, CA, USA) and covers an area of 440,000 m
2
 (Sastre, 2013). 
Earthrise Farms produces Arthrospira-based tablets and powder that are 
distributed in more than 20 countries around the world (Earthrise LLC, 
http://www.earthrise.com/). Moreover, other smaller companies sell a large 
variety of nutraceuticals products made from Arthrospira. The Myanmar 
Spirulina Factory (Yangon, Myanmar) sells tablets, chips, pasta and liquid 
extract, and Cyanotech Corp. (a plant in Kona, Hawaii, USA) produces products 
ranging from pure powder to packaged bottles under the name Spirulina 
pacifica (Cyanotech Corp., http://www.cyanotech.com/). In Brazil, the Olson 
Microalgas Macronutrição company (Camaquã, Rio Grande do Sul) produces 
Spirulina sp. LEB 18 capsules for sale as a dietary supplement (Olson Ltda, 
http://www.olson.com.br/). In 2005, the production value (in terms of annual 
turnover) of Arthrospira was equal to 40 million US $ (Table 4). Chlorella is 
produced by more than 70 companies. Taiwan Chlorella Manufacturing and Co. 
(Taipei, Taiwan) is the largest producer of dried biomass (400 t) (Taiwan 
Chlorella Manufacturing & Co., LTD, http://www.taiwanchlorella.com/). A 
significant production is also achieved by Algomed in Klötze, Germany (130 – 
150 t dry biomass per year) with tubular photobioreactors (Roquette Klötze 
GmbH & Co. KG, http://www.algomed.de/). In 2006, the production value (in 
terms of annual turnover) of Chlorella was equal to 38 million US $ (Table 4). 
D. salina is exploited for its β-carotene content that can reach 12% of dry 
weight (Del Campo et al., 2007). For human consumption, Cognis Nutrition and 
Health (Cognis Nutrition and Health Ltd, http://www.cognis.com/), the world’s 
largest producer of this strain, offers Dunaliella powder as ingredient in dietary 
supplements and functional foods. In 2013, the market value of β-carotene from 
D. salina was 270 million US $ (Rodríguez, 2014). In 1998, A. flos-aquae from 
Klamath Lake, mainly commercialized in forms of capsules, crystals or powders 
for human consumption was estimated to have a market value equal to 100 
million US $ (Charmicael et al., 2000). 
In 2004, the production value (in term of annual turnover) of ω-3 fatty acids 
was estimated to be 300 million US $, followed by astaxanthin, mainly 
extracted from H. pluvialis (10 million US $ estimated in 2004). Alternative 
sources of β-carotene and phycobiliprotein (including phycocyanin) assumed 
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another importance value in microalgae-based products market (285 US $ 
estimated in 2012 and 50 million US $ estimated in 2004, respectively) (Vigani 
et al., 2015, Table 4). 
 
Table 4 Market figures of microalgae-based products. 
Microalgae-based product  Number of 
producers 
Production value 
(annual turnover, 
mio US $) 
Production value of 
alternative sources  
(annual turnover, 
mio US $) 
Whole dryed microalgae:     
Arthrospira  15 40 (2005) no alternative 
Chlorella  70 38 (2006) no alternative 
High-value molecules:     
Astaxanthin  8 10 (2004) 200 (2004) 
Phycobiliprotein  
(incl. phycocyanin)  
2 na 50 (2004) 
ω-3 fatty acids  4 300 (2004) 14390 (2009) 
β-carotene  10 na 285 (2012) 
na: not available, mio: millions 
Note: In brackets the year for which the estimation was done 
Source: Enzing et al., 2014  
 
1.3 Overview of international food regulatory procedures 
To provide a general overview of major international approaches to the 
regulation of novel foods/ingredients and nutritive substances, the regulatory 
frameworks in the European Union (EU), the United States of America (USA), 
Canada, Australia and New Zealand are described. 
1.3.1 European Union 
The legislation for the authorisation and use of novel foods and novel 
ingredients in the EU consists of two regulations:  
 Regulation (EC) No 258/97 of the European Parliament and of the 
Council concerning novel foods and novel food ingredients (European 
Union, 1997); 
 Commission Regulation (EC) No 1852/2001 laying down detailed rules 
for making certain information available to the public and for the 
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protection of information submitted pursuant to European Parliament 
and Council Regulation (EC) No 258/97 (European Union, 2001).  
The Regulation (EC) No 258/97 was adopted in 1997 and applies to the placing 
on the market within the Community of foods and/or food ingredients which 
have not yet been used for human consumption to a significant degree within 
the Community. This Regulation includes foods and food ingredients:  
 with a new or intentionally modified primary molecular structure;  
 that consist of or are isolated from microorganisms, such as fungi or 
algae;  
 that consist of or are isolated from plants and food ingredients isolated 
from animals;  
 whose nutritional value, metabolism or level of undesirable substances 
has been significantly changed by the production process.  
The Regulation was not applicable to food additives, flavourings or extraction 
solvents. Food additives are substances added intentionally to foodstuffs to 
perform certain technological functions, for example to colour, to sweeten or to 
help preserve foods. In the European Union all food additives are identified by 
an E number. The most common additives to appear on food labels are 
antioxidants (to prevent deterioration caused by oxidation), colours, emulsifiers, 
stabilisers, gelling agents and thickeners, preservatives and sweeteners (Website 
EFSA, Food Additives). 
The general criteria applied to novel foods and ingredients are that they must 
not: 
 mislead the consumer;  
 present a danger for the consumer; 
 differ from foods or food ingredients which they are intended to replace 
to such an extent that their normal consumption would be nutritionally 
disadvantageous for the consumer.  
In Fig. 6 the premarket authorisation process applied to novel foods and novel 
food ingredients is illustrated. 
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Figure 6 Premarket authorisation process applied to novel foods and novel food 
ingredients in the EU 
 
The approval to market of the novel food or novel food ingredient is granted to 
the applicant (i.e. individual authorisation). However, another applicant may 
notify the European Commission the placing on the market of a food that is 
substantially equivalent to the authorised food; this notification must be 
substantiated by scientific evidence. 
In December 2013, the European Commission adopted a proposal for a 
Regulation of the European Parliament and of the Council on novel foods 
(Website European Union, Novel Foods). In November 2015, the Regulation 
(EU) 2015/2283 of the European Parliament and of the Council of 25 November 
2015 on novel foods, amended Regulation (EU) No 1169/2011 of the European 
Parliament and of the Council and repealed Regulation (EC) No 258/97 of the 
European Parliament and of the Council and Commission Regulation (EC) No 
1852/2001 (OJ L 327, 11.12.2015, pp. 1-22). The Regulation aims to ensure 
food safety and protection of public health, and to secure the functioning of the 
internal market for food, while supporting innovation for the food sector 
(European Union, 2015). 
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The same general criteria currently applied to novel foods and ingredients are 
applicable to the replacement regulation: such foods and ingredients should be 
safe; their use should not mislead the consumer; and where a novel food is 
intended to replace another food, it should not differ from that food in a way 
that would be nutritionally less advantageous for the consumer.  
The Regulation provides a simplified procedure for the pre-market approval of 
novel foods and novel food ingredients. Identified key changes are:  
 centralised EU-level procedure that separates risk assessment and risk 
management; all applications are submitted to the European 
Commission directly, rather than through individual EU member states 
as per the current arrangements; 
 the definitions (e.g. of novel food) are clarified and updated, although 
the 1997 cut-off date will remain; 
 individual authorisations are replaced with generic authorisations, 
removing the current procedure based on substantial equivalence;  
 the applicant can be a Consortium; 
 a simplified process for ‘traditional foods from third countries’ that is 
more proportionate to risk. In this case, if a history of safe food use in a 
third country for at least 25 years can be demonstrated by an applicant, 
and if member states or EFSA do not present reasoned safety 
objections, the food may be added to the EU list of novel foods (and 
can be sold on the EU market). If reasoned safety objections are 
presented, EFSA will conduct an assessment and the standard novel 
food authorisation procedure will be followed (with shorter deadlines). 
A cut-off date is an objective parameter that can provide a clear beginning point 
in determining whether a food or substance is subject to particular legislative 
requirements. However, not all foods are likely to require regulatory pre-market 
assessment and a cut-off date requires supporting criteria to determine which 
new foods should be subject to additional regulation. The EU definition of 
novel food does provide some additional clarification. The Regulation of novel 
foods in the EU introduces a simplified process for “traditional foods from third 
countries”, whereby establishing a history of safe use of a food may be 
sufficient to establish the safety of consumption by the food in the general 
population (FSANZ, Supporting document 4). 
 
General introduction 
25                                                                                                                                            
1.3.2 United States of America 
In the USA, the term “food additive means any substance the intended use of 
which results…, directly or indirectly, in its becoming a component or 
otherwise affecting the characteristics of… food” (Federal Food, Drug, And 
Cosmetic Act, Section 201). Food additives (that do not include substances 
generally recognized as safe (GRAS), substances used prior to January 1958, 
and those included in the exemptions of the Federal Food, Drug, and Cosmetic 
Act), require pre-market approval aimed at demonstrating safety under the 
intended conditions of use. The Food and Drug Administration (FDA) issues 
regulations, based on data submitted through petitions or obtained by its own 
initiative, specifying the conditions under which an additive has been 
demonstrated to be safe and, therefore, may be lawfully used (FDA 2014) 
(Niccolai et al., 2016). 
 
 
Figure 7 Premarket approval process applied to food additive in the USA 
  
Food businesses can commission a panel of experts to assess the GRAS status 
of a substance. A food business is not obliged to notify the FDA of its intention 
to market a GRAS substance; however they can do so if they wish. Upon receipt 
of a GRAS notification, the USFDA will provide an indication of whether the 
basis of the GRAS determination appears reasonable or not. While not a 
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decision, or full assessment, by the USFDA, this response provides an 
indication of the quality of the GRAS assessment undertaken by the food 
business. These USFDA responses are publicly accessible and a list of GRAS 
notifications is maintained on the USFDA website. 
Some published reviews of the GRAS system, noting that industry does not 
have to notify the USFDA of a GRAS determination, have expressed concern 
about the lack of transparency associated with these assessments of safety that 
result in an industry GRAS determination without the oversight of the USFDA.  
Although a food additive may have GRAS status, the USFDA may at any time 
prohibit its use or conduct further studies to determine its safety if new evidence 
suggests that a product already in use may be unsafe or if consumption levels 
have changed (FSANZ, Supporting document 4). 
1.3.3 Canada 
In Canada, any foods sold must meet the requirements of the Food and Drugs 
Act (Website Canada’s Food and Drug Act) and the Food and Drug Regulations 
(Website Canada’s Food and Drug Regulations). 
Part B, Division 28 of the Food and Drug Regulations regulates novel foods. 
The regulations define “novel food” as:  
 a substance, including a microorganism, that does not have a history of 
safe use as a food;  
 a food that has been manufactured, prepared, preserved or packaged by 
a process that has not been previously applied to that food and causes 
the food to undergo a major change;  
 a food that is derived from a plant, animal or microorganism that has 
been genetically modified such that: the plant, animal or microorganism 
exhibits characteristics that were not previously observed in that plant, 
animal or microorganism; the plant, animal or microorganism no longer 
exhibits characteristics that were previously observed in that plant, animal 
or microorganism; one or more characteristics of the plant, animal or 
microorganism no longer fall within the anticipated range for that plant, 
animal or microorganism. 
Therefore, the Canadian “novel food” requirements apply to both novel and 
nutritive substances as regulated in the Food Standards Code. The approval 
process applied to novel food in the Canada is illustrated in Fig. 8. 
Health Canada assesses the safety of all genetically-modified and other novel 
foods proposed for sale in Canada. Companies are required to submit detailed 
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scientific data for review and approval by Health Canada, before such foods can 
be sold. The process (B28.002) requires the manufacturer to notify the Director 
in writing of their intention to sell or advertise for sale the novel food; and 
receive a written notice from the Director.  
 
 
Figure 8 Premarket approval process applied to novel food in Canada 
 
The Canadian novel food regulation shares some commonalities with the 
Code’s novel food standard (novel foods are prohibited and defined) and with 
the US GRAS notification system (notification to Health Canada and letter of 
no objection to petitioner (if acceptable).  
Health Canada has developed “Guidelines for the Safety Assessment of Novel 
Foods” (Website Safety Assessment of Novel Foods) which includes 
consideration of a history of safe use of a food in another country as part of the 
evidence to support the safety of a novel food. The guidelines set out the type of 
information that would be needed to support a claim that a product has a history 
of safe use. The Health Canada guidelines have been noted as an example of the 
type of information that industry would need to hold to demonstrate a history of 
safe use (FSANZ, Supporting document 4). 
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1.3.4 Australia and New Zealand  
The Food Standards Australia New Zealand (FSANZ) considers as novel food 
all non-traditional food or its derivatives and requires safety assessment 
(Commonwealth of Australia Gazette, 2007). The regulatory reforms present in 
Australia and New Zealand introduced to ensure the safety of novel foods have 
lead to the development and implementation of three standards addressing each 
of the innovations summarised in Table 5. 
 
Table 5 Standars for novel foods 
 Novel foods/food ingredients* 
Purpose Ensure that novel foods undergo a risk based safety 
assessment prior to introduction to the food supply 
Foods captured Non-traditional foods which there is insufficient 
knowledge in the broad community to enable safe use 
Key requirements Sale prohibited unless explicitly permitted  
Subject to pre-market and approval process 
Special conditions may apply (e.g. labelling, 
restrictions on sale)   
* Standard 1.5.1 novel foods, Australia New Zealand Food Standards Code. 
Source: adapted from Healy et al., 2003 
 
The authorisation process applied to novel foods in Australia New Zealand is 
illustrated in Fig. 9. A key requirement of the authorisation process has been a 
pre-market safety assessment and approval process to assess the potential health 
impacts of the novel foods and food produced using novel technologies in both 
the short and long term. It is also recognised that the general community may 
wish to exercise a choice as to whether or not to accept the use of novel 
technologies and the food produced using them. 
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Figure 9 Authorisation process applied to novel foods in Australia and         
New Zealand 
 
Currently, FSANZ, with the Proposal P1024 (Website FSANZ, Proposal 
P1024), is reviewing the requirements for novel food applications (Website 
Standards 1.5.1). The Proposal seeks to improve the regulation of nutritive 
substances and novel foods to ensure appropriate pre-market safety assessment 
of these foods before they are sold in Australia and New Zealand.  
 
In conclusion, despite microalgae and cyanobacteria are considered a potential 
source of functional foods and nutraceuticals thanks to their valuable and 
balanced biochemical composition, the use of these microorganisms as food 
ingredient is still poorly developed in Europe due to high cost, low demand and 
strict Novel Foods legislation.  
The enormous biodiversity of microalgae in nature and in culture collections 
still needs accurate evaluation in terms of quality and safety before 
exploitation. An accurate selection of the best microalgae and cyanobacteria is 
the starting point for the future development of microalgae-based products.  
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2. Aim of the thesis and structure of the work 
2.1 Aim of the thesis 
The general aim of the thesis project was to evaluate the suitability of some 
microalgal and cyanobacterial biomasses for the production of innovative foods 
and nutraceuticals. To evaluate their potential, selected microalgae and 
cyanobacteria were analysed in terms of biochemical composition, in vitro 
toxicity and in vitro digestibility. To enhance the in vitro digestibility, a 
sonication pre-treatment was also investigated. In order to evaluate the in vivo 
safety and the potential health effects of two promising strains (Arthrospira 
platensis F&M-C256 and Tisochrysis lutea F&M-M36), a sub-chronic in vivo 
study with rats was carried out. The two organisms were chosen for their 
balanced biochemical composition and content of particular pigments 
(phycocyanin and fucoxanthin), essential aminoacids, vitamins, and minerals. 
To explore the potential application of microalgae and cyanobacteria in baked 
foods, A. platensis F&M-C256, Chlorella vulgaris Allma, Tetraselmis suecica 
F&M-M33 and Phaeodactylum tricornutum F&M-M40-based biscuits were 
prepared and analysed in terms of sensory and physical properties, bioactivity 
and in vitro digestibility. 
In addition, to improve the acceptability of microalgae by the consumer in terms 
of organoleptic quality and digestibility, A. platensis F&M-C256 and 
Tetraselmis suecica F&M-M33 were fermented. The study focused on these 
two microalgae because A. platensis and Tetraselmis chuii are already approved 
by EU as food, and, therefore, the results obtained would possibly have an 
immediate applicability. 
2.2 Structure of the work 
Chapter 1, the introductive chapter, describes microalgae photosynthesis and 
cultivation, main microalgal taxa, and the possible applications of microalgae, 
especially in the food and nutraceutical fields. The food regulatory procedures 
in the European Union, United States of America, Canada, Australia and New 
Zealand are also reported. Chapter 2 reports the aim of the thesis and the 
structure of the work. 
To use microalgal biomass for food purposes, there is a need to determine 
certain characteristics. Of major importance: the presence of toxic substances 
and digestibility. Chapter 3 reports the results of the in vitro toxicity of 
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microalgal and cyanobacterial strains selected as a possible new food source. In 
addition, when the potential application of new matrices for the production of 
functional foods is being investigated, the study of the nutritive function and the 
evaluation of digestibility are fundamental. To this purpose, in Chapter 4 the 
biochemical composition and the in vitro digestibility of some selected strains 
are evaluated. 
Results obtained from in vitro models are preliminary and must be confirmed by 
in vivo studies on mammals with the use of the whole algal biomass. These pre-
screenings (Chapter 3 and 4) allow reducing the number of candidate strains to 
be selected for further in vivo studies on mammals that are necessary, in most 
cases, to fulfill the mandatory requirement of sub-chronic toxicity data for novel 
food applications in the European Union. To this purpose, in Chapters 5 and 6 
the potential toxic and health effects of Arthrospira platensis F&M-C256 and 
Tisochrysis lutea F&M-M36 in rats is reported. 
After the food safety assessment and the nutritional evaluations, in Chapter 7 is 
explored the potential application of microalgae as functional ingredients within 
conventional foods, e.g. cookies. Microalgae-based cookies are analysed for 
their sensory and physical properties, bioactivity and in vitro digestibility. 
In Chapter 8 the use of Lactobacillus plantarum to ferment Arthrospira 
platensis F&M-C256 and Tetraselmis suecica F&M-M33 biomasses, is 
reported. The study aimed at improving the acceptability of microalgae-based 
products in terms of organoleptic quality and digestibility, and to evaluate the 
potential application for the production of functional foods. 
In Chapter 9 a general discussion is reported, which analyses the prospects of 
microalgae as a possible source of innovative foods and nutraceuticals in the 
light of the results of the research. 
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Abstract 
The general objective of the present work was to evaluate the toxicity of 11 
microalgal strains and one natural bloom, selected as potential food or food 
ingredients due to their nutritional quality, in two models, human dermal 
fibroblasts and Artemia salina. Methanolic and aqueous extracts of the 
biomasses were tested on A. salina for 24 and 48 hours at concentrations up to 
12.5 g L
-1
 of extracted biomass. Only aqueous extracts were tested on 
fibroblasts for 24 hours.  
Chlorella vulgaris Roquette, C. vulgaris Allma, Tetraselmis suecica F&M-M33 
and Porphyridium purpureum F&M-M46 showed no toxicity towards A. salina 
and fibroblasts. Only Klamath powder was toxic to both models with all types 
of extracts. Tisochrysis lutea (T-ISO) F&M-M36, C. sorokiniana F&M-M49 
grown in BG11 and C. sorokinina IAM C-212 showed toxicity, even if to 
different extents, to fibroblasts, and only with the methanolic extract to A. 
salina. The remaining strains showed no toxicity towards A. salina, but were 
toxic to fibroblasts: A. platensis M2 and Nannochloropsis oceanica F&M-M24 
exhibited low toxicity, Nostoc sphaeroides F&M-C117 medium toxicity and 
Phaeodactylum tricornutum F&M-M40 high toxicity. Although in some cases 
the two models provided contrasting results, this work confirms their validity 
for preliminary screening of toxicity. The models are able to indicate organisms 
and substrates of potential toxicity and may well serve as guidelines for in vivo 
tests on mammals, which are necessary to apply for novel food in the EU. 
Keywords: Brine shrimp, bioassay, Fibroblasts, Toxicity, Microalgae, Food 
 
 
1. Introduction 
Microalgae (including cyanobacteria) are oxygenic photosynthetic 
microorganisms that have long been recognized as a potential source of food. 
The high potential of microalgae as food is due to their balanced biochemical 
composition and high nutritional value (Tredici et al. 2009). They can have a 
high protein content with a balanced amino acid composition (Becker 2007), a 
good content of vitamins, minerals, short polyunsaturated fatty acids, including 
linoleic and linolenic acids and long-chain polyunsaturated fatty acids such as 
docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids (Bishop and Zubeck 
2012; Batista et al. 2013). Some strains are also good sources of carotenoids 
In vitro toxicity of microalgal and cyanobacterial strains of interest as food source                                
 
47                               
like lutein, astaxanthin and β-carotene (Del Campo et al. 2007). Chlorella, 
Arthrospira, Dunaliella, and Haematococcus are microalgae largely employed 
for human consumption (Tredici et al. 2009; Ibañez and Cifuentes 2013). 
In the EU, novel foods and food ingredients are defined as those that "have not 
been used to a significant degree for human consumption within the Union 
before 15
th 
May 1997" (European Union 1997). With the Regulation (EC) No 
258/97 the European Union, through the European Food Safety Authority 
(EFSA), guarantees that novel foods and food ingredients are subject to a single 
safety assessment through a unified procedure in order to protect public health. 
Foods and food ingredients to be authorized must not present a danger for the 
consumer, mislead the consumer and differ from foods that they are intended to 
replace to such an extent that their normal consumption would be nutritionally 
disadvantageous for the consumer (European Union 1997). In the US, if a 
substance intended for food use is not generally recognized as safe (GRAS) and 
is not included in the exemptions, it is considered a food additive, i.e. a 
substance "becoming a component of food or otherwise affecting the 
characteristics of food" (US Congress 2016). Food additives require premarket 
approval aimed at demonstrating safety under the intended conditions of use. 
The Food and Drug Administration (FDA) issues regulations, based on data 
submitted through petitions or obtained by its own initiative, specifying the 
conditions under which an additive has been demonstrated to be safe and, 
therefore, may be lawfully used (FDA 2014). The GRAS standard requires the 
industry to provide scientific evidence that the substance is not harmful under 
its intended conditions of use and once certified exempts the substance from 
pre-market approval (FDA 2014). The Food Standards Australia New Zealand 
(FSANZ) considers as novel food all non-traditional food or its derivatives and 
requires safety assessment (Commonwealth of Australia Gazette, 2007). 
Currently, FSANZ is reviewing the requirements for novel food applications 
(Standards 1.5.1). Algae not listed in the Standards need approval as novel food 
and thus safety assessment (FSANZ, Proposal P1024).  
The microalgae used prior to May 1997 in Europe and thus authorized as food 
in the EU are: Aphanizomenon flos-aquae from Klamath Lake, Arthrospira 
platensis, Chlorella luteoviridis, Chlorella pyrenoidosa and Chlorella vulgaris 
(European Union, Novel Food catalogue). The diatom Odontella aurita was 
authorized successively (European Union 2005) and, in 2014, also Tetraselmis 
chuii was approved as food, following the application by the Spanish company 
Fitoplancton Marino S.L. (AESAN 2013; AECOSAN 2014). Astaxanthin from 
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Haematococcus pluvialis was also recently authorized (EFSA 2014). To be used 
as food, with the exception of the species mentioned above, microalgae have to 
follow the novel food regulation (European Union 2015). In the US, C. 
protothecoides, A. platensis, D. bardawil, and astaxanthin from Haematococcus 
are included in the GRAS list (FDA, GRAS Notices). In Australia, all Chlorella 
(including C. sorokiniana) and Arthrospira species and derivatives for which a 
novel food application was submitted have been so far considered as traditional 
food, whereas A. flos-aquae was considered as novel food and safety 
assessment was required due to the potential presence of cyanobacterial toxins 
such as microcystins and nodularin (FSANZ 2016). These approved microalgae 
(and microalgal products) represent a very small number of species compared to 
the high number present in nature, from 30,000 to 1 million according to 
different sources (Guiry 2012).  
In this work, we tested three strains/products belonging to species already 
approved as food in the EU (C. vulgaris, A. flos-aquae from Klamath Lake 
blooms, A. platensis), and two species not approved at present (C. sorokiniana 
and T. suecica), but belonging to genera of approved species.. Five other 
microalgae were also tested: Nostoc sphaeroides, an edible cyanobacterium 
consumed in China and other Asian countries (Han et al. 2013), Tisochrysis 
lutea, Nannochloropsis oceanica and Phaeodactylum tricornutum, widely used 
(as well as Tetraselmis spp.) in aquaculture (Tredici et al. 2009; Muller-Feuga 
2013) and Porphyridium purpureum, rich in EPA, but to date used only in 
cosmetics (Arad and Levy-Ontman 2010; Rajasulochana and Preethy 2015). 
These strains as well as the natural bloom were chosen for their high potential 
as food sources thanks to a high protein content (A. platensis M2, Klamath 
powder, N. sphaeroides F&M-C117, T. suecica F&M-M33, C. sorokiniana 
F&M-M49 and IAM C-212, C. vulgaris Allma and Roquette) or for their ability 
to produce high amounts of polyunsaturated fatty acids (N. oceanica F&M-
M24, P. tricornutum F&M-M40, P. purpureum F&M-M46, T. lutea F&M-
M36), besides having interesting amounts of protein. 
The first concern when proposing microalgae as food or food ingredients is to 
establish their lack of toxicity towards the consumer. In this regard, several 
species of different algal groups have been reported to produce neurotoxins, 
hepatotoxins, diarrheic toxins, dermotoxins, etc., which are usually active at 
very low doses (Landsberg 2002). Besides biotoxins, microalgae and 
cyanobacteria are able to produce other secondary metabolites (cytotoxins) that 
may have noxious effects on human health (Carmichael 1992; Tredici et al. 
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2009). Finally, it is to consider that also molecules that do not enter in the 
category of toxins (Carmichael 1992), can have toxic effects if provided at 
excessively high dosages. This concept provides the rational behind legislation, 
which requires that the toxicity data provided be related to the dose of the 
biomass/extract/component that is intended for use. 
Toxicity tests for novel food applications require time-consuming and 
expensive procedures. Moreover, the EU strongly encourages the “3Rs” 
principle (replacement, reduction and refinement) for sparing animals used for 
scientific purposes (European Union 2010). In vitro tests and bioassays on 
invertebrates have the advantage of being less expensive and shorter in duration, 
offering a simplified model for a preliminary screening to be used as a guideline 
for further in vivo studies. To determine microalgal toxicity (intended in all the 
meanings reported above), model organisms such as crustaceans (Artemia or 
Daphnia) are often used (Vezie et al. 1996; Guilhermino et al. 2000; Biondi et 
al. 2004). In this study, we adopted the brine shrimp (Artemia salina) assay, an 
easy and low-cost toxicity test (Solis et al. 1993; Piccardi et al. 2000). It is to 
note that, despite it targets a whole organism, the brine shrimp assay is 
considered by several authors as an in vitro test (Sleet and Brendel 1985; 
Lagarto Parra et al. 2001; Carballo et al. 2002). Besides invertebrates, toxicity is 
often evaluated on mammalian cells, mainly cancer cell lines (Jaki et al. 1999; 
Carballo et al. 2002; Hisem et al. 2011). Some authors report a good correlation 
between the toxic activity measured with brine shrimps and that observed with 
tumor cell lines (Anderson et al. 1991). Here, we report the toxicity of 13 
microalgal extracts on A. salina and on human fibroblasts in order to evaluate 
the potential health risks of these microbial strains if used as food or food 
ingredients. 
 
2. Materials and methods 
2.1 Experimental plan 
Microalgal biomasses were extracted in methanol and/or water and tested 
against normal human dermal fibroblasts (NHDF) and the nauplii of the 
crustacean Artemia salina to evaluate their potential toxicity. The experimental 
design is reported in Table 1. 
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Table 1. Plan of the experiments 
 Extracts Effect of salt 
 MeOH H2O  
Fibroblasts (NHDF)    
Artemia    
 
2.2 Microalgal strains and biomass production 
The algae tested are listed in Table 2. A positive reference extract was prepared 
from Nostoc sp. M1, known from previous experiments carried out in our 
laboratory to be strongly cytotoxic. A negative reference extract was also 
prepared using organic lettuce (Lactuca sativa var. capitata). 
 
Table 2. Algae and algal products selected for toxicity screening 
  Strain 
Type of culture 
medium 
Biomass obtention 
CYANOBACTERIA   
Arthrospira platensis M2 alkaline in-house cultivation 
Klamath powder fresh commercial product 
(Erbologica SAS) 
Nostoc sphaeroides F&M-C117 fresh in-house cultivation 
Nostoc sp. M1 fresh in-house cultivation 
CHLOROPHYTES   
Chlorella sorokiniana F&M-M49 fresh/marine in-house cultivation 
Chlorella sorokiniana IAM C-212 fresh in-house cultivation 
Chlorella vulgaris Roquette fresh commercial product 
(Roquette Frerès) 
Chlorella vulgaris Allma fresh commercial product 
(Allma Microalgae) 
Tetraselmis suecica F&M-M33 marine in-house cultivation 
RHODOPHYTES   
Porphyridium purpureum  
F&M-M46 
marine in-house cultivation 
DIATOMS   
Phaeodactylum tricornutum  
F&M-M40 
marine in-house cultivation 
HAPTOPHYTES   
Tisochrysis lutea (T-ISO)  
F&M-M36 
marine in-house cultivation 
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EUSTIGMATOPHYTES   
Nannochloropsis oceanica  
F&M-M24 
marine in-house cultivation 
 
Most of the tested microalgae were produced at the facilities of Fotosintetica & 
Microbiologica S.r.l. or of the Institute of Ecosystem Study of the CNR, both in 
Sesto Fiorentino, Florence. The algae were produced in GWP
®
-II 
photobioreactors (Tredici et al. 2011; Zittelli et al. 2013) in semi-batch mode 
and the biomasses were harvested by centrifugation, frozen, lyophilized and 
powdered. The powdered biomasses were stored at -20°C until use. Only A. 
plantesis M2 biomass was washed with physiological saline solution to remove 
extracellular sodium bicarbonate and carbonate before freezing. All the 
freshwater strains were cultivated in BG11 (Rippka et al 1979) and all the 
marine strains in F (Guillard and Ryther 1962) medium, while A. platensis was 
cultivated in Zarrouk medium (Zarrouk 1966). C. sorokiniana F&M-M49 was 
cultivated in both BG11 and F medium (Guccione et al. 2014). The F medium-
grown biomass (unwashed) was used to test the effect on fibroblasts of sea salt 
residues (see below). T. suecica F&M-M33 was grown in the standard F 
medium as well as in the same medium deprived of nitrogen to induce 
carbohydrate accumulation. C. vulgaris Allma (Allma Microalgae, Lisbon, 
Portugal), C. vulgaris Roquette (Roquette Frères, Lestrem, France) and Klamath 
powder (Erbologica SAS, Serina, Bergamo, Italy) are commercial products. 
Klamath powder is obtained from a natural bloom mainly composed of A. flos-
aquae, harvested from Upper Klamath Lake (Oregon, USA). 
2.3 In vitro cytotoxicity on human fibroblasts 
2.3.1 Preparation of microalgal extracts 
Lyophilized microalgae were suspended (25 g L
-1
) in Dulbecco's Modified 
Eagle Medium (DMEM) without phenol red and sonicated for two cycles of 3 
minutes in ice, followed by a 3 minutes resting interval by using an ultrasonic 
homogeniser (Sonopuls HD 2070, Bandelin Electronic, Berlin, Germany), set at 
100% power. Microalgal suspensions were then centrifuged for 15 minutes at 
15,000 x g at 4 °C, filtered through a 0.2 µm filter and stored at -20 °C. 
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2.3.2 Cell cultures 
Human dermal fibroblasts (N°CC-2509), kindly provided by Prof. Lisa 
Giovannelli (NEUROFARBA, University of Florence), were maintained in 
DMEM without phenol red, supplemented with 10% fetal bovine serum (FBS), 
glutamine (2 mM), penicillin (100 IU mL
-1
) and streptomycin (100 µg mL
-1
) in 
a humidified incubator at 37 °C under a 5% CO2 atmosphere. 
2.3.3 Determination of cytotoxic activity of microalgal aqueous extracts on 
human fibroblasts 
NHDF cells of passages 12-14 were seeded in 96-well plates (5 × 10
3
 per well), 
kept for 24 hours and then treated with microalgal extracts for 24 hours. The 
concentrations tested were 12.5, 5.0, 2.5 and 0.5 g of extracted biomass per liter 
for 24 hours. Viability analysis was performed using Cell Titer 96™ Aqueous 
One solution cell proliferation assay kit (Promega, Madison, WI, USA). At the 
end of the incubation period, the treated cells were exposed to Aqueous One 
solution (Giovannelli et al. 2014) and incubated for 2 hours at 37 °C. The 
product of the reaction was measured at 490 nm using a spectrophotometer 
(Multilabel Counter 1240 Victor 3, Perkin Elmer, Waltham, MA, USA). 
2.4 Effect of salt interference 
To evaluate the interference of marine salts on fibroblast viability, artificial 
seawater (Tropic Marine, Adriatic Sea Equipment & Co, Rimini, Italy) at a 
salinity of 60 g L
-1
 was used to prepare culture media for NHDF at different 
salinities, from 30 to 0.6 g L
-1
. The experiment was set up and performed as 
reported above for the algal extracts. To further verify the effect of the salts that 
may remain in the algal biomass after centrifugation, C. sorokiniana F&M-M49 
grown in freshwater and in seawater was extracted and tested as previously 
described. 
To quantify the salt content of the biomasses, ashes were determined by 
incineration in a muffle furnace at 450 °C. 
2.5 Determination of cytotoxic activity of microalgal extracts on A. salina 
2.5.1 Extraction of biomasses 
Biomass extraction for A. salina tests was performed following two different 
protocols. One set of experiments was performed on methanolic extracts. 
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For each algal strain, as well as for the negative reference lettuce, an aliquot of 
0.5 g of dry biomass was extracted in 60 mL of methanol overnight at room 
temperature. The solvent was then separated from biomass by filtration on 
paper. The biomass residue was extracted again with 30 mL of methanol at 37 
°C for 4 hours, then the exhausted biomass was removed by filtration on paper. 
The two extracts (60+30 mL) were mixed and then evaporated under vacuum. 
The dry residues were suspended in 2.5 mL of methanol to obtain a final 
concentration of the extracts of 200 g L
-1
 of extracted biomass. Glassware and 
plastic-ware were kept in 0.27 M NaOH in 9:1 ethanol: water for 24 hours 
before usage, to prevent cross-contamination (Golakoti et al. 1995), and then 
washed with deionized water.  
Another set of experiments on A. salina was performed on aqueous extracts of 
microalgae and lettuce. Aliquots of the dry biomasses (0.2 g) were dispersed in 
1.5 mL of sterile water and sonicated for 3 minutes, and then the probe was 
washed with 0.3 mL of sterile water. The sonicated material was frozen at -
20°C. As soon as the material was taken out of the freezer, 0.2 mL of an 
antibiotic solution containing 3,200 µg mL
-1
 of streptomycin sulphate 
(chemist’s preparation) and 6,000 µg mL-1 of ampicillin (Amplital, Pfizer) were 
added to each sonicated biomass to prevent bacterial growth. After thawing, 
each sonicated biomass was homogenized and an aliquot was transferred into a 
sterile 1.5 mL test tube and centrifuged for 15 min at 18,000 x g at 4 °C. The 
supernatant was finally transferred to a new sterile test tube. The final extract 
concentration was of 100 g L
-1
 of extracted biomass. For this type of extraction 
only disposable material was used. 
2.5.2 Lethality tests on A. salina 
Cysts of A. salina (Premium, SHG, Ovada, Alessandria, Italy) were transferred 
for hatching in a glass bottle containing sterile artificial seawater (Tropic 
Marine) at 30 g L
-1
 salinity. The inoculated seawater was bubbled with air 
sterilized through 0.2 µm porosity filters. The incubation was carried out under 
constant illumination of 80 µmol photons m
-2
 s
-1
 at 25-27 °C. Once the cysts 
hatched, the nauplii were used to set up the experiments. 
The experiments were performed in 96-well microtiter plates on a final test 
volume of 100 µL. For methanolic extracts, the concentrations tested varied 
from 12.5 to 0.1 g L
-1
 of extracted biomass. An aliquot (12.5 µL) of the extract 
was transferred into the first well and the solvent let to evaporate. After 
evaporation, 20 µL of pure DMSO:water 1:10 were added to prepare the final 
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extract, that was then diluted in the other wells 1:2 in 10 µL of DMSO:water 
1:10 till the last concentration to be tested. Controls were prepared with 10 µL 
of DMSO:water 1:10. Each extract concentration and the control were tested in 
six replicates. Reference extracts were set-up with biomasses expected to 
produce a positive (Nostoc sp. M1) and a negative (lettuce) response in the test. 
For aqueous extracts, the concentrations tested were from 12.5 to 0.1 g L
-1
 of 
extracted biomass. An aliquot (25 µL) of the extract was transferred into the 
first well of the microtiter plate and diluted 1:2 in the other wells in 50 µL of 
artificial seawater (30 g L
-1
 salinity) containing antibiotics. The final 
concentration of antibiotics in each well was 160 µg mL
-1
 of streptomycin and 
300 µg mL
-1
 of ampicillin. Control was prepared with sterile artificial seawater 
(30 g L
-1
 salinity) containing antibiotics at the same concentrations as in the test 
wells. Each extract concentration and the control were tested in three replicates. 
Reference extracts were set-up with Nostoc sp. M1 and lettuce that were treated 
in the same way as the test extracts. 
After the test and reference extract dilutions and the control were prepared in 
the microtiter plates, 90 µL of seawater containing 5 nauplii were added to each 
well to reach the final test volume of 100 µL. The plates were then incubated at 
room temperature and the number of dead nauplii was counted under a direct 
light microscope (Nikon Eclipse E200, Nikon, Tokyo, Japan) at 40 
magnifications after 24 and 48 hours of incubation. 
Nauplii were considered as dead when no movement was observed in the 
reasonable time of the observation (Carballo et al. 2002, Lopes et al. 2011). 
Mortality was calculated according to Abbott (Abbot 1987): 
 
                   
       
  
     
 
where M is mortality; LC, living nauplii in the control after 24 or 48 hours; LT, 
living nauplii in the test or reference extract after 24 or 48 hours. 
2.6 Calculation of IC50 values 
For all microalgal extracts tested against NHDF and A. salina dose-response 
curves were obtained. The concentration (expressed as grams of extracted 
biomass per liter) which inhibits 50% of the population (IC50) was calculated by 
a linear regression model using log transformed data when necessary. When the 
experimental data did not include the 50% inhibition, IC50 values were 
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estimated, still through linear regression. For some extracts (indicated as “not 
determinable”) it was not possible to calculate an IC50 value because no toxicity 
was detected at the concentrations tested. IC50 values higher than 15 g L
-1
 were 
not indicated in extenso, as this amount was considered the threshold of non-
toxicity. 
The extracts were divided into four toxicity categories according to their IC50 
value: high toxicity (IC50≤5 g L
-1
); medium toxicity (5<IC50≤10 g L
-1
); low 
toxicity (10<IC50≤15 g L
-1
) and no toxicity (IC50 >15 g L
-1
). The latter category 
included also those extracts for which an IC50 value was not available. 
 
3. Results 
Extracts from 13 test biomasses were evaluated as well as those from two 
reference materials (Nostoc M1 and lettuce). Among the test biomasses, only 
for P. purpureum F&M-M46 calculation of the IC50 was not possible due to 
lack of toxicity in the tested range (Table 3).  
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Table 3. IC50 values calculated or estimated for  microalgal aqueous or 
methanolic extracts (expressed as g of extracted biomass per liter) on human 
fibroblasts (NHDF) and A. salina after 24 and 48 hours of exposure; data are 
reported as mean ± SD 
Strain IC50 value (g L
-1) 
 Fibroblasts   Artemia 
             H2O extract MeOH extract 
   24 h      24 h    48 h 24 h 48 h 
Nostoc sp. M1  
(positive reference) 
9.3 ± 2.9 nc 7.2 ± 0.2 8.2 ± 2.3 0.4 ± 0.1 
Lettuce  
(negative reference) 
nc >15* >15* nc nc 
A. platensis M2 11.5 ± 5.7 >15* >15* nc nc 
Klamath powder 8.8 ± 0.4 >15* 4.7 ± 1.9 1.7 ± 0.0 1.6 ± 0.1 
N. sphaeroides   
F&M-C117 
7.8 ± 1.3 >15* >15* nc nc 
C. sorokiniana  
F&M-M49 BG11 
12.6 ± 4.0* nc >15* 13.6 ± 2.9* 13.4 ± 2.3* 
C. sorokiniana  
F&M-M49 F 
2.7 ± 1.0 - - - - 
C. sorokiniana  
IAM C-212 
3.7 ± 0.09 nc nc 6.0 ± 0.6 5.6 ± 0.6 
C. vulgaris Roquette >15* nc >15* nc nc 
C. vulgaris Allma nc >15* >15* nc nc 
T. suecica F&M-
M33  
>15* nc >15* >15* >15* 
P. purpureum  
F&M-M46 
nc nc nc nc nc 
P. tricornutum  
F&M-M40 
2.3 ± 0.4 nc >15* >15* >15* 
T. lutea  
F&M-M36 
6.0 ± 2.2 >15* > 15* 6.0 ± 0.5 5.6 ± 0.9 
N. oceanica  
F&M-M24 
11.2 ± 2.1 nc nc nc nc 
* estimated value; nc, not calculable due to absence of toxicity in the tested 
range; -, not tested  
 
For C. vulgaris Roquette, C. vulgaris Allma and T. suecica, as well as for the 
negative reference lettuce, it was possible, for at least one of the extracts, to 
estimate the IC50, which value, however, was always higher than 15 g L
-1
 (Table 
3). These three biomasses as well as that of P. purpureum were considered as 
non toxic (Fig. 1).  
H2O extract 
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The remaining nine test biomasses and the positive reference Nostoc M1 
showed IC50 below 15 g L
-1
 (hence toxicity) for at least one extract and one 
model (NHDF or A. salina). Only Klamath powder showed an IC50 below 15 g 
L
-1
 for all the extracts with both models. The IC50 value of the water extract of 
Klamath powder against NHDF was in the range that we classified as medium 
toxicity (Table 3, Fig. 1), whereas both water and methanolic extracts showed 
IC50 against A. salina in the range that we considered of high toxicity (Table 3, 
Fig. 1). It is to note that the toxicity of the Klamath powder aqueous extract 
against A. salina was much higher after 48 hours of exposure, while the 
methanolic extract acted almost at its full potency already after 24 hours. A 
similar behavior was observed for the positive reference Nostoc M1 (Table 3, 
Fig. 1). The main difference was that the methanolic extract of Nostoc M1 
behaved like the aqueous one in terms of toxicity increase with exposure time. 
In fact, after 24 h the IC50 value of the methanolic extract was 8.2 g L
-1
 and 
decreased to 0.4 g L
-1
 after 48 h; the aqueous extract was not toxic after 24 
hours and showed an IC50 of 7.2 g L-1 after 48 hours (Table 3).  
For C. sorokiniana F&M-M49 grown in BG11, C. sorokiniana IAM C-212 and 
T. lutea F&M-M36 an IC50 below 15 g L
-1
 could be calculated for both models, 
although in the case of A. salina only for the methanolic extracts. IC50 values for 
T. lutea F&M-M36 extracts were in the range considered of medium toxicity 
(Table 3, Fig.1), as well as the methanolic extract from C. sorokiniana IAM-
C212, which aqueous extract showed instead an IC50 in the range of high 
toxicity against NHDF (Table 3, Fig. 1). IC50 values were in the range of low 
toxicity for both extracts from C. sorokiniana F&M-M49 grown in BG11 
(Table 3, Fig. 1). 
The remaining five biomasses were active only against NHDF. A. platensis M2 
and N. oceanica F&M-M24 extracts showed an IC50 higher than 11 g L
-1
 and 
laid in the low toxicity range; the IC50 of N. sphaeroides F&M-C117 was in the 
range of medium toxicity, whereas extracts from C. sorokiniana F&M-M49 
grown in F medium and P. tricornutum F&M-M40 showed an IC50 lower than 3 
g L
-1
 and were considered of high toxicity (Fig. 1, Table 3). 
To assess the contribution of artificial seawater salt to the cytotoxic effects 
observed, also considering the results obtained with C. sorokiniana F&M-M49 
grown in BG11 and F medium, we tested a range of salt concentrations (from 
30 to 0.6 g L
-1
) on NHDF. All the hypertonic concentrations (30, 15, 12 g L
-1
) 
strongly reduced cell survival as expected, 6 g L
-1
 caused a modest reduction, 
whereas 3 and 0.6 g L
-1
 did not show any cytotoxicity (data not shown). An IC50 
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of 11.2 ± 0.6 g L
-1 
was calculated. We can exclude toxicity of artificial seawater 
salt in our trials since the maximum salt concentration in microalgal extracts 
was estimated to be <3 g L
-1
. 
 
 
Fig. 1. Grouping of microalgal extracts according to their toxicity level, based 
on IC50 values. Aqueous extracts on NHDF after 24 hours, and aqueous and 
methanolic extracts on A. salina after 48 hours are reported. The toxicity levels 
are displayed in decreasing order (from darker to lighter color) 
 
4. Discussion 
Although the number of microalgal species worldwide is vast, only few have 
been isolated and studied with regard to biochemistry and physiology, and even 
less are exploited for commercial applications (Tredici et al. 2009). Less than a 
dozen microalgal species are presently accepted in the EU as food or food 
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ingredients (European Union 1997) and a similar situation is recorded also in 
the US and Australia. To increase this number it is necessary to go through the 
novel food approval regulations that require the assessment of the safety of the 
candidate food ingredient (European Union 2015; FDA 2014; FSANZ Proposal 
P1024). Starting from this perspective, this research aimed to evaluate, as 
preliminary step, the toxicity of microalgal biomasses of interest as food sources 
due to their nutritional qualities, using A. salina and human dermal fibroblasts 
as models. 
As far as toxicity on cells is concerned, most of the literature deals with tests 
against cancer cell lines (Jaki et al. 1999; Carballo et al. 2002; Bechelli et al. 
2011; Hisem et al. 2011) and only few studies, to our knowledge, focus on the 
cytotoxic effects of microalgae on non-cancerous cells (Prestegard et al. 2009; 
Lopes et al. 2011; Goh et al. 2014). In vitro cytotoxicity tests are performed to 
determine the intrinsic ability of a compound to cause cell death as a 
consequence of damage to the basic cellular functions. In this way, a screening 
for cytotoxicity using normal cells might be regarded as a general bioassay 
(Ekwall et al. 1990). Moreover, the use of a normal human cell lines, that 
present a non-aberrant phenotype, is an added value with respect to the use of 
cancerous cells that more typically show chromosome and phenotype 
aberrations (Jallepalli and Lengauer 2001; Fackental and Godley 2008). It is 
worth noting that there is little literature on toxicity of eukaryotic microalgae on 
cell lines and Artemia, while a wider number of papers deal with cyanobacteria. 
Six of the tested algal biomasses (T. lutea F&M-M36, Klamath powder, N. 
sphaeroides F&M-C117, C. sorokiniana F&M-M49 grown in F medium, C. 
sorokiniana IAM C-212 and P. tricornutum F&M-M40) showed a similar or 
even higher cytotoxicity on fibroblasts compared to the positive reference 
Nostoc M1, while only Klamath powder showed a toxicity similar to Nostoc 
M1behavior on A. salina. The toxic effects on fibroblasts of Nostoc M1, a 
cyanobacterium containing cryptophycin, a powerful antimitotic agent (Panda et 
al. 1997), were lower than expected from our previous data on antifungal 
activity of this strain (unpublished) and on cytotoxicity of other cryptophycin-
containing Nostoc strains (Piccardi et al. 2001). On A. salina, the toxic action of 
the aqueous extract was observed only after 48 hours of exposure, whereas with 
the methanolic extract the effect was more marked and present already after 24 
hours. This behavior, in both models, can be explained by due to the low 
solubility of cryptophycin (a cyclic depsipeptide) in water, and to the low 
division rate of fibroblasts compared to tumor cell lines and of nauplii cells that 
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might slows the action of the antimitotic venom. The IC50 value shown by 
Nostoc M1 on human fibroblasts in this study (9.3 g L
-1
) is much higher than 
that reported by Hrouzek et al. (2016) for the most cytotoxic Nostoc strain 
against murine fibroblasts (2.8 g L
-1
). 
Nostoc is one of the cyanobacterial genera with the highest frequency of 
cytotoxic metabolites. Among about 80 Nostoc strains tested, cytotoxicity 
frequency to different target cells was found to vary for the same extracts from 
26 to 76% (Hrouzek et al. 2016). Biondi et al. (2008) found 5 out of 6 Antarctic 
Nostoc isolates to be cytotoxic to HeLa cells. Cytotoxicity against murine 
tumour cell lines was found in 33% (Hrouzek et al. 2011), 60% (Hrouzek et al. 
2016) and 65% (Hisem et al. 2011) of the Nostoc strains tested. On A. salina, 
Piccardi et al. (2000) found toxicity in 24% of 50 Nostoc extracts, mainly 
aqueous. The same frequency of toxicity was found by Hisem at al. (2011) in 29 
methanolic extracts. It is worth noting that the genus Nostoc includes, besides 
highly toxic strains, edible species (as N. sphaeroides and N. flagelliforme) and 
that, in this study, the edible N. sphaeroides F&M-C117 showed medium 
toxicity to fibroblasts and no toxicity to A. salina. A similar toxicity pattern was 
shown by the aqueous extract from P. tricornutum F&M-M40. Toxicity of 
aqueous extracts from this algal species is reported by Prestegard et al. (2009) 
on rat hepatocytes (>30% death at 4 g L
-1
 of extracted biomass after one hour of 
exposure) and IPC leukemia cells (>30% death at 1.5 g L
-1
 after 18 hours). No 
literature data are available on toxicity of this alga to A. salina. 
Among the algae approved as food in the EU, the two commercial C. vulgaris 
strains were found not toxic (neither to fibroblasts nor to A. salina). A. platensis 
(the so-called spirulina), that on the basis of its longtime history (centuries) of 
human consumption is considered a safe food, in our work showed a low 
cytotoxic effect on fibroblasts and no toxicity to A. salina. Bechelli et al. (2011) 
found toxicity at 2 g L
-1
 of extracted biomass with ethanolic extracts of A. 
platensis on leukemia cells and no toxicity to normal bone marrow cells. One of 
the microalgae approved as food in the EU is A. flos-aquae from Klamath Lake 
(European Union, Novel Food catalogue). In our study medium toxicity to 
fibroblasts was observed with the aqueous extract from the biomass harvested 
from the natural bloom dominated by this alga in Klamath Lake, whereas high 
toxicity to A. salina was found in both aqueous and methanolic extracts. Our 
results confirm the findings from Bechelli et al. (2011) who observed a high 
cytotoxicity of the ethanolic extract of this bloom against both leukemia and 
normal bone marrow cells at concentrations lower than those found toxic in our 
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work. It is necessary to point out that, although some strains of Aphanizomenon 
are known to produce saxitoxin and neosaxitoxin (Ferreira et al. 2001; Ballot et 
al. 2010a, b), as well as mueggelone, responsible for neurotoxic and 
ichthyotoxic activity (Papendorf et al. 1997), so far Aphanizomenon flos-aquae 
from Klamath Lake has never been found to produce these toxins (Carmichael 
1992; Heussner et al. 2012). Up to now this cyanobacterium from Upper 
Klamath Lake (Oregon, US) has not been stably isolated, thus the only way to 
test its biomass is to harvest blooms from this lake. The toxicity of the bloom 
observed in our work could be due to: i) compounds produced by A. flos-aquae; 
ii) compounds produced by other microalgae present in the population, as for 
example Microcystis spp., often occurring in these blooms (Gilroy et al. 2000), 
although the microcystins would have affected A. salina (Vezie et al. 1996) but 
not fibroblasts (Matsushima et al. 1990); iii) compounds from biogenic 
contaminants (derived from plants, animals, and other microorganisms) or non-
biogenic sources (Chamorro-Cevallos et al. 2007). 
Among the other algae tested, only in few cases it is possible to compare our 
data with literature. We found toxicity of N. oceanica F&M-M24 aqueous 
extracts to fibroblasts at the highest concentration (low toxicity). Goh et al. 
(2014) found no cytotoxicity of N. oculata extracts to mouse fibroblasts. In our 
study, P. purpureum F&M-M46 did not exert toxic effects at the concentrations 
tested. Gardeva et al. (2012) found that the polysaccharide from P. purpureum 
reduced the viability of MCF7, HeLa and Graffi tumour cells. The methanolic 
extract of T. suecica F&M-M33 showed no toxicity to A. salina (our work), 
while the methanolic extracts of T. suecica CCAP 66/22D caused a 100% 
mortality on Artemia nauplii (Lincoln et al. 1996). 
The different toxicity patterns often observed in methanolic and aqueous 
extracts may derive from different molecules being extracted by the different 
solvents (Piccardi et al. 2000), or from the same component that is extracted by 
the solvents with a different efficiency (see the case of Nostoc sp. M1). 
In general, our results show that the sensitivity of fibroblasts towards microalgal 
aqueous extracts is higher compared to that of A. salina and only the extract 
from Klamath powder is toxic in both models. With the aqueous extracts a 
higher toxicity on A. salina was observed after 48 hours of exposure, thus 
further confirming the lower sensitivity of this model compared to fibroblasts, 
this is not necessarily a drawback. In accordance with our study, Hisem et al. 
(2011) report a lower sensitivity of A. salina compared to the cell model. The 
results obtained in our work with aqueous extracts on fibroblasts are more 
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coherent with those obtained with methanolic extracts on A. salina, although the 
fibroblasts higher sensitivity allowed to detect a larger number of potentially 
toxic biomasses. 
Tests on cell lines appear more adequate when the objective is to determine 
cytotoxic activity, as also stated by Hisem et al. (2011). These authors attribute 
the higher sensitivity of cells with respect to A. salina to the fact that 
cyanobacterial metabolites generally affect basal metabolic pathways present in 
the eukaryotic cell rather than systems in complex multi-cellular organisms. 
However, fibroblasts appear too sensitive for use in general toxicity screenings, 
while A. salina lethality test, in particular using a universal solvent (e.g. 
methanol) and an exposure time of at least 48 hours, appears far more reliable. 
Considering its easiness of realization and low cost, our work confirms the 
validity of this test in pre-screenings. 
 
5. Conclusions 
This work presents an in vitro analysis of the toxicity of 11 microalgal strains 
and one natural bloom of potential interest for food applications. Taken 
together, these data indicate that extracts from microalgae have a different 
pattern of inhibition (and thus toxicity) on A. salina and fibroblasts. Although 
these two models are useful and widely employed tools to screen the potential 
toxic effect, the attainment of results not fully in accordance, probably due to 
the different sensitivity and complexity of the models, should be taken into 
serious consideration. Clearly, results obtained from in vitro models or 
invertebrate bioassays are preliminary and must be confirmed by in vivo studies 
on mammals performed on the whole algal biomass and not only on extracts. 
These pre-screenings allow reducing the number of candidate strains to be 
selected for further in vivo studies on mammals that are necessary, in most 
cases, to fulfill the mandatory requirement of subchronic toxicity data for novel 
food applications, at least in the EU. In conclusion, from this study the two 
commercial C. vulgaris strains, T. suecica F&M-M33 and P. purpureum F&M-
M46 emerged as non-toxic and other two strains, A. platensis M2 and N. 
oceanica F&M-M24, as substantially non-toxic. T. lutea F&M-M36, the two C. 
sorokiniana strains, N. sphaeroides F&M-C117 and P. tricornutum F&M-M40 
showed some toxicity and need further investigation. Finally, Klamath powder 
was found to be the most toxic among the biomasses tested, inhibiting both 
models. 
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Abstract 
Microalgae are considered a fundamental source for the development of new 
food products and can be used to enhance the nutritional value of conventional 
foods, due to their valuable and balanced biochemical composition.  
The aim of this study is to investigate the biochemical composition and the in 
vitro digestibility of several microalgal and cyanobacterial strains of interest as 
food source. 
Arthrospira platensis F&M-C256, Klamath powder, and Nostoc sphaeroides 
F&M-C117 presented high protein (51-69%) and low lipid content (6-15%). 
Marine species contain high concentrations of PUFAs-ω3, mainly C20:5 ω3 
(EPA) and C22:6 ω3 (DHA) along with substantial amounts of C16:1, C18:1 
ω9 among MUFAs and C16:0 among SFA, whereas the freshwater algae 
contained high concentrations of the PUFA C18:3 ω3 (ALA) and an even 
higher amount of the SFA C16:0. The nutritional quality of lipid profile 
evaluated by different indexes indicated the high potential of these microalgae 
for human health. 
Cyanobacteria, showed the highest digestibility in terms of dry matter (DMD), 
organic matter (OMD), carbohydrate (CD) and crude protein (CPD). While, the 
green algae Chlorella sorokiniana F&M-M49 and Tetraselmis suecica F&M-
M33 and the marine Phaeodactylum tricornutum F&M-M40 and Porphyridium 
purpureum F&M-M46 showed lower digestibility values, mainly because of 
their robust cell wall or for the presence of exopolysaccharides that could have 
limited the action of digestive enzymes. 
Fiber can also entrap proteins in the cellular matrix, rendering them less 
bioavailable to enzymatic hydrolysis. No significant direct correlation between 
CPD and dietary fiber was found, and microalgae rich in fiber always reported 
lower DMD, OMD, and CD values. 
C. sorokiniana F&M-M49 and C. vulgaris Allma were pre-treated by sonication 
before pepsin incubation and the DMD obtained was compared to that of the 
untreated samples. The data obtained in this study confirm the positive effect of 
the sonication pretreatment and of the continuous stirring on cell dispersibility 
but without improving the digestibility of these Chlorella strains. 
Keywords: Microalgae, Biochemical composition, Digestibility, Food 
 
 
 
Biochemical composition and in vitro digestibility of 
microalgal and cyanobacterial strains of interest as food source 
 
73                                          
4 1. Introduction 
Microalgae (including cyanobacteria) as food source and food supplements are 
known for centuries and they are produced in Asian countries, USA, and 
Australia from several decades (Lee, 1997; Singh and Gu, 2010). Microalgae 
are mainly applied as food supplements, in the cosmetics industry, or as animal 
feed (Dufossé et al., 2005; Huntley et al., 2015; Singh and Gu, 2010). In 
Western countries the use as food or food ingredients is still rather limited 
compared to Asian countries. 
Arthrospira, Chlorella, Dunaliella, Aphanizomenon flos-aquae from Klamath 
Lake and Haematococcus pluvialis are microalgae largely employed for human 
consumption due to their balanced biochemical composition and high 
nutritional value (Tredici et al., 2009). Indeed, microalgae can contain high 
amount of proteins, vitamins, minerals (Becker, 2007; Liu et al., 2013) 
carotenoids (Del Campo et al., 2000; Wu et al., 2009), and long-chain 
polyunsaturated fatty acids (Becker, 2004).  
The microalgae business sector is currently very dynamic with several 
companies starting every year. In 2015, more than 100 companies with different 
sizes mainly producing Arthrospira (the so called spirulina) have been spread 
through all Europe, mostly in France. The products from microalgae have 
currently only three possible forms: paste (for aquaculture), dried powder (for 
food and feed), and extracts (for nutraceuticals) (Verdelho Vieira, 2015). 
In the EU, novel foods and food ingredients are defined as those that “have not 
been used to a significant degree for human consumption within the Union 
before 15
th
 May 1997” (EU, 1997). With the Regulation (EC) No 258/97, the 
European Union, through the European Food Safety Authority (EFSA), 
guarantees that novel foods and food ingredients are subject to a single safety 
assessment through a unified procedure in order to protect public health 
(Niccolai et al., 2016). According to this Regulation, the European Union 
include microalgae in the novel food category. A. flos-aquae from Klamath 
Lake, A. platensis, C. luteoviridis, C. pyrenoidosa and C. vulgaris are 
microalgae already authorized as food in the EU because used prior to May 
1997 (European Union, Novel Food catalogue). Odontella aurita, Tetraselmis 
chuii and H. pluvialis (for astaxanthin production) were also successively 
approved as food or food ingredient (EU, 2005; AECOSAN, 2014; AESAN, 
2013; EFSA, 2014). 
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In this work, strains belonging to species already approved as food (A. platensis, 
C. vulgaris and A. flos-aquae from Klamath Lake) and species not approved but 
belonging to the same genus already authorized (C. sorokiniana and T. suecica), 
species used in aquaculture as Isochrysis, Nannochloropsis and Phaeodactylum 
(Atalah et al., 2007; Priyadarshani, 2012) or in cosmetic field as Porphyridium 
(Marcati et al., 2014) were tested.  
Although the number of microalgal species worldwide is vast, only few have 
been isolated and studied with regard to biochemistry and physiology, and even 
less are exploited for commercial applications (Tredici et al., 2009). In this 
regard, knowledge of the chemical composition is mandatory as a first step in a 
screening methodology, since it will help to target valuable compounds (in 
particular antioxidants, pigments, and essential fatty acids), in the studied 
microalga (Batista et al., 2013). Environmental factors and growth conditions, 
such as temperature, illumination, CO2 supply, salinity, pH-value, mineral 
content, population density, and physiological status, can modify chemical 
composition (Tredici et al., 2009). Therefore, the growing conditions could be 
optimized to maximize the production for the biomolecules of interest (Batista 
et al., 2013). In this regard, the selection of microalgae species with balanced 
nutritional profiles is fundamental for successful novel foods development. A 
detailed physicochemical characterization of the microalgae is an essential stage 
that will allow determining which algae are best suited for different applications 
and purposes (Batista et al., 2013). 
When it wants to evaluate a possible application as food or food ingredients of 
new sources and predicting their nutritional quality, information on the 
digestibility of the various nutrients is of utmost important (Boisen and Eggum, 
1991). In vitro digestion models are widely used to study the structural changes, 
digestibility and release of food components under simulated gastrointestinal 
conditions (Hur et al., 2011; Minekus at al., 2014). Mainly plants, meats, fish, 
dairy, and emulsion-based foods were studied for their digestibility and the most 
frequently biological molecules used in the digestion models were digestive 
enzymes (pancreatin, pepsin, trypsin, chymotrypsin, peptidase, α-amylase and 
lipase), especially from porcine, rabbit or human origin (Minekus et al., 2014), 
bile salts, and mucin (Hur et al., 2011). It is worth nothing that differences in 
pH, mineral type, ionic strength and digestion time, which alter enzyme activity, 
may also considerably alter the results obtained between different studies 
(Minekus et al., 2014). In seaweed especially, phenolic molecules and 
polysaccharides are compounds that can limit the digestibility (Fleurence, 
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4 1999). As stated by Fleurence (1999), the algal polysaccharides behave like 
soluble or insoluble fibers. Studies performed on brown algae show the strong 
inhibitory action of soluble fibers on in vitro pepsin activity and their negative 
effects on protein digestibility (Horie et al., 1995). According by Becker (2004), 
microalgae with higher fiber content are scarcely suitable for human nutrition. 
It is necessary to point out what is intended to dietary fiber. Most of the authors 
agree with Trowell et al. (1976) that defined dietary fiber as “the sum of lignin 
and others polysaccharides that are not digested by endogenous secretions of the 
digestive tract of man”. Dhingra et al. (2012) showed the classification of 
dietary fiber components based on water solubility/fermentability. Cellulose, 
hemicellulose and lignin are water insoluble and less fermented fibers, on the 
contrary pectin, gums and mucilages are water soluble and well fermented 
fibers (Dhingra et al., 2012).  
In humans, a high content of fiber in cereals, fruits and vegetable have a 
positive effect on health, even if they could decrease the digestibility of the 
ingested food containing fibers. The recommended dietary fiber intakes for 
children and adults are 14 g/1000 kcal (Anderson et al., 2009). Principally, the 
positive effect of fiber consumption is related to: i) increase the volume of fecal 
bulk and decrease the time of intestinal transit, cholesterol and glycaemic levels; 
ii) trap substances that can be dangerous for the human organism (mutagenic 
and carcinogenic agents); iii) stimulate the proliferation of the intestinal flora 
(Beecher, 1999). 
In our study, Boisen and & Fernández (1997) method was used to investigate 
the in vitro digestibility of microalgal and cyanobacterial strains. Recently, 
many authors used Boisen & Fernández method (1997) to study the in vitro 
digestibility of food, feed, or of organic matrices (Giuberti et al., 2013, Huang et 
al., 2014, Malumba et al., 2015; Serena and Bach Knudsen, 2007). 
The main problem to deal with, when microalgae are being used as food, is the 
robust cell wall which restricts the access of the digestible enzymes to the cell 
components (Janczyk et al., 2005). With the exception of the cyanobacteria 
Arthrospira sp., A. flos-aquae and Nostoc sp., most of the other microalgae of 
commercial importance (mainly Chlorophyceae, especially Chlorella genus) 
have rigid indigestible cell walls, which, in many cases, makes necessary to 
break the cell wall (Doucha and Lívanský, 2008). Many authors described the 
sonication treatment as efficient method to destroy microalgal cells (McMillan 
et al., 2013; Safi et al., 2014; Wang et al., 2014). According to Janczyk et al. 
(2005) and in order to facilitate the enzymes access to the algal cell 
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components, a sonication processes on two Chlorella species was applied in this 
study.  
The aim of this work was to evaluate the biochemical composition and the in 
vitro digestibility of 10 microalgal strains and one natural bloom. A possible 
increase in vitro digestibility using a sonication treatment was also investigated 
with two Chlorella strains. 
 
2. Materials and methods 
2.1 Microalgal strains and biomass production 
The investigated algae are listed in Table 1. 
 
Table 1. Algae tested for biochemical characterization and in vitro digestibility 
Strain Sample 
abbreviation 
Type of culture 
medium 
Biomass obtention 
Arthrospira platensis 
F&M-C256 
Ap alkaline in-house cultivation 
Klamath powder K fresh commercial product 
(Erbologica S.A.S.) 
Nostoc sphaeroides F&M-
C117 
Ns fresh in-house cultivation 
Chlorella sorokiniana 
F&M-M49 
CsM49 fresh in-house cultivation 
Chlorella sorokiniana 
IAM C-212 
CsIAM fresh in-house cultivation 
Chlorella vulgaris Allma CvA fresh commercial product  
(Allma Microalgae) 
Tetraselmis suecica F&M-
M33 (starved)  
TsS marine in-house cultivation 
Tetraselmis suecica F&M-
M33 (nutrient replete 
medium) 
TsNR marine in-house cultivation 
Porphyridium purpureum                 
F&M-M46 
Pp marine in-house cultivation 
Phaeodactylum 
tricornutum                      
F&M-M40 
Pt marine in-house cultivation 
Tisochrysis lutea (T-ISO) 
F&M-M36 
Tiso marine in-house cultivation 
Nannochloropsis oceanica  
F&M-M24 
No marine in-house cultivation 
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4 Most of the biomasses tested in this study were produced at the facilities of 
Fotosintetica & Microbiologica S.r.l. or of the Institute of Ecosystem Study of 
the CNR, both located in Sesto Fiorentino, Florence (Italy). The algae were 
cultivated in GWP
®
-II photobioreactors (Tredici et al., 2011) in semi-batch 
mode, then the biomasses were harvested by centrifugation, frozen, lyophilized 
and powdered. The powdered biomasses were stored at -20°C until analysis. 
Only A. plantesis F&M-C256 biomass was washed with physiological solution 
during harvesting to remove bicarbonate excess. All the freshwater strains were 
cultivated in BG11 (Rippka et al., 1979) and all the marine strains in artificial 
seawater enriched with F medium nutrients (Guillard & Ryther, 1962). A. 
platensis F&M-C256 was cultivated in Zarrouk medium (Zarrouk, 1966). T. 
suecica F&M-M33 was also grown in standard F medium deprived of nitrogen 
source to induce carbohydrate accumulation. C. vulgaris Allma (Allma 
Microalgae, Portugal) and Klamath (Erbologica S.A.S.) powders were 
commercial products. In particular, Klamath powder is a natural bloom, mainly 
containing A. flos-aquae, harvested from Upper Klamath Lake (Oregon, USA). 
Twelve microalgal biomasses (see Table 1) were analyzed for their in vitro 
digestibility using an enzymatic method. Two of the tested biomasses (C. 
sorokiniana F&M-M49 and C. vulgaris Allma) were also used to study the 
effect of a sonication pre-treatment on in vitro digestibility. 
2.2 Biochemical composition 
All strains were analyzed for protein, carbohydrate, lipid, dietary fiber, ash and 
moisture. Elemental analysis was performed on dry biomass using a CHNSO 
Analyzer (Flash EA, 1112 Series, Thermo Electron Corporation, Massachusetts, 
USA) (Gnaiger and Bitterlich, 1984). 
Total protein content was estimated as N x 6.25, where N is the nitrogen content 
determined through the elemental analysis. Carbohydrate was determined 
following Dubois et al. (1951) and lipid following Marsh & Weinstein (1966). 
Dietary fiber was determined by AOAC Method 985.29 (AOAC Official 
Method 985.29). Moisture, ashes and fatty acids was analyzed following 
ISTISAN protocols (ISTISAN Report 1996/34, method B, page 7; ISTISAN 
Report 1996/34, pages 77-78; ISTISAN Report 1996/34, page 47, respectively). 
The extracts for the total phenolic content determination were prepared 
according to the procedure used by Hajimahmoodi et al. (2010). The assay was 
carried out according to Rajauria et al., 2013, using the Folin Ciocalteu assay. 
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All the analyses were performed in triplicate. Data are expressed as mean ± 
standard deviation. 
2.2.1 Lipid nutritional quality indexes  
The nutritional quality of the lipid fraction was estimated by three different 
indexes that were calculated based on the concentration of saturated fatty acids 
(SFA, lauric C12:0, myristic C14:0, palmitic C16:0, and stearic C18:0), 
monounsaturated fatty acids (MUFA, oleic C18:1 ω9), and polyunsaturated 
fatty acids (PUFA, linoleic C18:2 ω6, linolenic C18:3 ω3, arachidonic C20:4 
ω6 and eicosapentaenoic C20:5 ω3): 
 
(1) Atherogenicity index (AI) = [(C12:0 + (4 × C14:0) + C16:0)]/(ƩMUFA + 
Ʃω6 + Ʃω3) (Ulbricht and Southgate, 1991); 
 
(2) Thrombogenicity index (TI) = (C14:0 + C16:0 + C18:0)/[(0.5 × ƩMUFA) + 
(0.5 × Ʃω6) + (3 × Ʃω3) + (Ʃω3/Ʃω6)] (Santos-Silva et al., 2002); 
 
(3) Fatty acids hypocholesterolemic/hypercholesterolemic ratios (H/H) = 
(C18:1ω9 + C18:2ω6 + C20:4ω6 + C 18:3ω3 + C20:5ω3)/(C14:0 + C16:0) 
(Santos-Silva et al., 2002). 
2.3 In vitro digestibility  
The evaluation of in vitro digestibility was performed according to Boisen & 
Fernández (1997), modified to adapt it to our necessities. This in vitro analysis 
reproduces the enzymatic attack occurring in the proximal tract of the digestive 
system (gastric and pancreatic juice). Biomasses of 10 microalgal strains and 
one natural bloom were analyzed (Table 1). Casein (Acros Organics, Geel, 
Belgium) was used as reference material for protein with 100% digestibility 
(Fleurence, 2004). The analysis was performed in triplicate. Data are expressed 
as mean ± standard deviation. 
Step 1 
Samples of 1 g of finely ground material (particle size ≤1 mm) were weighed 
and transferred in 250 mL conical flasks. To each flask, 25 mL of phosphate 
buffer (0.1 M, pH 6.0) were added and mixed, then 10 mL 0.2 M HCl were 
added and pH was adjusted to a value of 2.0 by addition of 1 M HCl or 1 M 
NaOH. Then 3 ml of a freshly prepared pepsin water solution containing 30 mg 
Biochemical composition and in vitro digestibility of 
microalgal and cyanobacterial strains of interest as food source 
 
79                                          
4 of porcine pepsin with an activity of 0.8 FIP-U/mg (Applichem, Darmstdat, 
Germany) were added. A blank was also prepared with the same reactive but 
without algal biomass. The flasks were closed with a rubber stopper and placed 
on multipoint stirrers (IKA
®
 KS 260 basic, Königswinter, Germany) at 150 rpm 
in a thermostatically-controlled heating chamber (ProCLIMATIC, Imola, Italy) 
at 39 °C. The samples were stirred for six hours.  
Step 2 
After six hours at 39 °C, 10 mL of phosphate buffer (0.2 M, pH 6.8) and 5 mL 
of a 0.6 M NaOH solution were added to the samples and to the blank. The pH 
was adjusted to a value of 6.8 by addition of 1 M HCl or 1 M NaOH. Then 10 
mL of a freshly prepared pancreatin 50%-ethanol solution containing 500 mg of 
porcine pancreatin with an activity of 42362 FIP-U/g (Applichem, Darmstdat, 
Germany) were carefully mixed with the sample or blank. After closing with a 
rubber stopper, the flasks were placed again on the multipoint stirrers at 150 
rpm and further incubated at 39 °C for 18 hours. The undigested residues were 
then collected by centrifugation (J2-21M/E centrifuge, Beckman, Minnesota, 
USA) at 8000 rpm for 30 minutes. Then, the supernatant was filtered on 47 mm 
glass-fiber membranes with nominal porosity of 1.2 μm (FILTER-LAB, 
Barcelona, Spain), to determine any residual biomass and/or undissolved 
reagents re-suspended from the pellet or not sedimented. The undigested 
material (sedimented pellet) was washed with deionised water to remove any 
salts of the buffer, and then centrifuged with the same parameters mentioned 
above. The supernatant was removed after the second centrifugation (filtered, 
dried and weighed to be added to the weight of the undigested material), then 
the pellet and the filters were dried at 80 °C for six hours and then at 45 °C until 
constant weight. The blank was treated following the same steps mentioned 
above. 
Calculation 
The percentage of in vitro dry matter (DM), organic matter (OM), crude protein 
(CP) or carbohydrate (C) digestibility, was calculated according to Boisen & 
Fernández (1997): 
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where: 
 
DDM/OM/CP/C is the in vitro digestibility of dry matter or organic matter or crude 
protein or carbohydrate, expressed as percentage 
 
SWDM/OM/CP/C is the weight of the starting material (dry matter or organic matter 
or crude protein or carbohydrate) expressed in grams 
 
UWDM/OM/CP/C is the weight of the undigested material (dry matter or organic 
matter or crude protein or carbohydrate) or the amount of protein or 
carbohydrate expressed in grams 
 
RP is the residual particulate, any residual biomass and/or undissolved reagents 
re-suspended from the pellet or not sedimented expressed in grams 
 
B is the blank (all reagents without biomass) expressed in grams as dry weight, 
organic matter or crude protein or carbohydrate content 
 
The weight of the starting material of dry matter and organic matter were 
corrected for the moisture values. 
 
2.3.1 Sonication procedure to improve digestibility 
A sonication pre-treatment was tested with C. sorokiniana F&M-M49 and C. 
vulgaris Allma biomasses. We decided to test two strains of the Chlorella 
genus, one with a thick cell wall (C. sorokiniana F&M-M49) and one with a 
thin cell wall (C. vulgaris Allma) to evaluate a different effect on in vitro 
digestibility. 
One gram of sample prepared as described above, before pepsin addition was 
sonicated with an ultrasonic homogenizer (Microson
TM
 XL2000, Misonix Inc., 
Farmingdale, New York, USA) set at a frequency of 20 kHz and a power of 130 
W for 30 minutes, maintaining the temperature below 30 °C by immerging the 
sample flask in an ice bath. After sonication, pepsin was added and the rest of 
the analysis performed as already described. Micrographs before and after 
sonication were taken at 400 magnifications by an optical microscope (Zeiss 
West, Oberkochen, Germany) equipped with a digital camera and software 
(Infinity Lite and Infinity Capture, Lumenera, Ottawa, Canada), to verify the 
effect of the pre-treatment on cell aggregation and cell disruption. 
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4 2.4 Statistical and data analysis 
The results are expressed as mean values  standard deviation. The differences 
of the in vitro dry matter digestibility among the two strains sonicated and not 
sonicated were analyzed with one-way ANOVA and Tukey’s multiple 
comparison test with a level of significance of P<0.05. For statistical correlation 
analysis, Pearson's correlation coefficient was employed and a significant 
correlation at the 0.05 level was identified. GraphPad Prism 6.01 was used for 
these aims. 
3. Results and discussion 
3.1 Biochemical composition 
Table 2 shows the biochemical composition of 10 microalgae strains and one 
natural bloom. Proteins are considered fundamental macro-element of 
microalgal biomass to evaluate these microorganisms as a suitable food source. 
The estimations of crude protein in microalgae include other nitrogenous 
constituents like nucleic acids, glucosamides, amines, and cell wall materials 
(Becker, 2004). Five strains (A. platensis F&M-C256, Klamath powder, N. 
sphaeroides F&M-C117, C. sorokiniana F&M-M49, C. vulgaris Allma) 
showed protein values between 51 and 69%, with A. platensis F&M-C256 and 
Klamath powder (the two cyanobacteria) showing the highest values (68.9 and 
62.4%, respectively). A. platensis F&M-C256 protein content was comparable 
to the value found by Coca et al. (2015) and Shimamatsu (2009) (70%) but 
higher than reported for this alga by other authors (Batista et al., 2013; Kent et 
al., 2015; Ogbonda et al., 2007) (40–50%). The protein content of Klamath 
powder was exactly comparable than the one found by Becker (2007) for A. 
flos-aquae (62%); while, the protein content found for N. sphaeroides F&M-
C117 was lower than that reported as maximum protein content by Lv et al. 
(2014) for N. flagelliforme (58%). C. sorokiniana F&M-M49 and C. vulgaris 
Allma showed protein values rather comparable than that showed by Tibbets et 
al. (2015) for C. vulgaris (50%) and by Guccione et al. (2014) for C. 
sorokiniana (45%). The marine species and one freshwater strain (T. suecica 
F&M-M33 grown in nutrient replete medium, P. purpureum F&M-M46, P. 
tricornutum F&M-M40, T. lutea F&M-M36, N. oceanica F&M-M24 and C. 
sorokiniana IAM C-212) exhibited a content of protein ranged from 34 to 43%. 
N. oceanica F&M-M24 showed higher protein content compared to the values 
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found by Kent et al. (2015) for Nannochloropsis sp. and by Tibbets et al. (2015) 
for N. granulata (around 30%). As expected, the lowest value of protein (18%) 
was observed in starved T. suecica F&M-M33. It is interesting to note as most 
of the freshwater and cyanobacteria species reported higher values of protein 
(up to 69% in A. platensis F&M-C256). The protein content of almost every 
microalga compares favorably with that of the reference indicated by 
FAO/WHO and other food proteins (wheat, chickpea, milk powder) 
(FAO/WHO, 1991). 
The carbohydrate and total dietary fiber (TDF) contents in the microalgal 
biomasses were found to be very diverse. In most of the microalgae studied (A. 
platensis F&M-C256, Klamath powder, N. sphaeroides F&M-C117, C. 
sorokiniana F&M-M49, C. sorokiniana IAM C-212, P. purpureum F&M-M46, 
P. tricornutum F&M-M40, T. suecica F&M-M33 grown in nutrient replete 
medium, and N. oceanica F&M-M24) total carbohydrate varied between 10 and 
19%, which was within a 10–20% range found in literature (Batista et al., 2013; 
Feller et al., 2015; Guccione et al., 2014; Kent et al., 2015; Pugh et al., 2001). 
The carbohydrate content found in our study for N. sphaeroides F&M-C117 
showed a lower value (15%) compared to Becker (2004) and Tekenaka et al. 
(1998) for N. flagelliforme (>20%). C. vulgaris Allma, T. suecica F&M-M33 
grown in nutrient replete medium, and T. lutea F&M-M36 exhibited the lowest 
content of carbohydrate (from 6 to 10%), which were lower values compared to 
the range found in literature (Abiusi et al., 2014; Batista et al., 2013; Feller et 
al., 2015) (13-22%). It is worth nothing that starved T. suecica F&M-M33 
showed the highest value for carbohydrate together with the lowest value for 
protein.  
Intakes of dietary fiber equal to 14 g/1000 kcal can stimulate the proliferation of 
intestinal flora and can decrease cholesterol and glycaemic levels (Beecher, 
1999). Only Klamath powder seems to contain negligible quantities of TDF. 
The Company Earth’s essential Elements (E3Live™) also found for the 
commercial frozen A. flos-aquae a low amount of TDF (1.5%). C. sorokiniana 
IAM C-212, A. platensis F&M-C256, and C. vulgaris Allma were found to 
contain the lowest amounts of TDF (5.2, 6.2 and 7.1%, respectively), which 
were values usually reported in literature for these strains (Cheong et al., 2010; 
Belay, 2007; Gutiérrez-Salmeán et al., 2015; Matos et al., 2016). The other two 
freshwater strains (N. sphaeroides F&M-C117 and C. sorokiniana F&M-M49) 
and all the marine species showed higher TDF values between 10-18% (Table 
2). Most of these strains exhibited values of TDF comparable to the contents 
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4 found by Matos et al. (2016), while the contents of TDF indicated by the 
Company Algaen Corporation (AlgaeBerry
TM
) for Nostoc sp., by Fitoplancton 
Marino S.L. for T. chuii (AESAN, 2013) and by Natrah et al. (2007) for I. 
galbana were much lower (≤ 5%). 
It is interesting to note that the carbohydrate content was not correlated with the 
TDF (R
2
 = 0.002; P >0.05). In particular, among the species grown under 
nutrient sufficient conditions, the marine P. purpureum F&M-M46 showed high 
total carbohydrate content (17%) and high TDF content (15.4%) which could be 
associated with its content in sulfated exopolysaccharides (Rebolloso Fuentes et 
al., 2000). In contrast, Klamath powder exhibited an almost nil TDF content at 
the front of a carbohydrate level of 19%. In the case of T. suecica, a significant 
increase in carbohydrate and a 30% reduction of TDF were observed under 
nutrient deficiency. Under stress conditions, this microalga typically produces 
large amounts of carbohydrate as energy and carbon reserves (Bondioli et al., 
2012). 
As far as the lipid content of biomass is concerned, Klamath powder showed the 
lowest lipid content (6%) compared to the other microalgae, which was similar 
to the value of lipid found by Kushak et al. (2000) and Becker (2007) for A. 
flos-aquae (5% and 3%, respectively). Four microalgal biomass (A. platensis 
F&M-C256, C. vulgaris Allma, P. purpureum F&M-M46 and P. tricornutum 
F&M-M40) exhibited a lipid content in range of 11-21%, which was 
comparable to the range of values found in literature (Feller et al., 2015; Tibbets 
et al., 2015) (14-19%). Hori et al. (1990) reported a much lower lipid content 
(1%) for N. commune compared to N. sphaeroides F&M-C117 (15%). Six 
strains (C. sorokiniana F&M-M49, C. sorokiniana IAM C-212, starved T. 
suecica F&M-M33, T. suecica F&M-M33 grown in nutrient replete medium, T. 
lutea F&M-M36, and N. oceanica F&M-M24) exhibited values of lipid from 23 
to 29%, which were rather comparable to the range of lipid found by other 
authors (Abiusi et al., 2014; Batista et al., 2013; Guccione et al., 2014; Tibbets 
et al., 2015) (22-24%) (Table 2). 
Ash contents were generally low (4-9.4%) in freshwater species, on the 
contrary, marine strains exhibited significantly higher values up to 22% for P. 
purpureum F&M-M46 (Table 2). This information refers to high inorganic 
compounds presented in marine microalgae species, which is associated with 
the high salinity presented in the culture medium (Feller et al., 2015). 
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Table 2. Biochemical composition of 10 microalgal strains and one natural 
bloom. Data are expressed as % of dry weight including humidity.              
Mean values ± SD (n=3) are reported except for dietary fiber 
 S CP 
(%) 
CHT 
 (%) 
L 
(%) 
TDF 
(%) 
A 
(%) 
M 
(%) 
Ap 68.9 ± 1.0
a
 12.8 ± 0.21
f
 10.7 ± 0.56
g
 6.2 6.1 ± 0.10
f
 7.9 ± 0.20
c
 
K 62.4 ± 5.19
a
 18.8 ± 0.15
b
 6.1 ± 0.84
h
 0.1 6.2 ± 0.32
f
 6.8 ± 0.24
d
 
Ns 50.8 ± 1.45
c
 14.5 ± 0.53
e
 15.1 ± 1.19
e
 12.1 4.0 ± 0.25
g
 7.8 ± 0.28
c
 
CsM49  51.3 ± 0.48
c
 15.5 ± 0.08
d
 22.7 ± 2.00
d,e
 11.2 5.4 ± 0.11
f
 8.5 ± 0.24
b
 
CsIAM 39.9 ± 0.94
e,f
 10.7 ± 0.90
g,h
 27.9 ± 1.30
a
 5.2 9.4 ± 0.37
e
 7.5 ± 0.30
b,c
 
CvA 56.8 ± 2.70
b
 5.9 ± 0.25
i
 16.9 ± 2.83
d
 7.1 9.3 ± 1.47
e
 4.9 ± 0.17
f
 
TsS 18.3 ± 0.10
h
 36.8 ± 1.46
a
 22.4 ± 1.15
b
 12.6 14.8 ± 0.47
b
 6.1 ± 0.26
e
 
TsNR 40.2 ± 0.51
d,e,f
 10.2 ± 0.20
h
 28.5 ± 1.16
a
 18.1 15.7 ± 0.20
b
 7.2 ± 0.14
c,d
 
Pp 34.2 ± 0.10
g
 17.0 ± 1.72
c
 13.1 ± 1.12
f
 15.4 22.0 ± 0.88
a
 10.0 ± 0.39
a
 
Pt 38.8 ± 0.11
f
 11.0 ± 0.70
g
 20.5 ± 0.54
c
 14.7 14.8 ± 0.12
b
 8.0 ± 0.23
c
 
Tiso 42.9 ± 0.42
d,e
 8.6 ± 0.89
h
 27.9 ± 3.25
a
 11.9 11.5 ± 0.27
d
 6.3 ± 0.26
e
 
No 43.1 ± 0.10
d
 14.3 ± 0.19
e
 28.2 ± 2.04
a
 9.5 12.9 ± 0.84
c
 7.2 ± 0.21
c,d
 
Different letters in the same row correspond to significant differences (P<0.05). 
S Strain; CP Crude protein; CHT Total carbohydrate; L Lipid; TDF Total 
dietary fiber; A Ash; M Moisture; Ap A. platensis F&M-C256; K Klamath 
powder; Ns N. sphaeroides F&M-C117; CsM49 C. sorokiniana F&M-M49; 
CsIAM C. sorokiniana IAM C-212; CvA C. vulgaris Allma; TsS T. suecica 
F&M-M33 (starved); TsNR T. suecica F&M-M33 (nutrient replete medium); 
Pp P. purpureum F&M-M46; Pt P. tricornutum  F&M-M40; Tiso T. lutea 
F&M-M36; No N. oceanica F&M-M24 
 
Table 3 shows microalgae fatty acid content and profile. The proportion of total 
saturated (SFA), monounsaturated (MUFA), and polyunsaturated (PUFA)-ω3 
and -ω6 fatty acids were also reported. 
Palmitic acid (C16:0) was the most abundant SFA (1–6.7%) followed by 
myristic acid (C14:0, 0.02–3.1%), lauric acid (C12:0, 0.1-1.6%) and stearic acid 
(C18:0, 0.04–0.6%) (Table 3). The sum of all identified SFAs ranged from 18 to 
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4 47% of the total fatty acid content, which was in agreement with the values 
reported in literature (Abiusi et al., 2014; Feller et al., 2015; Matos et al., 2016). 
It has been found that T. lutea F&M-M36 contains 47% SFA, mainly comprised 
of C14:0, followed by A. platensis F&M-C256 with 45% SFA, predominantly 
C16:0; C. vulgaris Allma and P. purpureum F&M-M46 have intermediate SFA 
content (31 and 30%, respectively), while C. sorokiniana IAM C-212 and 
starved T. suecica F&M-M33 have the lowest SFA content (18%). 
As found by Matos et al. (2016), the highest monounsaturated fatty acids 
(MUFA) content was found in N. oceanica F&M-M24, representing 41% of 
total fatty acid content, followed by P. tricornutum F&M-M40 (30%) and C. 
sorokiniana F&M-M49 (29%). Whereas, A. platensis F&M-C256, C. 
sorokiniana IAM C-212, and P. purpureum F&M-M46 contained very low 
concentrations of MUFA (4-10%). The main MUFA detected in all species 
were palmitoleic acid (C16:1) and oleic acid (C18:1 ω9), with a high variation 
in quantity among the different species. C16:1 was the main MUFA found in 
the most marine species studied, ranging from 0.8 to 5.8%, except for the two T. 
suecica F&M-M33 and for P. purpureum F&M-M46 that had a very low 
content (from 0.04 to 0.2%) (Table 3). These results were comparable with 
those obtained by Feller et al. (2015) and Matos et al. (2016), who demonstrated 
that P. cruentum contains low levels of palmitoleic acid and higher levels of 
arachidonic acid (ARA, C20:4 ω6). The Expert Consultation of FAO stated that 
replacing SFA (C12:0-C16:0) as well as carbohydrates with MUFA reduces 
LDL and increases HDL cholesterol concentrations (FAO/WHO, 2008). Our 
data suggested that the marine species P. tricornutum F&M-M40 and C. 
sorokiniana F&M-M49 had optimal compositions due to the low SFA content 
(~27% of total fatty acids) compared to the other microalgae, a low 
carbohydrate content (11 and 16%, respectively), and a high MUFA content 
(30%). 
Among PUFAs composition, α-linolenic (ALA, C18:3 ω3) and 
eicosapentaenoic (EPA, C20:5 ω3) acids were the predominant PUFAs- ω3, 
while γ-linolenic (GLA C18:3 ω6), arachidonic (ARA, C20:4 ω6) and linoleic 
(LA C18:2 ω6) acids were the prevalent PUFAs-ω6. C. sorokiniana IAM C-
212, P. purpureum F&M-M46 and starved T. suecica F&M-M33 contained 
high PUFAs (73, 68, and 67% of total fatty acids). High proportions of PUFAs-
ω3 were observed in N. sphaeroides F&M-C117 (49%), C. sorokiniana IAM C-
212 (39%), starved T. suecica F&M-M33 (38%), P. purpureum F&M-M46 
(37%) and P. tricornutum F&M-M40 (36%). While high concentrations of 
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PUFAs-ω6 were found in A. platensis F&M-C256 (47%), C. sorokiniana IAM 
C-212 (34%) and P. purpureum F&M-M46 (30%) of the total fatty acids.  
These PUFAs were rather comparable with the values found in the literature 
(Abiusi et al., 2014; Batista et al., 2013; Feller et al., 2015; Gugger et al., 2002). 
Klamath powder and A. platensis F&M-C256 contained very low 
concentrations of PUFA (2 and 3%, respectively) and A. platensis F&M-C256 
had the least favourable ω3/ω6 ratio (0.004) among all microalgae (Table 3). 
This is generally typical for freshwater microalgae/cyanobacteria and makes 
them poor sources of nutritionally-essential long-chain PUFA, arachidonic acid 
(ARA, C20:4 ω6), eicosapentaenoic acid (EPA, C20:5 ω3) and 
docosahexaenoic acid (DHA, C22:6 ω3) (Matos et al., 2016). A well-balanced 
ratio between the ω3/ω6 PUFA is advantageous for human health and 1:4 is 
considered the recommended ratio to prevent cardiovascular diseases 
(Simopoulos, 2012). Except for A. platensis F&M-C256 and T. suecica F&M-
M33 grown in nutrient replete medium, all other microalgae showed ω3/ω6 
ratio of ≥1.0 (Table 3). Indeed, in cyanobacteria (e.g., A. platensis) the 
unsaturated double bonds are preferentially in the ω6 position while in 
Chlorophyceae they are mainly in the ω3 position (Batista et al., 2013; Matos et 
al., 2016). 
As found by Matos et al. (2016), A. platensis F&M-C256 was rich in γ-linolenic 
acid (GLA, C18:3 ω6) (1.7%). GLA has several beneficial health effects and 
GLA oils are mainly used for their antiinflammatory effects (Van Hoorn et al., 
2008). Clinical studies have shown that GLA regulates transepidermal water 
loss (TEWL), whereby, it prevents dryness and helps heal eczema and 
xeroderma. GLA is also shown to stimulate apoptosis of cancer cells without 
affecting healthy cells and can prevent weight regain after weight loss (Van 
Hoorn et al., 2008). 
Studies have shown that EPA and DHA, found in fish, crustaceans, and algae, 
are important for proper fetal development, including neuronal, retinal, and 
immune function. EPA and DHA may affect many aspects of cardiovascular 
function including inflammation, peripheral artery disease, major coronary 
events, and anticoagulation. Moreover, they have been linked to promising 
results in prevention, weight management, and cognitive function in those with 
very mild Alzheimer’s disease (Bucy et al., 2012; Swanson et al., 2012). 
Considering the health benefits related to the consumption of EPA and DHA, N. 
ocenica F&M-M24 and P. tricornutum F&M-M40 are interesting for nutrition 
applications because they were able to synthesize high amounts of EPA (3.2 and 
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4 4%, respectively). In addition, T. lutea can synthesize DHA, and thus these 
microalgae could be also used to enrich foods with this ω3 fatty acid. 
As shown in Table 3, N. sphaeroides F&M-C117, C. sorokiniana F&M-M49 
and C. vulgaris Allma have showed high α-linolenic acid (ALA, C18:3 ω3) 
compared to the other microalgae that contributed to an increased ω3/ω6 ratio 
up to 1.9. Since ALA plays an important role reducing the level of platelets 
stickiness due to the alteration of the aggregating potential, the importance of 
this fatty acid to human-cell functioning is evident. Indeed, the assumption of 
ALA can decrease the probability of thrombotic occlusion and reduce the 
atherosclerotic process (Connor, 1999).  
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Table 3. Fatty acids content and profile (% of dry weight) of the different microalgae 
 Cyanobacteria Chlorophyta Rhodophyta Bacillariophyta Haptophyta Eustigmatophyta 
 Ap K Ns CsM49 CsIAM CvA TsS TsNR Pp Pt Tiso No 
C12:0 - - 0.20 1.55 - 0.55 - 0.59 0.14 0.51 1.21 0.35 
C14:0 - 0.25 0.04 0.05 - 0.06 - 0.03 0.02 0.57 3.09 0.93 
C16:0 2.56 1.24 3.02 1.74 1.26 1.99 1.33 0.95 1.26 1.27 1.62 6.73 
C18:0 0.12 - 0.15 0.11 - 0.26 - 0.60 0.04 0.05 0.14 0.35 
Other SFA 0.02 - 0.13 0.05 - 0.14 - 0.73 0.04 0.60 1.04 0.24 
 SFA 2.70 1.49 3.50 3.50 1.26 3.00 1.33 2.90 1.50 3.00 7.10 8.60 
C16:1 0.29 - 1.23 0.15 0.17 0.44 0.04 0.04 0.16 2.42 0.79 5.82 
C18:1 ω9 0.18 - 0.48 2.52 0.52 1.81 1.95 1.37 0.02 0.90 2.91 3.06 
Other MUFA 0.03 - 0.004 1.43 - 0.05 - 0.49 0.02 0.08 0.10 0.04 
 MUFA 0.50 - 1.75 3.90 0.69 2.30 1.37 1.90 0.20 3.40 3.80 8.92 
C16:3 ω3 - 0.23 - - 0.87 - - - - - - - 
C16:4 ω3 - - - - - - 1.02 - - - - - 
C18:3 ω3 (ALA) 0.01 1.51 2.14 3.44 1.93 2.51 1.76 1.56 - 0.07 1.60 0.02 
C20:5 ω3 (EPA) - - - - - - - 0.39 1.87 3.97 - 3.15 
C22:6 ω3 (DHA) - - - - - - - - - - 1.01 - 
Other PUFA ω3 - - - 0.07 - - - - - - - - 
PUFA ω3 0.01 1.74 2.14 3.51 2.80 2.51 2.78 1.95 1.87 4.04 2.61 3.17 
C16:2 ω6 - - - - 0.56 - - - - - - - 
C18:2 ω6 1.15 0.33 1.08 2.38 1.85 1.85 1.19 1.88 0.35 0.53 1.13 0.28 
C18:3  ω6 (GLA) 1.66 - 0.03 0.04 - 0.01 - 0.03 0.01 0.08 0.04 0.07 
C20:2 ω6 - - - 0.04 - - - - 0.03 0.23 - 0.04 
C20:4 ω6 (ARA) - - 0.03 - - - - 0.11 1.06 0.07 - 0.48 
Other PUFA ω6 0.01 - - - - - - - 0.07 - - 0.09 
PUFA ω6 2.82 0.33 1.14 2.46 2.41 1.86 1.19 2.09 1.52 0.91 1.17 0.96 
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PUFA ω3 + ω6 2.83 2.07 3.28 5.97 5.21 4.37 4.87 3.97 3.39 4.95 3.78 4.13 
ω3/ω6 0.004 5.27 1.88 1.43 1.16 1.35 1.33 0.93 1.23 4.44 2.23 3.30 
TFA 6.0 3.56 8.5 13.4 7.16 9.7 7.29 8.5 5.0 11.3 15.1 21.7 
- traces or 0 value; Ap A. platensis F&M-C256; K Klamath powder; Ns N. sphaeroides F&M-C117; CsM49 C.sorokiniana F&M-M49; 
CsIAM C. sorokiniana IAM C-212; CvA C. vulgaris Allma; TsS T. suecica F&M-M33 (starved); TsNR T. suecica F&M-M33 (nutrient 
replete medium); Pp P. purpureum F&M-M46; Pt P. tricornutum F&M-M40; Tiso T. lutea F&M-M36; No N. oceanica F&M-M24 
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The nutritional quality of lipid profiles observed in the algae species was 
evaluated by different indexes as shown in Table 4. Foods with polyunsaturated 
to saturated fatty acid (P/S) ratio below 0.45 are considered by the FAO/WHO 
to be undesirable in the human diet (FAO/WHO, 2008), due to their potential to 
induce increases in blood cholesterol. The P/S ratio of beef is typically about 
0.1, and this ratio decreases with an increase of meat fatness (Scollan et al., 
2006). The P/S ratio in the microalgae studied in this work varied from 0.48 (N. 
oceanica F&M-M24) to 4.13 (C. sorokiniana IAM C-212), with presumable 
positive health effects in humans. 
The ratio hypocholesterolemic/hypercholesterolemic fatty acids (H/H) is an 
index based on current knowledge of the effects of individual fatty acids on 
cholesterol metabolism (Santos-Silva et al., 2002; Simat et al., 2015). 
Nutritionally, higher H/H values are considered more beneficial for human 
health because is related to a high PUFA content (Matos et al., 2016). The 
highest H/H values were found in N. oceanica F&M-M24, Klamath powder and 
in T. lutea F&M-M36 species (0.83, 1.08 and 2, respectively). These results are 
in agreement with H/H values for marine fish such as sardine and mackerel 
(2.46) reported by Fernandes et al. (2014). The fatty acids from microalgae, that 
are highly polyunsaturated, could have beneficial effects on cholesterol. 
Two other indexes (atherogenicity index, AI and thrombogenicity index, TI) are 
used to evaluate the potential for stimulating platelet aggregation according to 
Turan et al. (2007). Lower AI and TI values indicate a greater potential to 
protect against coronary artery disease. In our study, AI values ranged from 
0.10 (P. tricornutum F&M-M40) to 0.45 (N. oceanica F&M-M24); while A. 
platensis F&M-C256 showed the highest AI (1.58) (Table 4). Simat et al. 
(2015) reported AI values of 0.59–0.92 for the omnivorous fish bogue (Boops 
boops). The lowest TI value was observed in the marine N. oceanica F&M-M24 
(0.91), which is higher compared to the sardine TI value (0.20) reported by 
Fernandes et al (2014). 
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strains and one natural bloom 
Microalga P/S H/H AI TI 
A. platensis F&M-C256 1.04 0.77 1.58 0.52 
Klamath powder 1.39 1.08 0.14 1.23 
N. sphaeroides F&M-C117 0.94 0.64 0.33 1.22 
C.sorokiniana F&M-M49 1.71 0.35 0.13 4.66 
C. sorokiniana IAM C-212 4.13 0.21 0.11 3.41 
C. vulgaris Allma 1.46 0.42 0.21 3.01 
T. suecica F&M-M33 (S*)  3.66 0.25 0.12 3.68 
T. suecica F&M-M33 (NR*) 1.37 0.28 0.18 5.42 
P. purpureum F&M-M46 2.26 0.41 0.17 2.58 
P. tricornutum F&M-M40 1.65 0.49 0.10 3.01 
T. lutea F&M-M36 0.53 2.00 0.39 1.20 
N. oceanica F&M-M24 0.48 0.83 0.45 0.91 
* starved; ** grown in nutrient replete medium; P/S polyunsaturated/saturated; 
H/H Ʃ hypercholesterolemic/Ʃ hypocholesterolemic; AI atherogenicity index; 
TI thrombogenicity index 
 
Fig. 1 shows the total phenolic content (TPC) of the examined microalgae. 
Phenolic compounds, including simple phenols, flavonoids, phenylproponoids, 
tannins, lignins, phenolic acids, and their derivatives, synthesized as secondary 
metabolites are considered the major contributors to antioxidant capacity (Abd 
El-Baky et al., 2009). Cyanobacteria exhibited higher TPC values (from 13.1 to 
18.9 mg GAE g
-1
) compared to the other microalgae. In particular, A. platensis 
F&M-C256 showed the highest TPC (19 mg GAE g
-1
). TPC reported in the 
literature for Arthrospira varied from 2.4 to 49.8 mg GAE g
-1
 depending on 
culture medium (Abd El-Baky et al., 2009), extraction methods (Chaiklahan et 
al., 2013) and culture conditions (Kepekçi and Saygideger, 2012). P. purpureum 
F&M-M46 and N. oceanica F&M-M24 also showed high TPC (around 12 mg 
GAE g
-1
). These two microalgae exhibited higher TPC compared to the values 
found by Goiris et al. (2012) for P. cruentum and N. oculata ethanol/water 
extract (1.2 and 2 mg GAE g
-1
, respectively). P. tricornutum F&M-M40, T. 
lutea F&M-M36 and all Chlorophyta strains exhibited TPC from 3.6 mg GAE 
g
-1
 until 9.2 mg GAE g
-1
. The range of TPC found in our study were higher 
compared to the range of values found by Goiris et al. (2012) (1.7-3.8 mg GAE 
g
-1
), except for C. sorokiniana (not analysed by Goiris et al., 2012). Peng et al. 
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(2009) found for C. sorokiniana ethanol extract a TPC of 26.7 mg GAE g
-1
 
higher compared to that obtained in our study with C. sorokiniana F&M-M49 
and C. sorokiniana IAM C-212 (3.6 and 4.3 mg GAE g
-1
, respectively).  
 
 
Fig. 1. Total phenolic content (expressed as mg GAE g
-1
) in decreasing order of 
10 microalgal strains and one natural bloom. The analysis was performed in 
triplicates. Data are reported as mean ± SD. Different letters between columns 
correspond to significant differences (P<0.05) 
 
3.2 In vitro digestibility 
Until now, few microalgal species are presently accepted in the EU as food or 
food ingredients (EU, 1997). To extend this number is necessary to follow the 
novel food approval regulation that requires specific data to approve a new food 
(EU, 2015).  
The evaluation of in vitro digestibility is a fundamental analysis to provide 
information about the nutritional bioavailability of microalgal biomasses. As far 
as digestibility of microalgae is concerned, most of the literature deals with tests 
for macroalgae (Fleurence, 1999; Paiva et al., 2014; Tibbets et al., 2016) and 
only few studies, to our knowledge, focus on the digestibility of microalgae 
(Mišurcová et al., 2010; Machů et al., 2014; Tibbets et al., 2012). Moreover, it 
is difficult to compare the results of digestibility from various studies in the 
literature due to different algal samples, in term of strains and type of matrix 
(e.g. dried, frozen) and different methods of digestibility determination 
(Mišurcová, 2011). 
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determined by an enzymatic method using pepsin and pancreatin. Dry matter 
(DMD), organic matter (OMD), carbohydrate (CD) and crude protein (CPD) 
digestibilities were reported in Fig. 2. 
None of the strains exhibited digestibility values lower than 45%. Overall, the 
trends of DMD, OMD and CD are rather superimposable. On the contrary, CPD 
digestibility follows a completely different trend (Fig. 2). In particular, as far as 
DMD is concerned, values of digestibility between 47 and 68% were found in 
nine microalgal biomasses (P. purpureum F&M-M46, P. tricornutum F&M-
M40, T. suecica F&M-M33 grown in nutrient replete medium, starved T. 
suecica F&M-M33, N. oceanica F&M-M24, C. sorokiniana F&M-M49, T. 
lutea F&M-M36, N. sphaeroides F&M-C117, Klamath powder) with P. 
purpureum F&M-M46 as the least digestible (47%). The differences in DMD 
values between the microalgal and cyanobaterial samples could be related to the 
different structure of their cell walls (Mišurcová, 2011). Diatoms have cell walls 
made of opaline silica and green algal cell walls are typically composed of 
cellulose, hemicellulose, pectic compounds, and glycoproteins (Andersen, 
2013). Corteggiani Carpinelli et al. (2014) found N. gadiatana has set of genes 
for the synthesis and incorporation in the cell wall of cellulose and sulfated 
fucans and it is able to store carbon in polymers of β-1,3- and β-1,6-linked 
glucose called chrysolaminarin. These compounds contribute to maintaining the 
rigidity of the cell wall limiting the digestive action of enzymes such as pepsin 
and pancreatin (Becker, 2007).  
Besides cell walls components, polysaccharides can form stable complexes with 
proteins that become inaccessible for proteolytic enzymes during the 
digestibility process (Mišurcová, 2011). Porphyridium, the least digestible 
microalga, typically contain many polysaccharides (De Jesus Raposo et al., 
2013). 
C. vulgaris Allma, C. sorokiniana IAM C-212, and A. platensis F&M-C256 
showed the highest DMD values (from 70 to 78%) (Fig. 2). The highest 
digestibility of A. platensis F&M-C256 (78%) is related to its cell wall 
structure, typical of Gram-negative microorganisms. The low concentration 
(<1%) of β-1,2-glucan (first layer), a polysaccharide with low digestibility, the 
small thickness (12 nm) of the first layer, and the proteic and 
lipopolysaccharidic nature of the second layer resulted in a higher digestibility 
of this alga (Tomaselli, 1997). The easy breakage of its cell walls allowed a 
higher accessibility to its intracellular content by enzymes, and for this reason, 
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chemical or physical processing steps are not required in order to make its 
biomass more digestible (Balloni et al., 1980; Tomaselli, 1997). Devi et al. 
(1981) and Mišurcová et al. (2010) found an even higher DMD values for A. 
platensis (84% and 94%, respectively) compared to our study. The DMD 
showed by C. sorokiniana IAM C-212 was comparable to the value obtained by 
Mišurcová et al. (2010) for C. pyrenoidosa (75%). To our knowledge, no 
literature is available concerning DMD of the other investigated microalgae.  
CD followed the same trend of DMD and also in this case A. platensis F&M-
C256 was the most digestible strain (79%) and P. purpureum F&M-M46 the 
least digestible microalga (about 51%). Also the behavior of OMD was very 
similar to that of DMD, with the difference that seven strains (P. purpureum 
F&M-M46, P. tricornutum F&M-M40, T. suecica F&M-M33 grown in nutrient 
replete medium, starved T. suecica F&M-M33, N. oceanica F&M-M24, C. 
sorokiniana F&M-M49, T. lutea F&M-M36) showed values between 51 and 
65% and four strains (N. sphaeroides F&M-C117, C. vulgaris Allma, C. 
sorokiniana IAM C-212, A. platensis F&M-C256) plus Klamath powder 
exhibited OMD from 71 to 86% (Fig. 2).  
Concerning CPD, N. oceanica F&M-M24 and C. sorokiniana F&M-M49 
exhibited the least values (50 and 55%), while most of the strains (T. suecica 
F&M-M33 grown in nutrient replete medium, T. lutea F&M-M36, C. 
sorokiniana IAM C-212, starved T. suecica F&M-M33, P. tricornutum F&M-
M40, P. purpureum F&M-M46), including Klamath powder showed values 
from 62 to 70%. C. vulgaris Allma, A. platensis F&M-C256, and N. 
sphaeroides F&M-C117 were the most digestible strains (76, 81, 82%, 
respectively), which compares favourably with the true protein digestibility 
values found for beans, oats, and wheat (FAO/WHO, 2007). Many authors 
reported very diverse CPD values for different species of Chlorella (from 44 to 
97%, Janczyk et al., 2005; Morris et al., 2008; Mišurcova et al., 2010), 
Arthrospira (from 70 to 84%, Devi et al., 1981; Becker, 2004), and Nostoc (45–
50%, Hori et al. 1990). Tibbets et al. (2012) reported higher CPD for P. 
tricornutum, N. granulata, T. chuii and P. aerugineum (83-97%) compared to 
the values found in our study for these genera. This large variability may be 
related to species differences but more likely due to differences in methods used 
such as differences in enzyme mixtures, sample processing, assay conditions, 
and the extent of algal cell wall disruption (Mišurcova, 2011).  
Despite no significant linear correlation (R
2
 = 0.10; P> 0.05) between CPD and 
dietary fiber was found, reduced CPD of algae can also be attributed to 
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rendering them less bioavailable to enzymatic hydrolysis (Marrion et al. 2005). 
A significant negative correlation (R
2 
= 0.63; P<0.05) between DMD, OMD, 
and CD and the fiber content was found. Microalgae rich in fiber always 
reported lower DMD, OMD, and CD. When the low digestibility was not 
attributable to the high fiber contents (as for e.g. the case of C. sorokiniana 
F&M-M49), probably the nature of the cell wall caused the limited digestibility 
(Table 2, Fig. 2). 
Besides their antioxidant potential TPC was also important because of their 
potential negative effects on protein quality. Plant-based phenolic compounds 
have the ability to precipitate dietary protein, causing reduced protein 
digestibility and amino acid availability (Julkunen-Tiitto, 1985). The 
mechanism by which these compounds may reduce protein digestibility is 
through hydrogen-binding and/or oxidation of proteins and amino acids 
rendering them unavailable to proteolytic enzyme hydrolysis and subsequent 
intestinal absorption (Tibbets et al., 2015). For the majority of microalgae 
studied here, CPD was >60% and TPC was generally low (<19 mg GAE g
−1
; 
Fig. 1); however, no significant correlation between TPC and CPD was found 
(R
2 
= 0.16, P>0.05). As such, it seems unlikely that TPC in microalgal biomass 
will contribute to any significant detrimental effects on protein bioavailability. 
  96                          
4 
 
Fig. 2. Dry matter (in order of decreasing digestibility), organic matter, carbohydrate 
and crude protein digestibility (expressed as %) of 10 microalgal strains and one natural 
bloom. The analyses were performed in triplicate. Data are reported as mean value ± 
SD. Ap A. platensis F&M-C256; K Klamath powder; Ns N. sphaeroides F&M-C117; 
CsM49 C.sorokiniana F&M-M49; CsIAM C. sorokiniana IAM C-212; CvA C. vulgaris 
Allma; TsS T. suecica F&M-M33 (starved); TsNR T. suecica F&M-M33 (nutrient 
replete medium); Pp P. purpureum F&M-M46; Pt P. tricornutum F&M-M40; Tiso T. 
lutea F&M-M36; No N. oceanica F&M-M24 
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The robust microalgae cell wall, which restricts the access of the gut enzymes to 
the cell components, is one of the main reason which makes microalgae low 
digestible (Janczyk et al., 2005). Microalgae of commercial importance (mainly 
Chlorophyceae) have rigid indigestible cell walls and many authors described 
the sonication treatment as efficient method to open microalgal cell (McMillan 
et al., 2013; Safi et al., 2014; Wang et al., 2014). 
The dry biomass of two Chlorella strains, C. sorokiniana F&M-M49 and C. 
vulgaris Allma, were pre-treated by sonication before pepsin incubation and the 
DMD obtained was compared to that of the untreated samples. Untreated C. 
sorokiniana F&M-M49 and C. vulgaris Allma showed DMD values of 55 and 
70%, respectively, significantly different among them (P<0.05). A significant 
difference (P<0.05) also emerged when digestibility of the two sonicated strains 
was compared. Although the pre-treatment led to an increase of dry matter 
digestibility for both C. sorokiniana F&M-M49 and C. vulgaris Allma (Table 
5), these values were not significantly different (P>0.05) compared to those of 
the untreated samples. 
 
Table 5. In vitro DMD of two Chlorella strains with and without sonication 
pre-treatment. Analyses were performed in triplicate and data are reported as 
mean value ± SD 
Microalga Dry matter digestibility (%) 
C. sorokiniana F&M-M49 54.7 ± 4.02
a
 
C. sorokiniana F&M-M49 sonicated 59.7 ± 2.84
a
 
C. vulgaris Allma 69.5 ± 3.02
b
 
C. vulgaris Allma sonicated 73.1 ± 2.11
b
 
Different superscript letters represent significant differences (P<0.05) between 
treatments 
 
Microscope observations performed on suspensions of Chlorella biomass before 
and after sonication are showed in Figs 3 and 4. Sonication dissolved entirely 
the aggregates in C. sorokiniana F&M-M49 (Fig. 3b) and significantly reduced 
their dimension in C. vulgaris Allma (Fig. 4b). Few cells were completely 
disintegrated after sonication in both microalgae, although a cell weakening due 
to sonication, cannot be ruled out. From the microscopic observations, it is 
possible to underline that the sonication treatment dispersed the cells but did not 
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improve significantly the digestibility, on the other hand also the digestion 
process without sonication treatment allowed complete cells dispersion (Fig. 3c) 
or reduced aggregate dimensions (Fig. 4c) thanks to the adoption of a mixing 
regimen. To our knowledge, no literature is available concerning sonication 
methods for increasing the DMD of microalgae. 
The data obtained in this study confirm the positive effect of the sonication 
pretreatment and of the continuous stirring on cell dispersibility without a 
significant improvement in digestibility of these Chlorella strains. 
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Fig. 3. Microscopic aspect of C. sorokiniana F&M-M49 suspensions before 
sonication (a), after sonication without digestion (b) and after digestion without 
sonication treatment (c). Magnification 400x. Photomicrograph by the authors 
c 
b 
a 
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Fig. 4. Microscopic aspect of C. vulgaris Allma suspensions before sonication 
(a), after sonication without digestion (b) and after digestion without sonication 
treatment (c). Magnification 400x. Photomicrograph by the authors 
 
 
b 
a 
c 
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Abstract 
Arthrospira platensis (A. platensis) is a nutritious food source with several 
promising health promoting activities. We investigated the dietary safety of A. 
platensis F&M-C256 in rats, explored its potential health promoting effects and 
the underlying mechanisms. 
Male Sprague-Dawley rats were fed AIN-76 diet (control) or the same diet 
containing 20% A. platensis F&M-C256 for 1 month. A. platensis F&M-C256 
supplemented diet was well-tolerated: no behavioral abnormalities were 
observed, and food consumption, clinical observations and body weights were 
not affected (except for liver weight). The high salt content of the algal biomass 
resulted in an increased water consumption and urine excretion, but not in 
raised Na
+
 plasma levels. No histopathological alterations of the kidney, 
increased blood pressure or renal oxidative damage were observed. The 
digestibility of A. platensis F&M-C256 diet was slightly lower compared to 
controls and this was accompanied by an increased feces production and fecal 
water content. A. platensis F&M-C256 DNA content (about 4%) did not 
increase urinary uric acid excretion. No changes in organs weights or 
histopathology were observed. Clinical biochemistry parameters did not 
indicate any renal or hepatic impairment. Total cholesterol and LDL were 
unchanged, but a significant increase in HDL was found in the A. platensis 
F&M-C256 fed group. The reduction of liver weight was associated to 
significantly decreased plasma triglycerides, increased excretion of fecal lipids 
and to the induction of PPAR-α expression in the liver.  
A. platensis F&M-C256 is likely to be safe even at high dosages and may 
represent a promising source of functional foods for the prevention of 
dyslipidemias. 
Keywords: Microalgae; Food; Safety; Arthrospira platensis F&M-C256; 
Hypolipidemic effects; Dyslipidemias 
 
 
1. Introduction 
Arthrospira platensis, formerly known as Spirulina platensis, is a planktonic 
cyanobacterium that thrives in tropical and subtropical water bodies 
characterized by high levels of carbonate and bicarbonate and high pH (up to 
11) in Africa, Asia, Central and South America (Tomaselli, 1997). A. platensis 
is cultivated worldwide and is the microalga with the largest annual biomass 
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production, in excess of 5000 t (Borowitzka, 2013). Taking advantage of the 
selective (high alkalinity) culture medium, most of the Arthrospira biomass is 
produced in open systems, mainly raceway ponds (Belay, 2008; Milledge, 
2011), while cultivation in photobioreactors, being more expensive, is mainly 
limited to research (Tredici & Chini Zittelli, 1997). The largest production 
facilities are located in China, United States, and India, although diffuse small 
scale production facilities are common in many countries, including France. 
In terms of nutrition, A. platensis is a source of macro and micronutrients 
including proteins, iron, γ-linolenic acid, vitamins, minerals, sulfated 
polysaccharides and phycocyanin and a number of unexplored bioactive 
compounds (Kulshreshtha et al., 2008). Protein content and aminoacidic 
composition are comparable to those of soybean, thus A. platensis represents an 
alternative source of high-quality protein that could meet the needs of 
malnourished people (Becker, 2007). Currently, A. platensis is mainly used as 
dietary supplement in the health food market, in the form of powder, capsules or 
tablets. A. platensis is also increasingly used as a food ingredient, incorporated 
into pasta, biscuits, bread, candies, yogurt and soft drinks (Christaki et al. 2011; 
Pulz and Gross 2004).  
Although the safety of Arthrospira for human consumption is supported by its 
long history of use as food (Abdulqader et al., 2000; Belay, 2008) also 
recognized in the food regulations of most countries (e.g. Europe, Australia, 
US) (Borowitzka, 2013; Niccolai et al., 2016), further risk assessment should be 
conducted. Several toxicity studies have been performed both in in vitro and in 
vivo models. Although in vitro models are faster, easier and less expensive they 
can only be adopted in pre-screenings, as they are unable to provide information 
on the interactions in complex organisms, thus studies in in vivo models are still 
necessary (Niccolai et al., 2016). Few in vivo toxicological studies are available 
in the literature. Salazar et al. (1998) in a sub-chronic toxicity study found no 
adverse effects in mice fed Arthrospira maxima up to 30% in the diet. Among 
the few reports on A. platensis, Hutadilok-Towatana et al. (2008) tested the 
acute and sub-chronic effects of dietary supplementation in mice and rats, 
respectively, observing no adverse effects.  
In addition to its nutritional value, Arthrospira shows several activities of 
pharmacological interest such as antioxidant (Khan et al., 2005), anti-
inflammatory (Mao et al., 2000; Ali et al., 2015). Hypolipidemic effects have 
been demonstrated for A. maxima and Arthrospira spp. in various animal 
models (Torres-Durán et al., 1999; Blé-Castillo et al., 2002; Moura et al., 2011;  
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Muga et al., 2014). Hypolipidemic activity of A. platensis have been also 
demonstrated in mice and in rats (Kato et al., 1984; Iwata et al., 1990) and in 
rabbits (Colla et al., 2008; Kim et al., 2010). In all these studies, the 
hypolipidemic effects were investigated in chemically or dietary-induced 
experimental models of hyperlipidemias. To date, the knowledge of A. platensis 
effects in a balanced, normo-fat diet is limited. The aim of this study was 
therefore to investigate the dietary safety of 20% Arthrospira platensis F&M-
C256 in a 4-week feeding trial in rats, verify its effects on lipid metabolism and 
explore the underlying mechanisms. 
 
2. Materials and methods 
2.1 Biomass production, preparation and gross composition 
Arthrospira plantesis F&M-C256 (A. platensis F&M-C256) from the F&M 
Culture Collection of Microalgae and Cyanobacteria was cultivated in GWP
®
 
photobioreactors (Tredici et al., 2004) in semi-batch mode. The biomass was 
harvested by centrifugation, washed with NaCl solution, frozen, lyophilized and 
powdered. The powdered biomass was stored at -20°C until use. Elemental 
analysis was performed on dry biomass using a CHNSO Analyzer (Flash EA, 
1112 Series, Thermo Electron Corporation, Massachusetts, USA) (Gnaiger and 
Bitterlich, 1984). Total protein content was estimated as N x 6.25, where N is 
the nitrogen content determined through the elemental analysis. Carbohydrate 
was determined following Dubois et al. (1956) and lipid following Marsh & 
Weinstein (1966). Humidity was analyzed following ISTISAN protocols 
(ISTISAN Report 1996/34, Method B, Page 7). Fiber was determined according 
to AOAC (AOAC Official method 985.29). Protein, carbohydrate, lipids and 
fiber content were 59%, 16%, 7% and 12.4%, respectively. 
2.2 Diet preparation 
Dietary components (Piccioni, Gessate, Milan, Italy) were based on the 
American Institute of Nutrition (AIN)-76 diet containing 5% fat (corn oil). The 
microalga-supplemented diet was modified to compensate for proteins, lipids, 
carbohydrate and fibers deriving from A. platensis F&M-C256 biomass (Table 
1). 
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Table 1. Composition of the experimental diets 
g/100 g of diet (d.w.) 
AIN-76  
(control diet) 
A. platensis F&M-C256 
supplemented AIN-76  
Dry frozen biomass  - 20 
Corn oil  5 3.6  
Sucrose  50 50 
Starch 15 11.8  
Casein  20 8.2  
Cellulose 5 2.5   
Mineral Mix AIN 76 3.5 3.5 
Vitamin Mix AIN 76 1 1 
Coline 0.2 0.2 
DL Methionine 0.3 0.3 
 
2.3 Animals and treatment design 
All procedures were carried out in agreement with the European Union 
Regulations on the Care and Use of Laboratory Animals (OJ of ECL 358/1, 
12/18/1986), according to Italian regulations on the protection of animals used 
for experimental and other scientific purposes (DM 116/1992), after approval 
from the Italian Ministry for Scientific Research. After 1 week of 
acclimatization in plastic cages, male Sprague-Dowley rats, aged 6-8 weeks, 
were divided in two experimental groups. Rats were fed AIN-76 (control diet) 
or A. platensis F&M-C256 supplemented AIN-76 ad libitum for 1 month (N = 
8/diet group). The microalga-supplemented diet contained 20% of lyophilized 
microalgal biomass. Water was available ad libitum, the lighting regime was a 
standard 12 h light and 12 h dark, temperature was maintained constant at 
21±2°C. At the end of the study, rats were euthanized by inhalation of CO2. 
Following the sacrifice, selected organs and tissues (liver, kidney, colon, 
caecum, bladder, stomach, heart) were weighed and stored for macroscopic and 
histopathology examination, for the determination of oxidative stress 
parameters and gene expression. Blood was collected for clinical analyses (lipid 
profile, kidney and liver function). 
2.4 Clinical observations and body weights 
All animals were observed daily for morbidity and mortality. Detailed physical 
examinations were conducted on all animals weekly, beginning one week prior 
to the beginning of the experiments and one week prior to necropsy. Individual 
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animal body weights were recorded weekly starting from the first day of the 
experiment. Mean body weights and mean body weight changes were calculated 
for the corresponding intervals. Final body weights were recorded prior to 
sacrifice. 
2.5 Feed consumption and digestibility of the diets 
During the third week of treatment, the animals were placed in metabolic cages 
for one day in order to collect 24-hour urine and feces, to assess the palatability 
of the diet by measuring food daily consumption, to measure water daily 
consumption and the diet digestibility. Samples of feed and fecal samples were 
collected, weighed and oven-dried at 55°C until constant weight to determine 
humidity. The coefficient of digestibility was calculated as follows: 
Digestibility % = [feed dry weight – 24-hours feces dry weight /feed dry 
weight] x 100. 
2.6 Clinical pathology 
Blood samples were collected from all animals prior to scheduled necropsy. 
Plasma and urinary chemical parameters were performed at the General 
Laboratory of the Azienda Ospedaliero Univesitaria di Careggi, Florence, Italy, 
and included: urea, creatinine, alkaline phosphatase, alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), total cholesterol, LDL, HDL, uric 
acid, and sodium. 
2.7 Macroscopic and microscopic examinations 
A complete necropsy was conducted on all rats. The necropsy included an 
examination of the external surface, of all orifices, and of the cranial, thoracic, 
abdominal and pelvic cavities, including viscera. Selected tissues and organs 
were collected and placed in 10% neutral-buffered formalin. At necropsy, the 
following organs of all animals were weighed: brain, heart, kidneys, liver, 
bladder, caecum, colon, spleen. 
2.8 Histological analysis  
For histological evaluations tissue samples of heart, kidneys, liver, urinary 
bladder and brain were collected and fixed in 4% phosphate buffered formalin 
for 12 hours. Samples were dehydrated in ethanol and embedded in paraffin. 5-
µm thick sections were hematoxilin-eosin stained and observed for 
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morphological analysis. Regarding heart, the thickness of the ventricular wall 
was measured. In detail, five microscopical fields per animal were registered by 
a digitizing camera applied to a light microscope with a 20x objective, each 
field corresponding to a test area of 141,100 μm2. On the digitized images 
measurements of ventricular wall thickness were carried out using ImageJ 1.33 
image analysis software (http://rsb.info.nih.gov/ij) by two independent 
observers in blind fashion. 5-µm thick sections of frozen liver and feces were 
obtained and stained with Sudan Black (Sigma Aldrich, Milan Italy) in order to 
evaluate the presence of neutral triglycerides and lipids. 
2.9 Blood Pressure Measurements  
Systolic, diastolic blood pressure, mean arterial pressure (MAP) and hearth 
frequency were monitored in conscious rats by noninvasive computerized tail-
cuff method (Visitech BP-2000 Series II Blood Pressure Analysis System, 
Virginia, USA) at week 3 of treatment after two days of training. 
2.10 Fecal water content 
Fresh fecal samples were harvested when the rats were killed and frozen at -
20°C until analyses. To determine the degree of diarrhea, fecal samples were 
dried in a dehumidified oven at 50°C until constant weight and the water 
content was expressed as a percentage of the fresh fecal weight (Castagnini et 
al., 2009). 
2.11 Tibio-tarsal joint edema assessment 
The thickness of the tibio-tarsal joint of rats fed A. platensis F&M-C256 
supplemented AIN-76 diet was measured by using a micrometer (screwgauge) 
and compared to the joint thickness of the control group.  
2.12 RT-PCR 
RNA was extracted from tissue homogenates by using a commercially available 
kit following manufactures’ instructions (Macherey-Nagel, Bethlehem, USA). 
For first-strand cDNA synthesis, 1 µg of total RNA from each sample was 
reverse-transcribed by using the RevertAid RT Kit (Thermo Scientific, 
Waltham, MA, USA). Primers were designed on the basis of the rat GenBank 
sequences (Table 2). For each target gene, the relative amount of mRNA in the 
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samples was calculated as the ratio of each gene to b-actin mRNA (Luceri et al., 
2002). 
 
Table 2. Primer sequences 
  Gene Primer forward Primer reverse Base pair 
  b-actin ACCACAGCTGAGAGGGAAATC  AGAGGTCTTTACGGATGTCAACG 281 
 OGG1 CCTGGCTGGTCCAGAAGTAG TTTCCCAGTTCTTTGTTGGC 345 
 APEX GCTCAGAGAACAAACTCCCG TTGTTTCCTTTGGGGTTACG 385 
 UNG TCCGGACCCCGACTCCTGGC GCGGGGGTGGAACTGGCCTC 419 
 SOD2 TTAACGCGCAGATCATGCAGC TGGCCTTATGATGACAGTGAC 807 
 PPAR-a GTCCTCTGGTTGTCCCCTTG CCTCTCCGAGGGACTGAGAA 389 
 HMGCR CAGCTGTACCATGCCGTCTA AAAGAGCCAGAAACCAAGCA 433 
 
2.13 Microalgal DNA content  
DNA was extracted from 50 mg of microalgal biomass by sonication in 500 µl 
Lysis buffer (TrisHCl 0.1M; EDTA 5.10-2M ; SDS 0.2%; NaCl 0.2M). Then, 
100 µl of Proteinase K (10 mg/ml, Qiagen, Hilden, Germany) were added to 
100 µl of lysate and the samples were incubated overnight at 56°C and gently 
shacked at 300 rpm. At the end of incubation, 20 µl of sodium acetate (3M pH 
5.2 Sigma Aldrich, Milan Italy) and 500 µl of absolute ethanol were added and 
incubated overnight at -80°C. The samples were centrifuged at 14,000 rpm for 
30 min. The supernatant was discharged and the pellet was washed twice (300 
µl of 70% ethanol) and then centrifuged as described above. Finally, the ethanol 
was removed and the pellet was re-suspended in 20 µl of H2O. 
2.14 Fecal lipid content  
Dried fecal samples were re-suspended in 500 µl of normal saline. Then 500 µl 
of chloroform-methanol (2:1, v/v) were added in order to extract the lipids. The 
suspension was then centrifuged at 1,000 g and the solvent was aspirated, and 
evaporated. The residue was weighed and fecal lipids were expressed as a 
percentage of fecal dry weight (http://www.bio-protocol.org/e1375). 
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2.15 Carbonyl residues (CO) and ferric reducing ability of plasma (FRAP) 
CO levels in the liver and kidneys were determined by the method of Correa-
Salde and Albesa (2009). The FRAP values were measured according to the 
method used by Benzie and Strain (1996) as described by Lodovici et al. 
(2015). 
2.16 Statistical analysis 
Data were analyzed using statistical methods and values were presented as 
mean with the standard error (SE) and the number of animals (N) used to 
calculate the mean. Body weight gain, necropsy body weight, clinical chemistry 
and gene expression were analyzed using un-pair t-test with Mann Whitney 
correction. 
 
3. Results 
3.1 Survival, clinical observations, body weights 
All animals survived until the time of sacrifice. At necropsy, in the bladder of 1 
out of the eight rats fed A. platensis F&M-C256 diet an amorphous formation 
was found. Excretion of dark-red feces was not observed throughout the feeding 
period and there were no other treatment-related clinical manifestations. The 
growth curves of the animals during the study were consistent with historical 
background data (Figure 1, panel A). Compared to the control group, no 
treatment-related statistically significant effects of the diet rich in microalgal 
biomass were noted on body weight or weight gain (Figure 1, panel A and B, 
51.0 ± 6.6 g in control group vs 65.5 ± 8.4 g in A. platensis F&M-C256 group). 
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Figure 1. Effect of feeding rats with a 20% A. platensis F&M-C256 diet on 
body weight and weight gain 
 
3.2 Food and water consumption, digestibility of the diet and feces production 
The overall feed consumption of animals receiving the A. platensis F&M-C256 
diet was similar to that of the controls. The palatability of the diets was good 
since animals completely consumed the food administered daily. The 
digestibility of the A. platensis F&M-C256 diet was quite lower (-0.9%) 
compared to the control diet. In rats fed the A. platensis F&M-C256 rich diet, a 
tendency (+ 68%) to an increased production of feces was observed. Besides, 
the fecal water content increased compared to controls (60% vs 50%). It is 
worth nothing that the treatment with A. platensis F&M-C256 was also 
associated to a significant increase in water consumption compared to control 
rats (Table 3) and this effect was accompanied by an augmented urine 
excretion.  
 
Table 3. Effects of A. platensis F&M-C256 rich diet on water daily 
consumption, feces production, fecal water content and urine production 
 Water 
daily 
consumption (ml) 
Urine 
daily 
production (ml) 
Feces 
daily 
production (g) 
Water 
fecal 
content (%) 
Control diet           
(n=4) 
21.53 ± 1.68 
 
7.00 ± 1.29 1.85 ± 0.38 50.42 
A. platensis 
F&M-C256 diet 
(n=8) 
27.18 ± 1.24* 12.63 ± 0.99** 2.71 ± 0.38 60.32 
*p<0.05; ** p<0.01 
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3.3 Organ weight 
No significant changes in brain, heart, spleen, caecum, kidney and bladder 
weight to body weight was observed. A significant reduction of liver weight 
was observed in A. platensis F&M-C256 fed rats when compared to controls  
(p<0.01) (Table 4). 
 
Table 4. Effects of A. platensis F&M-C256 rich diet on group mean organ 
weight adjusted to necropsy body weight in rats 
 brain 
weight/ 
body 
weight (g) 
heart 
weight/ 
body 
weight (g) 
spleen 
weight/ 
body 
weight (g) 
liver 
weight/ 
body 
weight (g) 
caecum 
weight/ 
body 
weight (g) 
kidney 
weight/ 
body 
weight (g) 
bladder 
weight/ 
body weight 
(g) 
Control 
diet (n=4) 
0.005 0.004 0.002 0.047 0.009 0.007 0.000 
A. platensis 
F&M-C256 
diet (n=8) 
0.0052 0.0036 0.002 0.033** 0.0090 0.0067 0.0005 
*p<0.05 
 
3.4 Effects of A. platensis F&M-C256 on clinical chemistry parameters 
Serum creatinine values, urea, aspartate transaminase (GOT), alkaline 
phosphatase and alanine aminotransferase (ALT) did not indicate any renal or 
hepatic impairment. Compared to control group, total cholesterol concentration 
was unchanged in the A. platensis F&M-C256 fed group, but a significant 
increase in HDL was found. Triglycerides significantly diminished in A. 
platensis F&M-C256 fed rats (from 187 to 52.5 mg/dL) (Table 5). The urinary 
uric acid content was similar in the two groups (10.8 ± 1.3 mg/dL in the control 
group vs 11.9 ± 2.9 mg/dL in the A. platensis F&M-C256 group). No 
differences in sodium excretion were observed (74 ± 10.7 mEq/L vs 82.3 ± 5 
mEq/L in controls and A. platensis F&M-C256 fed rats respectively). 
Table 5. Effect of A. platensis F&M-C256 on clinical chemistry parameters 
 Urea 
(g/L) 
Creatinin 
(mg/dL) 
AST 
U/L 
ALT 
U/L 
Alkaline 
phosphatase 
(U/L) 
Triglycerides 
(mg/dL) 
Control 
diet (n=4) 
   0.42±0.04 0.34±0.06 290.5±176.5 75.0±16 155.0±28.0 187±62 
A. platensis 
F&M-C256 
diet (n=8) 
    0.27±0.02* 0.35±0.01 147.3±14.0 48.8±2.3* 147.0±16.4 52.5±10.9* 
*p<0.05 
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Table 5. Continued 
 Total 
cholesterol 
(mg/dL) 
HDL 
(mg/dL) 
LDL 
(mg/dL) 
Control 
diet (n=4) 
73.0±4.0 55.0±5.0 
 
   5.0±0.01 
A. platensis  
F&M-C256 diet (n=8) 
76.2±2.2 72.7±2.4* 5.0±0.01 
*p<0.05 
 
3.5 Blood pressure 
Systolic and diastolic blood pressure as well as heart rate and MAP were not 
significantly affected by A. platensis F&M-C256 rich diet (Table 6). 
 
Table 6. Blood pressure parameters 
 Systolic  
(mm Hg) 
Diastolic 
(mm Hg) 
Heart rate 
(beats/min) 
MAP 
(mm Hg) 
Control diet (n=4) 142.9 ± 5.3 81.1 ± 7 386.2 ± 32.3 100.8 ± 6.6 
A. platensis  
F&M-C256 diet (n=8) 
135.8 ± 14.5 79.7 ± 6.7 387.5 ± 28.2 99.2 ± 9.7 
MAP= mean arterial pressure 
 
3.6 Tibio-tarsal joint edema assessment 
No significant difference was found in the mean tibio-tarsal joint thickness 
between groups, data not shown. 
3.7 Histological analysis 
Histological analyses conducted on sagittal sections of whole brain did not 
show any sign of morphological damage in brain or in cerebellar areas. The 
liver showed a normal morphological structure. In hepatocytes no clear cyto-
pathological signs such as steatosis, hemosiderine accumulation or biliary stasis 
were present. In the bladder of 1 out of the eight rats fed A. platensis F&M-
C256 diet areas with crystalloid appearance included within amorphous areas 
were observed. In one kidney of the same animal, a eosinophilic amorphous 
content was found  in the lumen of proximal and distal convoluted tubules 
(Figure 2). The kidneys of the remaining animals did not show any 
morphological damage. 
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Figure 2. Representative images of amorphous areas in kidney and urinary 
bladder of one rat fed A. platensis F&M-C256. Panel A: digitalized image of 
kidney with amorphous content in proximal and distal convolute tubules (black 
arrows). Panel B: digital reconstruction of whole urinary bladder. Amorphous 
eosinophilic mass with some crystalloid areas was evident in the lumen (black 
asterisk). Scale bar: 100 µm 
 
3.8 Oxidative stress and antioxidant status in the liver and kidney 
FRAP and carbonyl residues assays were performed in order to evaluate the 
antioxidant status and protein oxidative damage in the liver and kidney. No 
significant differences were found (data not shown). 
3.9 Expression of oxidative stress-related genes in the kidney 
To investigate oxidative stress related parameters in the kidney, the expression 
of the DNA repair enzymes UNG, OGG1, APEX and that of the antioxidant 
enzyme SOD2, was investigated; the expression of OGG1 was slightly but 
significantly reduced in A. platensis F&M-C256 fed rats compared to controls. 
No significant treatment related difference in the expression of the other 
enzymes was observed (Table 7). 
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Table 7. Expression of UNG, OGG1, APEX and SOD2 in the kidney of A. 
platensis F&M-C256 fed rats 
 UNG OGG1 APEX SOD2 
Control diet 
(n=4) 
0.48 ± 0.12 0.52 ± 0.04 0.91 ±0.17 0.94 ± 0.13 
A. platensis 
F&M-C256      
diet (n=8) 
0.53 ± 0.05 0.38 ± 0.04* 0.71 ± 0.08 0.81± 0.12 
*p<0.05. The relative amount of mRNA in the samples was calculated as the 
ratio of each gene to the housekeeping gene, β-actin. 
 
3.10 Expression of lipid metabolism-related genes in the liver 
To explore the possible molecular basis of the observed effects on lipid 
metabolism, we analyzed the expression of PPAR-α and HMGCR genes in the 
liver. We did not find any differences in HMGCR expression between the two 
groups (0.63 ± 0.04 in the controls vs 0.61 ± 0.02 in A. platensis F&M-C256 fed 
rats), but we found a significant over expression of PPAR-α in the liver of rats 
fed A. platensis F&M-C256 diet (Figure 3). 
 
Figure 3. Expression of PPAR-α in the liver of A. platensis F&M-C256 fed rats 
and in rats fed standard diet (Controls).*= p<0.05 
 
3.11 Fecal lipids excretion 
Compared to the control group, rats fed A. platensis F&M-C256 diet showed an 
increased (+56%) fecal lipid excretion (Table 8). 
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Table 8. Percentage of lipids in stool samples of A. platensis F&M-C256 fed 
rats and in rats fed control diet 
 Fecal lipid excretion (%) 
Control diet (n=4) 13.7 ± 2.5 
A. platensis F&M-C256 diet (n=8)  21.4 ± 2.7* 
*p<0.05 
 
3.12 Microalgal DNA content 
DNA content in A. platensis biomass was 4% of dry weight. 
 
4. Discussion 
In the last years, there has been a growing interest in functional foods because 
of the beneficial health effects that they can promote and their potential to 
prevent chronic diseases such as diabetes, obesity, cardiovascular diseases and 
metabolic syndrome. Microalgae are an almost unexplored natural source of 
bioactive ingredients of high nutritional and nutraceutical value. The first 
concern when proposing microalgae as food or food ingredients for human 
consumption is to establish their lack of toxicity towards the consumer. In this 
regard, several species of different algal groups have been reported to produce 
neurotoxins, hepatotoxins, diarrheic toxins, dermotoxins, which are usually 
active at very low doses (Landsberg, 2002). Besides toxins, microalgae are able 
to produce other secondary metabolites that may have noxious effects on human 
health (Tredici et al., 2009). We assessed the tolerability of a diet containing a 
relatively high amount of Arthrospira platensis F&M-C256 biomass in rats. 
Overall our results indicate that a diet supplemented with 20% algal biomass 
was well tolerated during the 30 day feeding period and no treatment-related 
morbidity or mortality was detected. Some previous studies on the safety of 
microalgae tested from 1% to 20% biomass in the diet (Stewart et al., 2008). 
The high amount of biomass in our experimental diet (20%) was chosen to 
evaluate the potential of microalgae as foods or food components for human 
use. Data reported so far indicate a general safety profile of A. platensis in 
animals at dosages up to 120 mg/kg. The novelty of this study is in the fact that 
the sub-chronic toxicity of A. platensis F&M-C256 was investigated at doses 
compatible with dietary supplementation and did not take into account the 
historical use of this microalga as food whose dosage might vary from 10-40 g 
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per person a day (as Dih´e biscuits in Africa) (Ciferri, 1983; Marles et al., 
2011). 
The NOAELs (No Observed Adverse Effect Level) appear to be over 10 g/kg 
BW/d for A. platensis and 30% in the diet for Arthrospira sp. (corresponding to 
30 g/kg BW/d) (Chamorro et al. 1988). Human studies also showed that A. 
platensis at a dose of 1.7 g/kg BW did not result in any adverse effects in 
children (Simpore et al., 2005). Yamani et al. (2009) indicated that an intake of 
about 10 g of spirulina per day for 6 months, did not induce adverse effects in 
HIV patients. However, some adverse effects were reported as reviewed in 
Marles et al. (2011). 
The nucleic acid content is an important concern since the biochemical 
degradation of leads to uric acid, which can produce kidney stones and induce 
gout attacks in the long term. Arthrospira content of nucleic acids is about 4-6% 
of its dry weight (Gutiérrez-Salmeán et al., 2015). The World Health 
Organization recommends that the daily total nucleic acid consumption in 
humans should not exceed 4 g, which represents the nucleic acid content of 
about 80 g of dry Arthrospira biomass. Feeding a diet containing 20% of A. 
platensis F&M-C256 in rats corresponds to feeding 3 g of biomass a day; given 
that the DNA content of A. platensis F&M-C256 is about 4% we can estimate 
that the total content of nucleic acids (DNA+RNA) is around 10%, which 
translates into 0.3 g of nucleic acid per day. It is therefore reasonable to 
consider that the nucleic acid content of A. platensis F&M-C256 does not pose 
health problems, even at high dosages. The amorphous neo-formation found in 
the bladder of 1 out of 8 A. platensis F&M-C256 fed rats, suggestive of an uric 
acid crystal and possibly related to the DNA content of microalgae was 
therefore interpreted as a finding of sporadic occurrence since no other 
morphological alterations at bladder or kidney level were found. Feeding the 
diet containing A. platensis F&M-C256 did not affect food consumption, 
clinical observations and body weights indicating that the overall health status 
of the animals was not affected. To our knowledge, no detailed data have been 
reported on in vivo digestibility of a diet containing A. platensis F&M-C256. 
We observed that the diet containing spirulina was slightly less digestible than 
controls and that the fecal water content was higher suggesting that A. platensis 
F&M-C256 might have a probiotic effect. This is supported by previous 
findings (Parada et al., 1998). 
Since A. platensis F&M-C256 has a quite high Na
+
 content (555 mg/100 g), 
long-term consumption of this alga especially in a large amount would 
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probably lead to hypernatremia and its related disorders. In our sub-acute 
toxicity study, we could not detect any increases in Na
+
 plasma levels. This 
indicates no accumulation of Na
+
 in the circulation due to continuous intake of 
A. platensis even at high dosage. Moreover, no microscopic histopathological 
alterations of the kidney, neither blood pressure or oxidative stress related 
damage in the kidney were observed. Of course, we cannot exclude that the 
high Na
+
 content could represent a potential harm of A. platensis F&M-C256 
over long term consumption. At organ level, no macroscopic and/or 
histopathological observations suggestive of adverse effects due to the 
treatment were noted, including any signs of steatosis or hepatocellular 
damage. Similarly, we did not observe any change of biological significance in 
organ weights with the exception of the liver. In our experiment, the reduction 
of liver weight was associated to a significant reduction in the levels of 
triglycerides and an increased excretion of fecal lipids: 126 mg in rats fed 
control diet and 342 mg in rats fed A. platensis F&M-C256.  
Data from preclinical studies with various animal models, demonstrated the 
hypolipidemic activity of Arthrospira. A high fat diet supplemented with 
Arthrospira resulted in a significant reduction in total serum cholesterol, LDL, 
VLDL cholesterol and increased HDL in mice and in rats (Kato et al., 1984; 
Iwata et al., 1990) in hamsters (Riss et al., 2007) and rabbits (Colla et al., 
2008). The ingredients responsible for this hypolipidaemic activity remain to be 
identified, but C-phycocyanin has been suggested as the active component 
(Nagaoka et al., 2005). All these studies were performed in experimentally-
induced hypercolesterolemia or by using pro-atherogenic, high risk diets. Our 
results demonstrate that spirulina is able to reduce risk factors for 
cardiovascular diseases even in a well balanced dietary regimen. This result is 
of particular interest because it suggests that the dietary use of this microalga 
might be useful in the prevention of dyslipidemias other than in the cure of 
such disorder. 
The lipid-lowering effects of Arthrospira have been described in type 2 diabetes 
(Lee et al., 2008), nephrotic syndrome (Samuels et al., 2002), and in 
hypercholesterolemic patients (Park et al., 2008). Recently, Arthrospira 
supplementation at a dose of 1 g per day for 12 weeks, resulted in a significant 
reduction of triglycerides concentration in dyslipidaemic patients (Mazokopakis 
et al., 2014). A recent meta-analysis revealed a significant effect of 
supplementation with spirulina in reducing plasma concentrations of total 
cholesterol, LDL-C and triglycerides, and increasing those of HDL-C (Serban et 
al., 2016). 
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Our and previous results suggest that A. platensis influence lipid metabolism in 
the liver but to date, the underlying mechanisms for the hypolipidemic effect, 
are not known. Some experimental studies have attributed the beneficial effects 
of spirulina to its antioxidant capacity (Kim et al., 2010). However in our 
experimental settings, total antioxidant status in the plasma or liver oxidative 
damage were unchanged. We therefore analyzed the hepatic expression of 
PPAR-α gene encoding for proteins that control lipoprotein metabolism. 
Treatment with fibrates, a widely used class of lipid-modifying agents, results in 
a substantial decrease in plasma triglycerides and is usually associated with an 
increase in HDL cholesterol concentrations through the activation of the 
peroxisome proliferator-activated receptors (PPAR-α). Very interestingly, our 
results demonstrate for the first time that feeding a diet containing A. platensis 
F&M-C256 for one month induces the expression of PPAR-α in the liver, thus 
providing a mechanistic explanation of the observed hypolipidemic effect. 
 
5. Conclusions 
Feeding rats a diet containing 20% of A. platensis F&M-C256, which results in 
daily dose of 12 g/kg, is without significant adverse effects. The extrapolated 
ADI (Acceptable Daily Intake) for humans results to be 120 mg/Kg which is in 
line of any anticipated human consumption (8.4 g/d) suggesting that the use of 
A. platensis F&M-C256 as food or food component for humans, is likely to be 
safe even at high dosage. Our observations further support previous findings 
indicating that consumption of A. platensis F&M-C256 is without significant 
adverse effects and that this microalga exerts beneficial effects on risk factors 
for cardiovascular diseases. Besides, A. platensis F&M-C256 might represent an 
emerging and promising source of functional foods or nutraceuticals for the 
prevention of dyslipidemias. 
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Abstract 
Tisochrysis lutea is a marine microalga, mainly used in aquaculture, which 
contains biologically active compounds with potential applications in functional 
foods and nutraceuticals. We investigated the dietary safety of 1 month feeding 
Tisochrysis lutea F&M-M36 in rats, explored its potential heath promoting 
effects and the underlying mechanisms. 
Male Sprague-Dawley rats were fed AIN-76 diet (control) or the same diet 
containing 20% T. lutea F&M-M36 for 1 month. T. lutea F&M-M36 
supplemented diet was well-tolerated since food consumption, clinical 
observations and body weights were not affected. The high salt content of this 
microalga (6.1%) resulted in an increased water consumption and in a 
significative raised urinary Na
+
. No significant changes in brain, spleen, 
caecum, kidney, bladder weight to body weight, increase blood pressure or renal 
oxidative damage were observed. While, a significant increase in heart and liver 
weight was observed in T. lutea F&M-M36 treated group. The digestibility of T. 
lutea F&M-M36 diet was slightly less compared to controls (-4%) and this was 
accompanied by an increased feces production and fecal water content. T. lutea 
F&M-M36 DNA content was 4% and caused slightly urinary uric acid 
excretion. Clinical biochemistry parameters did not indicate any renal or hepatic 
impairment, but a significant increase in total cholesterol and HDL was found in 
T. lutea F&M-M36 group. An increase expression of HMGCR in the liver of 
the T. lutea F&M-M36 group compared to control diet fed rats was observed. 
T. lutea F&M-M36 could represent a promising source of functional foods and 
nutraceuticals. 
Keywords: Safety; Microalgae; Food; Tisochrysis lutea F&M-M36 
 
 
1. Introduction 
Microalgae are considered one of the most promising sources for new 
functional foods or nutraceuticals thanks to their balanced biochemical 
composition, high nutritional value and their capacity to produce several 
bioactive compounds (Bishop and Zubeck, 2012). Depending on the species, 
microalgae contain vitamins, essential elements, essential amino acids and 
polyunsaturated fatty acids (PUFAs) (Batista et al., 2013). Alternative sources 
of PUFAs are clearly desirable, and some microalgae which synthesise these 
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fatty acids are particularly attractive, especially because these ingredients are 
naturally encapsulated, retarding oxidation processes (Borowitzka, 2013). 
Notably, microalgae also contain phycobiliproteins and a wide variety of 
carotenoids such as fucoxanthin known for its ability to reduce the risk of 
atherosclerosis, diabetes, cancer and metabolic syndrome (Chacon-Lee and 
Gonzalez-Marino, 2010) and astaxanthin, an antioxidant, anti-inflammatory and 
insulin sensitizing molecule (Yuan et al., 2011). Furthermore, the yield, quality 
and diversification of phytochemicals may be easily maintained or changed by 
controlling their culture media and growth conditions, which may be improved 
to ameliorate the concentrations of specific compounds (de Jesus Raposo and de 
Morais, 2015). Although microalgae are rich sources of these functional 
compounds, more research is needed before their ingredients can be used in 
foods (Niccolai et al., 2016). The marine microalga Isochrysis galbana is a rich 
source of PUFAs, mainly eicosapentaenoic acid (EPA; 20:5ω3) (Christaki et al., 
2011; Custódio et al., 2014) and of fucoxanthin (Kim et al., 2012), a promising 
ingredient in the food and feed industries (Batista et al., 2013; Custódio et al., 
2014; Thu et al., 2015). The possibility to use I. galbana microalga biomass as a 
new functional ingredient in biscuits and pasta has been evaluated by Gouveia 
et al. (2008) and Fradique et al. (2013), with good results in terms of color, 
texture and fatty acid profile (Gouveia et al., 2008; Fradique et al., 2013). 
Herrero et al. (1993) performed a one month study to assess the nutritional 
properties of 12% protein I. galbana in rats and found out that microalga rich 
diet reduced triglycerides levels, a significantly reduced weight increase and 
increased water consumption compared to control diet. Orally administered I. 
galbana (50 mg/day) for 2 months also promoted body weight loss in control 
rats and maintained weight in diabetic rats (Nuño et al., 2013). These findings 
suggest that I. galbana might represent a new source of healthy food for human 
consumption. In this regard, no comprehensive study on the dietary safety of 
Tisochrysis lutea has been conducted so far. We, therefore, performed a sub-
acute toxicity study in rats fed 20% T. lutea F&M-M36 in the diet. 
 
2. Materials and methods 
2.1 Biomass production, preparation, and gross composition  
Tisochrysis lutea (T-ISO) F&M-M36 wad provided from Archimede Ricerche 
S.r.l. in Camporosso, Imola (Italy). The microalga was cultivated in GWP
®
 
photobioreactors (Tredici and Rodolfi, 2004) in semi-batch mode, then the 
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biomasses were harvested by centrifugation, frozen, lyophilized and powdered. 
The powdered biomasses were stored at -20°C until analysis.  
Elemental analysis was performed on dry biomass using a CHNSO Analyzer 
(Flash EA, 1112 Series, Thermo Electron Corporation, Massachusetts, USA) 
(Gnaiger and Bitterlich, 1984). Total protein content was estimated as N x 6.25, 
where N is the nitrogen content determined through the elemental analysis. 
Carbohydrate was determined following Dubois et al. (1956) and lipid 
following Marsh & Weinstein (1966). Humidity was analyzed following 
ISTISAN protocols (ISTISAN Report 1996/34, Method B, Page 7). Fiber was 
determined according to AOAC (AOAC Official method 985.29). Protein, 
carbohydrate, lipids and fiber content were 42%, 4%, 15%, and 18%, 
respectively. Fatty acid composition was evaluated by Laboratori CLODIA 
(Verona, Italy). Saturated fatty acids (SFA), monounsaturated fatty acids 
(MUFA), polyunsaturated fatty acids (PUFA), ω-3, ω-6, and ω-9 were 7.1%, 
3.8%, 3.8%, 2.6%, 2.7%, and 2.9% of dry weight, respectively. 
2.2 Diet preparation, animals and treatment design 
Dietary components (Piccioni, Gessate, Milan, Italy) were based on the 
American Institute of Nutrition (AIN)-76 diet containing 5% fat (corn oil). The 
microalga-supplemented diet was modified to compensate for proteins, lipids, 
carbohydrate and fibers deriving from Tisochrysis lutea F&M-M36 biomass 
(Table 1). 
 
Table 1. Composition of the experimental diets 
g/100 g of diet (d.w.) 
AIN-76  
(control diet) 
Tisochrysis lutea F&M-M36 
supplemented AIN-76  
Dry frozen biomass  - 20 
Corn oil  5 1.7  
Sucrose  50 50 
Starch 15 13.3 
Casein  20 11.7 
Cellulose 5 1.4 
Mineral Mix AIN 76 3.5 3.5 
Vitamin Mix AIN 76 1 1 
Coline 0.2 0.2 
DL Methionine 0.3 0.3 
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All procedures were carried out in agreement with the European Union 
Regulations on the Care and Use of Laboratory Animals (OJ of ECL 358/1, 
12/18/1986), according to Italian regulations on the protection of animals used 
for experimental and other scientific purposes (DM 116/1992), after approval 
from the Italian Ministry for Scientific Research.  
We used 6- to 8-week male Sprague-Dawley rats. The animals were housed in 
plastic cages with wire tops and maintained at a temperature of 22°C, with a 
12:12-h light-dark cycle, according to the European Union Regulations on the 
Care and Use of Laboratory Animals [European Community (1986) European 
community regulations on the care and use of laboratory animals (Law 
86/609/EC)]. After their arrival from the supplier, animals were quarantined for 
a few days, during which they were fed a standard lab chow. Rats were then 
randomly allocated to two experimental groups: Rats fed AIN-76 diet (controls) 
or a microalgae supplemented AIN-76 ad libitum for 1 month (N = 8). 
At the end of the study, rats were euthanized by inhalation of CO2. Following 
the sacrifice, selected organs and tissues (liver, kidney, colon, caecum, bladder, 
stomach, heart) were weighed and stored for macroscopic and histopathology 
examination, for the determination of oxidative stress parameters and gene 
expression. Blood was collected for clinical biochemistry (lipid profile, kidney 
and liver function). 
2.3 Clinical observations and  body weight 
All animals were observed daily for morbidity and mortality. Detailed physical 
examinations were conducted on all animals weekly, beginning one week prior 
to the beginning of the experiments and one week prior to necropsy. Individual 
animal body weights were recorded weekly starting from the first day of the 
experiment. Mean body weights and mean body weight changes were calculated 
for the corresponding intervals. Final body weights were recorded prior to 
sacrifice. 
2.4 Feed consumption and digestibility of the diet 
During the third week of treatment, the animals were placed in metabolic cages 
for one day in order to collect 24-hour urine and feces, to assess the palatability 
of the diet by measuring food daily consumption, to measure water daily 
consumption and the diet digestibility. Samples of feed and fecal samples were 
collected, weighed and oven-dried at 55°C until constant weight to determine 
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humidity. The coefficient of digestibility was calculated as follows: 
Digestibility % = [feed dry weight – 24-hours feces dry weight /feed dry 
weight] x 100. 
2.5 Clinical pathology  
Blood samples were collected from all animals prior to scheduled necropsy.  
Plasma chemistry parameters were performed at the General Laboratory of the 
Azienda Ospedaliero Univesitaria di Careggi, Florence, Italy and included: urea, 
creatinine, alkaline phosphatase, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), total cholesterol, LDL, and HDL. 
2.6 Macroscopic and microscopic examinations 
A complete necropsy was conducted on all rats. The necropsies included an 
examination of the external surface, all orifices, and the cranial, thoracic, 
abdominal and pelvic cavities, including viscera. Selected tissues and organs 
were collected and placed in 10% neutral-buffered formalin. At necropsy, the 
following organs were weighed from all animals: brain, heart, kidneys, liver, 
bladder, caecum, colon, spleen. 
2.7 Histological analysis  
For histological evaluations tissue samples (heart, kidney, liver, urinary bladder, 
and brain) were collected and fixed in phosphate buffered 4% formalin for 12 
hours. Samples were dehydrated in ethanol and embedded in paraffin. 5 µm tick 
sections were hematoxilin-eosin stained and observed for morphological 
analysis. Regarding heart, the thickness of ventricular wall was measured. In 
detail, five microscopical fields per animal were registered by a digitizing 
camera applied to a light microscope with a 20x objective, each field 
corresponding to a test area of 141,100 μm2. On digitized images measurements 
of ventricular wall thickness were carried out using ImageJ 1.33 image analysis 
software (http://rsb.info.nih.gov/ij) by two independent observers in blind 
fashion. 5 µm tick sections of frozen liver and feces were obtained and stained 
with Sudan Black (Sigma Aldrich, Milan, Italy) in order to evaluate the 
presence of neutral triglycerides and lipids. 
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2.8 Blood Pressure Measurements 
Systolic, diastolic blood pressure, mean arterial pressure (MAP) and frequency 
were monitored in conscious rats by noninvasive computerized tail-cuff method 
(Visitech BP-2000 Series II Blood Pressure Analysis System) at week 3 of 
treatment after two days of training. 
2.9 Fecal water content 
Fresh fecal samples were harvested when the rats were killed and frozen at -
20°C until analyses. To determine the degree of diarrhea, fecal samples were 
dried in a dehumidified oven at 50°C until stable in weight and the water 
content was expressed as a percentage of the fresh fecal weight (Castagnini et 
al., 2009). 
2.10 Tibio-tarsal  joint  edema assessment 
The thickness of the tibio-tarsal joint of rats fed T. lutea F&M-M36 
supplemented AIN-76 diet was measured  by using a  micrometer (screwguage) 
and compared to the joint thickness of control group. 
2.11 RT-PCR 
RNA was extracted from tissue homogenates by using a commercially available 
kit following manufactures’ instructions (Macherey-Nagel, Bethlehem, USA). 
For first-strand cDNA synthesis, 1 µg of total RNA from each sample was 
reverse-transcribed by using the RevertAid RT Kit (Thermo Scientific, 
Waltham, MA USA). Primers were designed on the basis of the rat GenBank 
sequences (Table 2). For each target gene, the relative amount of mRNA in the 
samples was calculated as the ratio of each gene to b-actin mRNA (Luceri et al., 
2002).  
 
Table 2. Primer sequences 
Gene Primer forward Primer reverse Base pair 
b-actin ACCACAGCTGAGAGGGAAATC  AGAGGTCTTTACGGATGTCAACG 281 
OGG1 CCTGGCTGGTCCAGAAGTAG TTTCCCAGTTCTTTGTTGGC 345 
APEX GCTCAGAGAACAAACTCCCG TTGTTTCCTTTGGGGTTACG 385 
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UNG TCCGGACCCCGACTCCTGGC GCGGGGGTGGAACTGGCCTC 419 
SOD2 TTAACGCGCAGATCATGCAGC TGGCCTTATGATGACAGTGAC 807 
PPAR-a GTCCTCTGGTTGTCCCCTTG CCTCTCCGAGGGACTGAGAA 389 
HMGCR CAGCTGTACCATGCCGTCTA AAAGAGCCAGAAACCAAGCA 433 
 
2.12 Microalgal DNA content  
DNA was extracted from 50 mg of microalgal biomass sonicated in 500 µl 
Lysis buffer (TrisHCl 0.1M; EDTA 5.10-2M ; SDS 0.2%; NaCl 0.2M). Then, 
100 µl of Proteinase K (10mg/ml Qiagen,) were added to 100 µl of lysate and 
the samples were incubated overnight at 56°C and gently shacked at 300 rpm. 
At the end of incubation, 20 µl of sodium acetate (3M pH 5.2, Sigma Aldrich, 
Milan, Italy) and 500 µl of absolute ethanol were added and incubated overnight 
at -80°C. The samples were centrifuged at 14,000 rpm for 30 min. The 
supernatant was discharged and the pellet was washed twice (300 µl of 70% 
ethanol) and then centrifuged as described above. Finally, the ethanol was 
removed and the pellet was re-suspended in 20 µl of H2O. 
2.13 Fecal lipid content  
Dried fecal samples were re-suspended in 500 µl of normal saline. Then 500 µl 
of chloroform-methanol (2:1, v/v) were added in order to extract the lipids. The 
suspension was then centrifuged at 1,000 g and the solvent was aspirated, and 
evaporated. The residue was weighed and fecal lipids were expressed as a 
percentage of fecal dry weight (http://www.bio-protocol.org/e1375). 
2.14 Carbonyl residues (CO) and ferric reducing ability of plasma (FRAP) 
CO levels in the liver and kidneys were determined by the method of Correa-
Salde and Albesa (2009). The FRAP values were measured according to the 
method used by Benzie and Strain (1996) as described by Lodovici et al. 
(2015). 
2.15 Statistical analysis 
Data were analyzed using statistical methods and values were presented as 
mean with the standard error (SE) and the number of animals (N) used to 
calculate the mean. Body weight gain, necropsy body weight, clinical chemistry 
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and gene expression were analyzed using un-pair t-test with Mann Whitney 
correction. 
 
3. Results 
3.1 Survival, clinical observations, body weights 
All animals survived at the time of sacrifice. At necroscopy, the abdominal fat, 
but not the brain from rats fed T. lutea F&M-M36 were colored in orange. In 
the bladder from 1 out of the eight rats fed T. lutea F&M-M36 an amorphous 
formation was found. Excretion of dark-red feces was not observed throughout 
the feeding period and there were no other treatment-related clinical 
observations.  The growth curves of the animals fed T. lutea F&M-M36 were 
similar to those of the controls (Figure 1, panel A). However, when we 
compared the body weight gain of rats fed T. lutea F&M-M36 to that in the 
control group, we observed a tendency to a lower growth (p=0.06) (Figure 1, 
panel B). 
 
 
Figure 1. Effect of feeding rats with 20% T. lutea F&M-M36 biomass on body 
weight (panel A) and weight gain (panel B) 
 
3.2 Food and water consumption, digestibility of the diet and feces production 
The overall feed consumption of animals receiving T. lutea F&M-M36 biomass 
was similar to that of the controls and animals completely ended the diet 
administered daily indicating a good palatability of the microalga supplemented 
diet. The digestibility of the diet was reduced in T. lutea F&M-M36 (-4%) fed 
rats compared to control diet. In rats fed T. lutea F&M-M36 rich diet, the 
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amount of feces produced daily was significantly (p<0.05) augmented 
compared to control rats as well as the percentage of fecal water content. T. 
lutea F&M-M36 supplemented diet led to a doubled water daily consumption 
and triplicated urine daily production (Table 3). 
Table 3. Effects of T. lutea F&M-M36 on water daily consumption, feces 
production fecal water content and urine production 
 Water 
daily consumption 
(ml) 
Urine 
daily 
production (ml) 
Feces 
daily 
production (g) 
Water 
fecal 
content (%) 
Control diet 
(n=4) 
21.53 ± 1.68 
 
7.00 ± 1.29 1.85 ± 0.38 50.42 
T. lutea 
F&M-M36 
diet (n=8) 
42.01 ± 1.90**     21.56 ± 1.13**  3.80 ± 0.36* 64.51* 
*p<0.05; ** p<0.01 
 
3.3 Organ weight 
No significant changes in brain, spleen, caecum, kidney and bladder weight to 
body weight was observed. A significant increase in heart weight was observed 
in T. lutea F&M-M36 treated group when compared to control diet (p<0.05). A 
significant reduction of liver weight was also observed in T. lutea F&M-M36 
fed rats when compared to control diet (p<0.05) (Table 4). 
Table 4. Effects of T. lutea F&M-M36 on group mean organ weights adjusted 
to necropsy body weight in rats 
 brain 
weight/ 
body 
weight (g) 
heart 
weight/ 
body 
weight (g) 
spleen 
weight/ 
body 
weight (g) 
liver 
weight/ 
body 
weight (g) 
caecum 
weight/ 
body 
weight (g) 
kidney 
weight/ 
body 
weight (g) 
bladder 
weight/ 
body weight 
(g) 
Control 
diet (n=4) 
0.005 0.004 0.002 0.047 0.009 0.007 0.000 
T. lutea 
F&M-M36 
diet (n=8) 
0.006 0.005* 0.002 0.037* 0.011 0.008 0.001 
*p<0.05 
 
3.4 Effects of T. lutea F&M-M36 on clinical chemistry parameters 
Serum creatinine values, urea, aspartate transaminase (GOT), alkaline 
phosphatase and alanine aminotransferase (ALT) did not indicate any renal or 
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hepatic impairment. Compared to control group, total cholesterol concentration 
was significantly higher in animals fed T. lutea F&M-M36 but this effect was 
mainly ascribed to the augmented HDL (+212%). Triglycerides were also 
significantly diminished in T. lutea F&M-M36 fed rats (-73%) (p<0.05) (Table 
5). The urinary content of uric acid was slightly reduced in T. lutea F&M-M36 
compared to controls (10.8 ± 1.3 mg/dL in the control group vs 7.1 ± 0.48 
mg/dL in T. lutea F&M-M36). A significant increase in urinary Na
+
 was found 
(74 ± 10.7 mEq/L vs 266.3 ± 19.07 mEq/L in controls and T. lutea F&M-M36 
rats respectively). 
Table 5. Effect of T. lutea F&M-M36 on clinical chemistry parameters  
 Urea 
(g/L) 
Creatinin 
(mg/dL) 
AST 
U/L 
ALT 
U/L 
Alkaline 
phosphatas
e (U/L) 
Triglycerides 
(mg/dL) 
Control 
diet (n=4) 
0.42±0.04 0.34±0.06 290.5±176.5 75.0±16 155.0±28.0 187±62 
T. lutea 
F&M-M36 
diet (n=8) 
0.33±0.02 0.34±0.01 180.0±67.5 59.2±4.5 173.7±12.9 52.3±5.2* 
 
Table 5. Continued 
 Total 
cholesterol 
(mg/dL) 
HDL  
(mg/dL) 
LDL 
(mg/dL) 
Control 
diet (n=4) 
73.0±4.0 55.0±5.0 
 
   5.0±0.01 
T. lutea 
F&M-M36 
diet (n=8) 
  131.5±6.2** 
 
  117.9±5.8** 
 
7.0±1.29 
*p<0.05; ** p<0.01 
 
3.5 Blood pressure 
Systolic and diastolic blood pressure, as well as pulse and MAP, were not 
significantly affected by microalgae rich diets. However, a tendency toward a 
reduction of these parameters were observed in the group fed T. lutea F&M-
M36 (Table 6). 
 
Table 6. Blood pressure parameters 
 Systolic Diastolic Pulse Mean arterial pressure 
Control diet (n=4) 142.9 ± 5.3 81.1 ± 7 386.2 ± 32.3 100.8 ± 6.6 
T. lutea F&M-M36 diet (n=8) 130.2 ± 7.6 66.8 ± 14.4 351.3 ± 27.2 88 ± 12.7 
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3.6 Tibio-tarsal joint edema assessment 
No significant difference was found in the mean tibio-tarsal joint thickness 
between groups, data not shown.  
3.7 Histological analysis  
Histological analysis conducted on sagittal sections of whole brain did not 
highlight any sign of morphological damage nor in brain nor in cerebellar areas. 
The liver in all experimental groups showed a normal morphological structure. 
In hepatocyte no clear cytopathological signs such as steatosis, hemosiderine 
accumulation or biliary stasis were present. In the urinary bladder of 1 out of the 
eight rats fed T. lutea F&M-M36 an eosinophilic formation was found. This 
mass occupying the entire lumen of urinary bladder was characterized by the 
presence of areas with crystalloid appearance inserted in amorphous areas. In 
the kidney of the same animals, an eosinophilic amorphous content was found 
in the lumen of proximal and distal convoluted tubule (Figure 2). The kidneys 
of remaining animals did not show any morphological damage. The Sudan 
Black staining has not revealed the presence of neutral triglycerides and lipids 
in liver and feces in any of the experimental groups (data not shown).  
 
 
Figure 2. Representative images of amorphous substance in kidney and urinary 
bladder. Panel A (x10 objective): digitalized image of kidney with amorphous 
content in proximal and distal convolute tubules (black arrows). Panel B (x4 
objective): lumen of urinary bladder. Amorphous eosinophilic mass with some 
crystalloid areas was evident in the lumen (black asterisk). Scale bar: 100 µm  
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3.8 Kidney oxidative stress and antioxidant status 
To investigate oxidative stress related parameters in the kidney, the expression 
of the DNA repair enzymes UNG, OGG1, APEX was performed as an indirect 
method to measure DNA damage at kidney level. None of these parameters 
differed significantly comparing rats fed T. lutea F&M-M36 to controls. 
Antioxidant status was evaluated by measuring FRAP and SOD2 expression 
and no significant treatment related difference was observed. Similarly, 
carbonyl residues as a measure of protein oxidative damage, was not affected 
(Table 7). 
 
Table 7. Expression of UNG, OGG1, APEX and SOD2 in the kidney of           
T. lutea F&M-M36 fed rats 
 UNG OGG1 APEX SOD2 
Control diet (n=4) 0.48 ± 0.12 0.52 ± 0.04 0.91 ±0.17 0.94 ± 0.13 
T. lutea 
 F&M-M36 diet (n=8) 
0.40 ± 0.05 0.41 ± 0.05 0.93 ± 0.11 0.69 ± 0.07 
 
3.9 Expression of lipid metabolism-related genes in the liver 
To explore the possible molecular basis of the effects on lipid metabolism, we 
analyzed the expression of PPAR-α, PPAR-γ and HMGCR genes in the liver. 
We observed an increase expression of HMGCR in the liver of the T. lutea 
F&M-M36 group (p<0.05) compared to control diet fed rats. The increased 
expression of PPAR-γ in T. lutea F&M-M36 group did not reach the statistical 
significance.  
3.10 Fecal lipids excretion 
Compared to control diet, rats fed T. lutea F&M-M36 showed an increased                 
(+ 75%) fecal lipid excretion (Table 8). 
 
Table 8. Percentage of lipids in stool samples of T. lutea F&M-M36 fed rats 
and in rats fed control diet 
 Fecal lipids excretion (%) 
Control diet (n=4) 13.7 ± 2.5 
T. lutea F&M-M36 diet (n=8) 24.7 ± 3.5* 
*p<0.05 
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3.11 Microalgal DNA content 
DNA content in T. lutea F&M-M36 biomass was 4% of dry weight biomass. 
 
4. Discussion 
Microalgae are aquatic, photosynthetic microorganisms with many advantages 
over other crops since they can be grown in hostile climatic conditions such as 
desert and coastal areas or in highly controlled close-culture systems (Mata et 
al., 2010). Chlorella, Arthrospira, Dunaliella, and Haematococcus are 
microalgae largely employed for human consumption due to their balanced 
biochemical composition and their high nutritional value (Ibañez and Cifuentes, 
2013). The marine microalga Isochrysis is mainly used in aquaculture (Patil et 
al., 2007). Isochrysis contains biologically active compounds with potential 
applications in functional foods and nutraceuticals (Buono et al., 2014; Custódio 
et al., 2014; Luo et al., 2015). In particular, the peculiar content in 
eicosapentaenoic acid (EPA; 20:5ω3) (Custodio et al., 2014) and fucoxanthin 
(Kim et al., 2012; Crupi et al., 2013) allows considering this microalga an 
interesting ingredient for the development of healthy food products. 
Environmental conditions, such as light intensity and nitrogen availability, are 
able to affect the cellular chemical composition of I. galbana, mainly lipid 
content and fatty acid composition (Sukenik and Wahnon, 1991).  
Overall 20% T. lutea F&M-M36 in the diet was well-tolerated during the 30 
days feeding period and no treatment-related mortality was detected. This 
coincides with the reported absence of adverse effects in albino and male 
Sprague–Dawley rats administered I. galbana (Herrero et al., 1993; Nuño et al., 
2013, respectively). Food consumption, clinical observations and body weights 
indicate that the overall health status was not affected. However, it is to note 
that rats fed T. lutea F&M-M36 showed a tendency to a reduction in body 
weight gain compared to controls. These observations are limited to the 30 days 
feeding but we cannot exclude significant effects in longer feeding periods. As 
stated by Zeng et al. (2004), I. galbana polymers are shaped by different 
monomers, the beta-glucosidic bonds of which may allow them to act as dietary 
fiber in the gastrointestinal tract. Dietary fiber affects satiety, energy, and body 
composition, reducing appetite and energy intake, consequently leading to 
weight reduction (Nuño et al., 2013). Moreover, Maeda et al. (2005) indicate 
that fucoxanthin can promote fat burning within fat cells, increasing the 
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expression of thermogenin. The increased expression of thermogenin due to the 
consumption of a fucoxanthin rich diet in rats is activated from fatty acids in 
adipocytes of brown tissue (Maeda et al., 2005). In a study of Abidov et al. 
(2010), fucoxanthin also increased the resting energy expenditure (REE) in 
obese non-diabetic women. 
Despite the general health status of rats was not affected, T. lutea F&M-M36 
high salt content is a safety concern. Due to the relevant issue of salt content, 
the study specifically focused on the hydro saline balance, blood pressure and 
renal damage. The hydro saline imbalance was supported by the increased water 
consumption accompanied by urinary levels increase. Blood pressure was not 
affected over one month feeding, but it is not possible to exclude long term 
effects. Notoriously, data from the literature report an increased risk of 
cardiovascular events in high salt diets (Graudal et al., 2014). In the T. lutea 
F&M-M36 group, an increase in hearth weight was noted. This increase appears 
to be para-physiological since it lacked correlating to both macroscopic and 
microscopic changes at hearth or kidney level or to blood pressure 
measurement. Clinical biochemistry parameters and histopathology also did not 
show any impairment at kidney levels. The amorphous neo-formation found in 
the bladder of both microalgae fed rats was interpreted as a uric acid crystal of 
incidental/sporadic occurrence and possibly related to the DNA content of 
microalgae (Jin et al., 2012). 
Salinity is, therefore, a big safety issue which must be solved by using strategies 
to reduce its content, e.g. washing the biomass after the harvest (Harun et al., 
2010), or by using lower doses of this microalga. 
By virtue of the claimed health promoting activities of fucoxanthin, it was also 
explored kidney oxidative stress and antioxidant status but none expression of 
the tested repair enzymes (UNG, OGG1, APEX), FRAP, and SOD2 differed 
significantly comparing rats fed T. lutea F&M-M36 to controls.  
The orange coloration of the abdominal fat in T. lutea F&M-M36 fed rats was 
interpreted as the result of the accumulation of a lipophilic pigment. Similar 
findings were reported by Stewart et al. (2008) and by Takahashi et al. (2005) in 
rats fed an astaxanthin rich diet. 
The reduction of liver weight observed was not related to signs of steatosis or 
other morphological signs of hepatocellular damage. Interestingly, the reduction 
of liver weight, was associated with a significant reduction in the levels of 
triglycerides groups. Moreover, fecal neutral sterol content was increased 
suggesting that the reduced levels of triglycerides might be due to increased 
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excretion of lipids. This effect was further explored by analyzing the expression 
of genes implicated in the control of lipid metabolism such as PPAR-α, PPAR-
γ, and HMGCR in the liver. In our experimental condition, T. lutea F&M-M36 
group displayed significantly augmented total cholesterol levels and an 
increased expression of hepatic HMGCR. However, the raise in total cholesterol 
observed T. lutea F&M-M36 group was mainly due to a significant increase in 
good cholesterol HDL. In our study, T. lutea F&M-M36 contains a high amount 
of  polyunsaturated fatty acids (PUFAs) (around 4%). PUFAs are able to reduce 
cholesterol and triglycerides levels and their daily consumption has been 
associated with the prevention of cardiovascular diseases, atherosclerosis, 
metabolic syndrome and diabetes (Endo and Arita, 2016). 
 
5. Conclusions 
Feeding a diet containing 20% of T. lutea F&M-M36 results in daily dose of 12 
g/kg is without significant adverse effects. Our observations further support the 
previous findings indicating the dietary T. lutea F&M-M36 is able to exert 
beneficial effects on risk factors for cardiovascular diseases. T. lutea F&M-M36 
might thus represents an emerging and promising source of functional foods or 
nutraceuticals. 
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Abstract 
Microalgae use as food ingredients is still poorly developed in Europe due to 
high cost, low demand, and strict Novel Foods legislation. The aim of this work 
was to evaluate microalgae (Arthrospira platensis F&M-C256, Chlorella 
vulgaris Allma, Tetraselmis suecica F&M-M33 and Phaeodactylum 
tricornutum F&M-M40) as a mean to enhance functional properties of cookies. 
Two biomass levels were tested and compared to control: 2% (w/w) typically 
used in algal-based products and a significantly higher content, 6% (w/w), to 
provide algal-bioactives in a higher amount. The cookies physical properties 
were evaluated during eight weeks after production and no significant 
differences were found in terms of colour and texture stability. Cookies 
prepared with A. platensis and C. vulgaris presented significantly higher protein 
content. A. platensis also provided a significant structuring effect, in terms of 
cookies texture. All microalgae-based cookies showed significantly higher total 
phenolic content (TPC) compared to the control. P. tricornutum cookies 
exhibited the highest TPC. Microalgal cookies presented significantly higher in 
vitro antioxidant capacity (AC) compared to the control. No significant 
difference in in vitro digestibility (IVD) between microalgal cookies and the 
control was found. In general, increasing microalgae content from 2% to 6% 
resulted in a significant increase in the cookies TPC and AC, while digestibility 
was slightly lower. 
Keywords: Microalgae; Novel foods; Digestibility; Antioxidants; Phenolics 
 
 
 
1. Introduction 
Microalgae are an innovative and promising food ingredient, rich in nutrients 
such as high value proteins, long-chain polyunsaturated fatty acids, carotenoids, 
vitamins, minerals, and phenolics as well as other bioactive molecules (Plaza et 
al., 2009). In the last years, increasing attention has been drawn to this 
alternative ingredient by the food industry, with algae identified in the top food 
trend list for 2016 by the Global Food Forum (2016). Different companies are 
investing in this sector, such as Terravia (ex-Solazyme, USA), currently 
producing and commercializing algal food ingredients such as protein isolates 
and culinary oils (Terravia, 2016). Another example is Dulcesol Group, leader 
in baked products and pastries sector in Spain, which has also invested in a 
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microalgae production unit for developing a healthy baked product line 
(Dulcesol, 2016). Moreover, many other smaller companies are starting to pay 
attention to this area as consumers are increasingly aware of the benefits of alga 
inclusion in a healthy diet (Vigani et al., 2015). Microalgae have been also 
considered to have a great potential as a sustainable feedstock for food 
commodities (Draisma et al., 2013). However, the use of microalgae as a food 
source is still poorly developed in Europe, which has been mainly attributed to 
technical difficulties related to their cultivation, low demand in European 
countries compared to Asian markets and to strict European legislation 
regarding Novel Foods (Vigani et al., 2015). 
In the last years some papers have been published on the development and 
characterization of food products integrated with microalgal biomass (Gouveia 
et al., 2007, 2008; Batista et al., 2012; Fradique et al., 2013; Singh et al., 2015), 
commonly with contents below 3% (w/w). Also, many papers deal with the 
bioactive properties of microalgal biomass and/or extracts (e.g. Plaza et al., 
2009; Liu et al., 2011; Custodio et al., 2014), but very few deal with the 
bioactive compounds of microalgae foods and their resistance to different 
processing steps (e.g. Fradique et al., 2013). There is a lack of knowledge on 
how the food processing conditions influence digestibility, bioavailability and 
bioactive properties of the microalgal functional ingredients in different food 
matrixes. 
Cookies are considered a convenient nutrient dense snack food, widely 
consumed by European citizens from all age groups. The aim of this work was 
to study microalgae as a mean to enhance functional properties of this baked 
food matrix, especially at higher biomass incorporation levels. It was intended 
to use significantly higher concentrations than the ones found in commercial 
products (typically below 3% w/w), in order to provide higher level of bioactive 
compounds, whilst not compromising digestibility. Four microalgal strains were 
tested: Arthrospira platensis F&M-C256, Chlorella vulgaris Allma, Tetraselmis 
suecica F&M-M33, and Phaeodactylum tricornutum F&M-M40. 
The Novel Foods Regulation (EC) nº 258/97, recently reviewed by Regulation 
(EU) nº 2283/2015, determines that any food that has not been used to a 
significant degree for human consumption within the European Union before 
15
th
 May 1997 must be submitted to a safety assessment, in order to protect 
public health, through a unified procedure led by the European Food Safety 
Authority (EFSA). 
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A. platensis (commonly known as spirulina), consumed by human populations 
since ancient times (Abdulqader et al., 2000), and C. vulgaris, C. luteoviridis 
and C. pyrenoidosa have been consumed in Europe for several decades and are 
thus authorized as food in the European Union. A. platensis has been widely 
consumed as nutritional supplement due to its associated health benefits, such as 
high protein (up to 60%), vitamin B12, γ-linolenic acid (GLA) and phycocyanin 
content (Hongsthong & Bunnag, 2009). Chlorella is also rich in protein, as well 
as pigments and glucans which can act as immunostimulant (Reyes-Suárez et 
al., 2008; Tabarsa et al., 2015). In the present work a commercial C. vulgaris 
biomass (Allma, Lisbon, Portugal) was used. 
Tetraselmis chuii has recently been authorized for commercialization as novel 
food ingredient through an application by the company Fitoplancton Marino 
S.L. (Cadiz, Spain) (AESAN 2013; AECOSAN 2014). In the present study, 
another species belonging to the same genus, T. suecica, was used. This marine 
chlorophyte is characterized by high content of polyunsaturated fatty acids and 
α-tocopherol (Pérez-Lopéz et al., 2014).  
P. tricornutum is a marine diatom which has not yet been submitted to novel 
food application. Nevertheless, it was included in the present study considering 
its high content in eicosapentaenoic acid (EPA 20:5 ω3) as well as in 
fucoxanthin, a carotenoid associated with antioxidant, anti-diabetes and anti-
obesity effects (Gilbert-López et al., 2016; Mikami & Hosokawa, 2013). 
Moreover, previous in vitro toxicity tests by Niccolai et al. (2016) showed no 
adverse effects of methanolic and aqueous extracts of these biomasses on 
Artemia salina. 
 
2. Materials and methods 
2.1 Microalgal strains and biomass production 
Arthrospira platensis F&M-C256 and Tetraselmis suecica F&M-M33 were 
provided by Archimede Ricerche S.r.l., located in Camporosso, Imperia (Italy) 
and Phaeodactylum tricornutum F&M-M40 was produced at the facility of 
Fotosintetica & Microbiologica S.r.l., located in Sesto Fiorentino, Florence 
(Italy). The algae were cultivated in GWP
®
-I (Chini Zittelli et al., 2013) or 
GWP
®
-II photobioreactors (Tredici et al., 2015; Tredici et al., 2016) in semi-
batch mode, then the biomasses were harvested by centrifugation, frozen, 
lyophilized and powdered. The powdered biomasses were stored at -20 °C until 
analysis. A. platensis F&M-C256 biomass was washed with tap water to remove 
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excess bicarbonate before being frozen. Chlorella vulgaris Allma was purchase 
from Allma. The two marine strains (Tetraselmis suecica F&M-M33 and 
Phaeodactylum tricornutum F&M-M40) were cultivated in F medium (Guillard 
and Ryther, 1962), while A. platensis F&M-C256 was cultivated in Zarrouk 
medium (Zarrouk, 1966). 
The biochemical composition of the four microalgal biomasses is presented in 
Table 1. 
 
Table 1. Biochemical composition of the four microalgal biomasses used in the 
experiments (% dry weight). Results are expressed as average ± standard 
deviation. 
 
    Protein (%)   Carbohydrate (%)    Lipid (%)     Ash (%) 
Arthrospira platensis 
F&M-C256 
68.9 ± 1.0 12.8 ± 0.2 10.7 ± 0. 6 6.1 ± 0.1 
Chlorella vulgaris 
Allma 
56.8 ± 2.7 5.9 ± 0.3 16.9 ± 2.8 9.3 ± 1.5 
Tetraselmis suecica 
F&M-M33 
40.2 ± 0.5 10.2 ± 0.2 28.5 ± 1.2 15.7 ± 0.2 
Phaeodactylum 
tricornutum F&M-M40  
38.8 ± 0.1 11.0 ± 0.7 19.3 ± 1.7 14.8 ± 0.1 
 
 
2.2 Cookies preparation 
Cookies were prepared according to a previously optimized formulation 
(Gouveia et al., 2007, 2008), using wheat flour, sugar, baking powder, 
margarine, and microalgae biomass, as indicated in Table 2. All percentages are 
presented in w/w. The ingredients were mixed in a food processor (Bimby, 
Vorwerk, Germany), kneading 15 seconds at speed 4. The cookies were then 
moulded into 48 mm diameter and 4 mm height circles and baked at 120 ºC for 
40 min. After cooling, sample cookies were stored in hermetic containers, 
protected from light. Some of the cookies were immediately crushed to powder 
(using an electric mill) and used for chemical composition, antioxidant capacity 
and in vitro digestibility analyses. 
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Table 2. Cookies formulations (%). 
F1 control cookies formulation; F2 2% cookies formulation; F3 6% cookies 
formulation 
 
2.3 Cookies analyses 
2.3.1 Colour analysis 
The colour of sample cookies was measured instrumentally using a Minolta CR-
400 (Japan) colorimeter with standard illuminant D65 and a visual angle of 2°. 
The results were expressed in terms of L∗, lightness (from 0 to 100%); a∗, 
redness to greenness (60 to −60 positive to negative values, respectively); b∗, 
yellowness to blueness (60 to −60 positive to negative values, respectively), 
according to the CIELab system. Hue angle, hºab, was also calculated, as defined 
by: hºab=arctan(b
∗/a*). The total colour difference between sample cookies 
along storage time (up to eight weeks), as well as between raw and cooked 
samples, was determined according to: ΔE*=[(ΔL∗)2+(Δa∗)2+(Δb∗)2]1/2. The 
measurements were conducted under the same light conditions, using a white 
standard (L*=94.61, a*=-0.53, b*=3.62), under artificial fluorescent light at 
room temperature, replicated 10 times for each sample. 
2.3.2 Texture analysis 
The cookie texture was measured using a texturometer TA.XTplus (Stable 
MicroSystems, UK) in penetration mode with a cylindrical aluminium probe of 
2 mm diameter plunged 3 mm at 1 mm s−
1
. The resistance to penetration, or 
hardness, was measured by the total area below the force vs. time curve, 
Ingredients F1 
(control) 
F2        F3 
 
     g/100g g/100g  g/100g 
Wheat flour 49 47 43 
 
Sugar 20 20 20 
 
Margarine 20 20 20 
 
Water 10 10 10 
 
Baking powder 1 1 1 
 
Microalga 0 2 6 
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corresponding to the penetration work (N•s). Measurements were repeated 10 
times for each sample, along time (up to eight weeks). 
2.3.3 Chemical composition 
All chemical composition analyses were repeated, at least in triplicate, 
according to the methods described below. 
2.3.3.1 Moisture content 
Cookie moisture content was determined gravimetrically using an automatic 
moisture analyser PMB 202 (aeADAM) at 130 °C, until constant weight. 
2.3.3.2 Total Ash 
Total ash content was determined gravimetrically by incineration at 550 ºC in a 
muffle furnace. 
2.3.3.3 Crude Protein 
Crude protein was determined by the Kjeldhal method according to the AOAC 
950.36 official method for baked products. The determined total nitrogen 
content was multiplied by a conversion factor of 5.7 to obtain the cookie crude 
protein content. 
2.3.3.4 Crude fat content 
The cookie crude fat content was determined according to the procedure used 
for cereals and derived products in the Portuguese standard method NP4168 
(1991). This procedure is based on the hydrolysis of the bonds between lipids, 
proteins, and carbohydrates by using hydrochloric acid, ethanol and formic acid, 
followed by filtration and extraction with n-hexane in a Soxhlet extractor for 6 
h. The crude fat residue was determined gravimetrically, after solvent 
evaporation in a rotary evaporator and oven drying. 
2.3.3.5 Fatty acid profile 
The cookies fatty acid profile was determined by GC/MS. The lyophilized 
biomasses were extracted and methylated according to the studies of Pal et al. 
(2011) and of Recht et al. (2012). Samples of lyophilized biomass (10-20 mg) 
were weighed in a test tube with screw cap, with 350 µL of a 1 mg mL
-1
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solution of internal standard (fatty acid C19:0), previously evaporated. Then, 
2.5 mL of a 2% (v/v) solution of H2SO4 into MeOH were added and heating to 
85 °C for 1.5 hours, if necessary applying a little mixing. Thereafter, the 
reaction was turned off by adding 1 mL of MilliQ water. Then, 1 mL of hexane 
was added, and the solution was vortexed and centrifuged for 5 min. After 
centrifugation, the supernatant (hexane) was collected and transferred to another 
tube and this step was repeated 3-4 times. Then the hexane extract was 
evaporated under a stream of N2. Finally, the dry residues were recovered in 1 
mL of hexane and injected into the GC/MS. 
GC/MS was composed by an HP5890 gas chromatograph coupled to an 
HP5970 mass selective detector (Hewlett Packard, USA) operating in EI mode, 
70 eV. The gas chromatograph was equipped with a Zebron ZB-WAXplus 
capillary column (Phenomenex, Bologna, Italy), 60 m x 0.25 mm, 0.25 µm d.f. 
The injector temperature was maintained at 255 °C and injections were made in 
split mode (split ratio 1:20, injection volume 1 µL). The oven temperature 
program started at 70 °C and raised to 150 °C at 16 °C min
-1
, then to 210 °C at 5 
°C min
-1
, then to 250 °C at 1.5 °C min
-1
 and hold for 5 min. The carrier gas was 
helium at 165 kPa head pressure. Mass spectrometer operated in scan mode in 
positive ion, in 41–650 m/z range (1.33 scan s-1). Fatty acids were identified by 
comparing retention times with those of authentic standards (37 Component 
FAME Mix, Supelco, Italy) and the experimental EI mass spectra with those of 
the NIST mass spectral database, version 05. Fatty acids were quantified using 
the methyl ester of C19:0 fatty acid, not present in the samples, as the internal 
standard, making a single point calibration curve for less abundant fatty acid, 
corrected for the fatty acid amount in the mix, or a six points one for the more 
abundant. 
2.3.3.6 Phycocyanin content 
Phycocyanin content was determined in A. platensis cookie and dough samples, 
according to the method developed by Boussiba & Richmond (1979) modified 
by Reis et al. (1998). This method is based on the extraction of these water 
soluble pigments with phosphate buffer at pH 7, 0.1M at low temperatures and 
spectrophotometrically quantification at 620 nm (C-Phycocyanin) and 650 nm 
(C-allophycocyanin).  
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2.3.3.7 Total phenolic content 
The extracts were prepared according to the procedure used by Hajimahmoodi 
et al. (2010). Samples (0.1 g) were mixed with 2 mL deionised water solution 
(80 °C) and the microalgae cell walls disrupted using an ultrasonic homogenizer 
(Microson
TM
 XL2000, Misonix Inc., Farmingdale, New York, USA) set at a 
frequency of 20 kHz and a power of 130 W for 30 min at room temperature. 
Samples were then centrifuged (5,000×g, 10 min, at 25 °C) and the supernatants 
recovered. The extraction was repeated three times and the supernatants 
combined and filtered on 47 mm membranes with a nominal porosity of 1.2 μm 
(FILTER-LAB, Barcelona, Spain). All extracts were stored at -20 °C. 
The total phenolic content assay was carried out according to Rajauria et al., 
2013, using the Folin Ciocalteu assay. To each sample (100 μL of the extract), 
2% sodium carbonate (2 mL; Sigma-Aldrich, Italy) was added. After 2 min, 
50% Folin Ciocalteu reagent (100 μL; Sigma-Aldrich, Italy) was added. The 
reaction mixture was incubated in darkness at 25 °C for 30 min. The absorbance 
of each sample was measured at 720 nm using a UV-Vis spectrophotometer 
reader (Cary
®
 50 UV-Vis spectrophotometer, VARIAN Inc., California, USA). 
Results were expressed in gallic acid equivalents (mg GAE/g) of dry microalgal 
biomass and cookies, through a calibration curve with gallic acid (0 to 500 μg 
mL
-1
, Sigma, Italy). 
2.3.4 Antioxidant capacity 
The antioxidant capacity of the cookies and microalgae samples was assessed 
by direct quencher procedure, as optimized by Serpen et al. (2008, 2012) for 
cereal products. The quantification method was FRAP (Ferric Reducing 
Antioxidant Power), characterized by the reduction of Fe
3+
 to Fe
2+
 depending on 
the available reducing species, followed by the alteration of colour from yellow 
to blue measured spectrophotometrically (Benzie & Strain, 1996). Thirty (30) 
mg of powdered samples were weighed into a centrifuge tube (15 mL capacity). 
The reaction was started by adding 3.3 mL of FRAP working solution, 
composed of sodium acetate buffer 0.3M (pH3.6) : TPTZ 10 mM (in HCl 40 
mM) : FeCl3 20 mM in a proportion of 10:1:1 (v/v/v) . The tube was shaken 
rigorously in a vortex and incubated at 37 ºC for 10 min in the dark. 
Centrifugation was performed at 4,000×g for 5 min and the supernatant filtered 
by 0.45 µm syringe filter membranes. Absorbance values were measured at 595 
nm and were subtracted by blank assay values (A0 – blank without sample with 
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reagents; Ae – blank with sample without reagents). Standard calibration curves 
were constructed by plotting colour formation at 595 nm against different 
concentrations of Trolox standard solutions that were submitted to the same 
FRAP protocol. The antioxidant capacity of the samples was expressed in terms 
of mmol of Trolox Equivalent Antioxidant Capacity (TEAC) per kilogram of 
sample.  
2.3.5 In vitro digestibility 
The cookies in vitro digestibility was assessed by the Boisen & Fernández 
(1997) method. The in vitro analysis reproduces the chemical-enzymatic 
catalysis that occurs in the proximal tract of the mammalian digestive system. 
Biomass and cookies were powdered before analysis. Samples of 1 g of finely 
ground material (particle size ≤ 1 mm) were weighed and transferred in 250 mL 
conical flasks. To each flask, phosphate buffer (25 mL, 0.1 M, pH 6.0) was 
added and mixed, followed by HCl (10 mL, 0.2 M). The pH was adjusted to 2.0 
by the addition of HCl (1 M) or NaOH (1 M). A freshly prepared pepsin water 
solution (3 mL; Applichem, Darmstadt, Germany) containing 30 mg of porcine 
pepsin with an activity of 0.8 FIP-U/mg was added. The flasks were closed with 
a rubber stopper and placed on multipoint stirrers at 150 rpm, for 6 h, in a 
thermostatically-controlled heating chamber (ProCLIMATIC, Imola, Italy) at 
39 °C. Following incubation, phosphate buffer (10 mL, 0.2 M, pH 6.8) and 
NaOH solution (5 mL, 0.6 M) were added to each sample. The pH was adjusted 
to 6.8 by addition of HCl (1 M) or NaOH (1 M). A freshly prepared pancreatin 
ethanol:water solution (10 mL, 50:50 v/v) containing 500 mg of porcine 
pancreatin with an activity of 42362 FIP-U/g (Applichem, Darmstdat, 
Germany) was added to each sample. After closing with a rubber stopper, the 
flasks were incubated again at 39 °C, 150 rpm, for 18 h. A reagent blank 
without biomass was also prepared. 
The undigested residues were collected by centrifugation (ROTANTA 460 R 
centrifuge, Hettich Zentrifugen, Tuttlingen, Germany) at 18,000×g for 30 min. 
The undigested material (sedimentation pellet) was washed with deionised 
water until the pellet was completely covered by water to remove any salts from 
the buffer and then centrifuged with the same parameters reported above. 
The supernatant was removed after the second centrifugation, and filtered on 47 
mm glass-fiber membranes with a pore diameter of 1.2 μm (FILTER-LAB, 
Barcelona, Spain). The pellet and filter papers were dried at 80 °C for 6 h, and 
then at 45 °C until a constant mass was reached. To account for any residual 
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biomass or undissolved reagents not sedimented during centrifugation, the mass 
of the dried residue on each filter paper was added to the mass of the undigested 
material (pellet). The reagent blank was processed in the same manner. The 
percent in vitro digestibility of dry matter was calculated according to Boisen 
and Fernández (1997): 
 
 
 
 
 
where: 
 
D is the in vitro digestibility of dry matter expressed as percentage 
 
 
SW is the mass of the starting material expressed in grams  
 
 
UW is the mass of the undigested material expressed in grams 
 
 
RP is the residual particulate, any residual biomass and/or undissolved reagents 
re-suspended from the pellet or not sedimented expressed in grams 
 
 
B is the blank (all reagents without biomass) expressed in grams 
 
2.4 Statistical analysis 
Statistical analysis of the experimental data was performed using STATISTICA 
from StatSoft (version 8.0), through variance analysis (one way ANOVA), by 
the Scheffé test – Post Hoc Comparison at a significance level of 95% (p<0.05). 
All results are presented as average ± standard deviation.  
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3. Results and discussion  
The cookies with microalgal biomass incorporation presented visual attractive 
and unusual appearances (Fig. 1). Innovative green tonalities varied, depending 
on the microalga used, from a blueish-green (A. platensis) to a brownish-green 
(P. tricornutum). The microalgae cookies presented an average diameter of 47.1 
mm and an average thickness of 7.5 mm while the control cookies were slightly 
thicker (8.3 mm on average).  
 
 
Fig. 1 Control cookie (1) and cookies with 2% (w/w) and 6% (w/w) microalgal 
biomass (2 - A. platensis, 3 – C. vulgaris, 4 – T. suecica, 5 – P. tricornutum) 
 
3.1 Colour stability 
The results obtained for the cookie colour parameters L*, a*, b* and hº are 
presented in Fig. 2. Regarding the luminosity parameter L*, a reduction in 
luminosity with increasing alga concentration can be observed.  
An increase in microalgal concentration has also led to lower values of the 
chromatic parameters a* and b* (in modulus), while the hue tonality remains 
constant (100º-120º between yellow and green).  
These results may seem unexpected, considering that in Fig. 1, the cookies with 
6% alga seem to have more intense green colours. Apparently, the darkening, 
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associated with tonality maintenance of hue tonality “mask” the colour intensity 
reduction. In previous studies, a similar effect was found for C. vulgaris 
(Gouveia et al., 2007) and Isochrysis galbana (Gouveia et al., 2008) cookies, 
where a reduction in a* and b* parameters upon increasing microalgal biomass 
concentration from 0.5% to 3.0% (w/w) was observed. This effect may be 
related to a higher pigment degradation along baking process or with a colour 
saturation effect.  
Cookies with 2% C. vulgaris and T. suecica presented the highest a* values (in 
modulus) and intermediate b* values (22.8-25.3) (Fig. 2), which is in agreement 
with the high chlorophyll content that characterizes chlorophyte algae (Plaza et 
al., 2009). A. platensis cookies presented tonalities similar to the chlorophyte 
cookies, although with less intensity (lower a* and b* values), reflecting the 
lower chlorophyll and carotenoid content generally present in this alga (Batista 
et al., 2013). On the other hand, P. tricornutum cookies presented low a* values 
(in modulus) and the highest b* values, resulting in a hue angle tonality of 100º, 
closer to yellow (90º) than to green (180º). These results should be related to the 
presence of fucoxanthin, a carotenoid usually present in high concentrations in 
this marine diatom (Gilbert-López et al., 2016).  
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Fig. 2 Colour parameters, L*, a*, b* and hº of cookies with 2% and 6% (w/w) 
microalgal biomass incorporation, in week 0 (Ap – A. platensis, Cv – C. 
vulgaris, Ts – T. suecica, Pt – P. tricornutum).  
 
Table 3 presents the total colour differences (ΔE*) between baked and raw 
(dough) sample cookie. Microalgal cookies show significantly higher colour 
differences upon baking than the control cookie (ΔE*=7.6), with the highest 
values for P. tricornutum cookie samples (ΔE*=19-24). These differences result 
mainly from a general increase in luminosity (probably associated to water 
evaporation) and an accentuated hue angle tonality decrease in the case of P. 
tricornutum (results not shown) which should be related to pigment loss upon 
baking. 
The colour stability along conservation time can also be observed in Table 3 
through the calculation of total colour difference of each sample along time in 
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relation to week 0. In all cases ΔE* is lower than 5 (except for P. tricornutum 
6% in week 8: 5.42) which means that the cookie colour differences are not 
detected by normal human vision (Castellar et al., 2006). Therefore, it can be 
concluded that the developed cookies present stable colorations along eight 
weeks storage. 
 
Table 3. Total colour variation (ΔE*) between cooked and raw cookie samples 
and colour stability along conservation time (ΔE* in relation to week 0). 
 
 
3.2 Texture stability 
The cookies texture was evaluated by penetration tests (as described in section 
2.3.2), and the resulting hardness, expressed by resistance to penetration work 
(total area below force vs. time curve), was calculated from the texturograms 
and presented in Fig. 3. 
No significant differences (p>0.05) were found between the cookies with 2% 
alga when compared to the control (and between different algae), which means 
that adding 2% biomass does not promote cookie structural changes that can 
alter the resistance to probe penetration. Increasing microalgae concentration 
from 2% to 6% causes significant (p<0.05) hardness increase, from 24-29 N•s 
(2% cookies) to 37-38 N•s for 6% C. vulgaris and T. suecica cookies, to 50 N•s 
for P. tricornutum and 63 N•s for A. platensis cookies.  
Total colour 
difference (ΔE*) 
Raw vs.  
Cooked 
Week 1 vs. 
Week 0 
Week 2 vs. 
Week 0 
Week 3 vs. 
Week 0 
Week 4 vs. 
Week 0 
Week 8 vs. 
Week 0 
Control 7.63 0.84 0.86 1.23 1.55 1.89 
A. platensis 2% 16.01 0.60 0.66 1.16 1.63 1.86 
 6% 15.58 0.73 0.89 0.94 0.94 0.77 
C. vulgaris 2% 11.22 0.70 1.17 0.96 0.74 1.12 
 6% 12.58 0.75 1.26 1.11 1.32 3.13 
T. suecica 2% 15.93 1.02 1.73 2.43 2.49 2.78 
 6% 10.85 1.83 2.12 2.40 3.80 4.69 
P. tricornutum 2% 18.97 1.50 2.03 2.48 2.37 4.19 
 6% 23.63 1.31 2.57 2.37 3.35 5.42 
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These results can be related to previous water and oil absorption tests carried 
out on the same microalgae (Fragoso, 2016), in which significantly higher 
(p<0.05) absorption values (4.4-5.2 gH20/galga and 0.8-1.2 goil/galga) were attained 
in relation to wheat flour (2.1 gH20/gflour and 0.7 goil/gflour). The highest values 
were attained for A. platensis, followed by P. tricornutum, C. vulgaris and T. 
suecica, which can be directly related to the different nature of these algae cell 
walls (peptidoglycan, silica and cellulose/hemicellulose, respectively). It is 
assumed that, when microalgae are added to the cookie dough, they absorb 
more water and oil/fat, reinforcing the cookie internal structure. These data 
suggest that it would be possible to increase the water content and reduce the 
flour content, resulting cookies with the same texture properties than the control 
cookie.  
These results are also in agreement with previous studies where it was observed 
a linear increase in cookies hardness with C. vulgaris (Gouveia et al., 2007) and 
I. galbana (Gouveia et al., 2008) at concentrations of 0.5% and 3.0%. Singh et 
al. (2015) also observed that the level of A. platensis, from 1.6 to 8.4%, had 
positive effect on the hardness of sorghum flour biscuits. The same “texturing” 
or “structuring” effect of microalgae has been described also in other type of 
food products, such as fresh pastas with A. maxima and C. vulgaris (Fradique et 
al., 2010). 
The evolution of cookies hardness along time can also be observed in Fig. 3. 
The control and 2% alga cookies do not present significant (p>0.05) changes in 
hardness along eight weeks, except for 2% A. platensis cookie which increased 
significantly (p<0.05). For the 6% cookies, in general, the texture results are 
more variable along time, with significant differences (p<0.05) observable in 
most cases, without a clear variation tendency.  
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Fig. 3 Texture, expressed by penetration work (hardness, area N•s), of cookies 
with 2% and 6% (w/w) microalgal biomass incorporation, along time (Ap – A. 
platensis, Cv – C. vulgaris, Ts – T. suecica, Pt – P. tricornutum).  
 
3.3 Chemical composition 
Table 4 presents the chemical composition of the cookies prepared with 
microalgal biomass incorporation. All cookies presented moisture values 
ranging from 3.2 to 5.0%, which is typical for this type of dried foods.  
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position (g/100g) of cookies with 2% and 6% (w/w) microalgal biomass incorporation. Results are expressed as average ± 
standard deviation. Different letters in the same column correspond to significant diferences (p<0.05). IDF stands for Insoluble 
Dietary Fiber and SDF stands for Soluble Dietary Fiber.  
 
 
* Carbohydrates were calculated by difference 
 
Moisture 
(g/100g) 
Total Ash  
(g/100g) 
Crude Fat 
(g/100g) 
Crude Protein  
(g/100g) 
Carbohydrates* 
(g/100g) 
Energy Value 
(Kcal/100g) 
Control 3.8 ± 0.2 
ab 2.7 ± 0.2 a 16.1 ± 0.1 a 4.9 ± 0.5 a 69.4 448 
A. platensis 2% 3.8 ± 0.1 
ab 2.6 ± 0.4 a 16.1 ± 0.5 a 6.1 ± 0.2 abc 64.7 441 
 6% 5.0 ± 0.2 
d 2.3 ± 0.1 a 16.1 ± 0.1 a 7.8 ± 0.3 de 60.2 434 
C. vulgaris 2% 3.2 ± 0.1 
a 2.3 ± 0.1 a 16.3 ± 0.2 a 5.9 ± 0.5 abc 66.1 447 
 6% 4.8 ± 0.3 
cd 2.6 ± 0.1 a 16.9 ± 0.4 a 8.0 ± 0.6 e 59.5 439 
T. suecica 2% 3.4 ± 0.2 
ab 2.4 ± 0.2 a 16.1 ± 0.1 a 5.2 ± 0.1 a 66.9 445 
 6% 3.3 ± 0.1 
a 3.2 ± 0.1 a 16.3 ± 0.4 a 6.9 ± 0.4 cd 63.4 442 
P. tricornutum 2% 3.9 ± 0.1 
ab 2.3 ± 0.2 a 16.1 ± 0.1 a 5.1 ± 0.2 ab 65.2 441 
 6% 4.3 ± 0.2 
bc 3.0 ± 0.1 a 16.2 ± 0.1 a 6.6 ± 0.4 bc 62.5 437 
 
174 
 
 
Microalgae cookies – Physical and chemical properties, 
antioxidant activity and in vitro digestibility 
175 
7
7
6 
No significant changes were observed on the cookies mineral content upon 
microalgal addition (2.3-3.2%) neither on the crude fat content (16.1-16.9%). 
Regarding the fatty acid profile no major differences were found between the 
control and microalgae cookies, with predominance of palmitic acid (16:0), 
followed by oleic acid (C18:1) and linoleic acid (C18:2) (Table 5). 
 
Table 5. Main fatty acids present in the cookies enriched with different levels 
of microalgae (% dry weight). SFA – Saturated Fatty Acids; MUFA – 
Monounsaturated Fatty Acids; DUFA – Diunsaturated Fatty Acids; PUFA – 
Polyunsaturated Fatty Acids; TFA – Total Fatty Acids 
 
 A. platensis  C. vulgaris    T. suecica    P. tricornutum    Control  
 2% 6% 2% 6% 2% 6% 2% 6%  
C12:0 0.19 0.25 0.28 0.32 0.20 0.30 0.17 0.22 0.26 
C14:0 0.16 0.19 0.20 0.20 0.16 0.20 0.17 0.28 0.20 
C16:0 5.10 5.25 5.44 5.32 4.92 5.10 5.28 5.14 5.25 
C18:0 0.87 0.83 0.90 0.85 0.85 0.79 0.88 0.78 0.82 
C18:1 5.44 5.44 5.77 5.72 5.40 5.55 5.62 5.55 5.62 
C18:2 4.36 3.70 3.90 4.05 4.27 3.79 4.56 3.84 3.76 
C18:3 ω3 - 0.28 0.22 0.36 0.18 0.32 - 0.25 0.19 
∑ SFA 6.32 6.52 6.82 6.69 6.13 6.39 6.50 6.42 6.53 
∑ MUFA 5.44 5.44 5.77 5.72 5.40 5.55 5.62 5.55 5.62 
∑ DUFA 4.36 3.70 3.90 4.05 4.27 3.79 4.56 3.84 3.76 
∑ PUFA - 0.28 0.22 0.36 0.18 0.32 - 0.25 0.19 
TFA 16.12 15.94 16.71 16.82 15.98 16.05 16.68 16.06 16.10 
 
 
Despite the fact that the biomass of the marine microalgae T. suecica and P. 
tricornutum contain long chain fatty acids (≥C20), especially 4% EPA 
(C20:5ω3) in P. tricornutum (Table 6), there are no traces of these fatty acids in 
the cookies. This could be due to thermal degradation upon baking at 120 ºC for 
40 min.  
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Table 6. Main fatty acids present in the microalgal biomass (% dry weight). 
SFA – Saturated Fatty Acids; MUFA – Monounsaturated Fatty Acids; DUFA – 
Diunsaturated Fatty Acids; PUFA – Polyunsaturated Fatty Acids; TFA – Total 
Fatty Acids. 
 A. platensis C. vulgaris T. suecica P. tricornutum 
C12:0 - 0.55 0.59 0.51 
C14:0 - 0.06 0.03 0.57 
C14:1 0.01 0.02 - - 
C16:0 2.56 1.99 0.95 1.27 
C16:1 0.29 0.44 0.04 2.42 
C18:0 0.12 0.26 0.60 0.05 
C18:1 0.18 1.81 1.37 0.90 
C18:2 1.15 1.85 2.56 0.53 
C18:3 ω3 0.01 2.51 1.53 0.07 
C18:3 ω6 1.66 0.01 0.03 0.08 
C 20:0 0.02 0.03 - 0.01 
C 20:1  - - 0.06 - 
C 20:2 - - - 0.23 
C20:3 ω6 0.01 - - - 
C 20:4 - - 0.11 0.07 
C20:5 - - 0.39 3.97 
C 24:1 - - - 0.05 
∑ SFA 2.70 2.89 2.17 2.41 
∑ MUFA 0.48 2.27 1.47 3.32 
∑ DUFA 1.15 1.85 2.56 0.76 
∑ PUFA 1.68 2.52 2.06 4.19 
TFA 6.01 9.53 8.26 10.68 
 
 
The main chemical composition changes arising from microalgae incorporation 
in cookies are related to protein content (Table 4). The protein content of 
microalgae cookies was always higher than the control cookie (4.9%). 2% algal 
cookies ranged from 5.1 to 6.1% protein while 6% cookies ranged from 6.6 to 
8.0% protein. The highest values were attained for A. platensis and C. vulgaris 
cookies. It can be concluded that the inclusion of microalgae in cookies, 
particularly A. platensis and C. vulgaris, can be regarded as an effective 
nutritional fortification in terms of protein.  
In the case of A. platensis, it should also be noted the presence of phycocyanin, 
a blue pigment with associated nutraceutical properties (Fernández-Rojas et al., 
2014). Even after thermal treatment, the cookies presented 172 mg/kg and 363 
mg/kg phycocyanin for 2% and 6% incorporation level, respectively (in 
microalgal biomass: 8% w/w). In previous studies (Batista et al., 2006), 
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phycocyanin has been used as colouring and functional ingredient in oil-in-
water food emulsions, proving also to be a powerful structuring agent.  
Fig. 4 presents the phenolic content of microalgae cookies and microalgae 
biomass. The addition of microalgae results in an effective supplementation of 
phenolic compounds, which are practically absent in the control cookie. A. 
platensis 6% cookie presented the highest phenolic content (0.90 mg GAE/g), 
which is in agreement with this algae composition (19 mg GAE/g), followed by 
P. tricornutum 6% cookie (0.62 mg GAE/g). Both A. platensis and P. 
tricornutum 2% cookies still showed much higher phenolic content than the 
chlorophyte algae at the highest concentration (C. vulgaris and T. suecica). 
Other authors have highlighted the potential of phenolic compounds production 
from A. platensis (Kepekçi & Saygideger, 2012) and P. tricornutum (Santana-
Casiano et al., 2014), as well as their correlation with the antioxidant activity of 
these algae extracts. 
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Fig. 4 Total phenolic content (expressed as gallic acid equivalents mg g
-1
 dry 
weight) of four microalgal strains (a) and in cookies enriched with different 
levels of microalgae (b) (Ap – A. platensis, Cv – C. vulgaris, Ts – T. suecica, Pt 
– P. tricornutum). 
 
3.4 Antioxidant capacity 
The antioxidant capacity of microalgae-enriched cookies was tested through the 
FRAP method. From Fig. 5 it is evident that adding microalgae increases 
antioxidant capacity of the cookies.  
P. tricornutum microalgal biomass presented the highest (p<0.05) antioxidant 
capacity (248 mmol TEAC/kg), followed by C. vulgaris (193 mmol TEAC/kg) 
and by A. platensis and T. suecica (about 160 mmol TEAC/kg). The antioxidant 
capacity of the microalgae cookies is in agreement with the microalgae biomass 
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results, although no significant differences were found for cookies prepared 
with different algae, at the same concentration. In the case of P. tricornutum, 
this could be due to antioxidants loss upon baking, namely fucoxanthin 
pigment. In fact, from the colour difference results (Table 3) it was already 
noticed colour loss on this sample upon cooking.  
For all the microalgae studied, a significant (p<0.05) increase in antioxidant 
capacity was observed when increasing biomass concentration from 2% to 6%. 
Overall, cookies with 2% alga showed values around 7.0 and 9.5 mmol 
TEAC/kg while 6% cookies showed values around 11.8 to 15.4 mmol 
TEAC/kg. 
Some other authors have studied the antioxidant capacity of A. platensis 
enriched cookies. El Baky et al. (2015) also observed increasing antioxidant 
activity for biscuits containing 0.3 to 0.9% A. platensis biomass. Singh et al. 
(2015) presented a linear response surface methodology (RSM) model with 
linear positive correlation between A. platensis concentration in sorghum flour 
biscuits (1.6 to 8.4%), and antioxidant activity (DPPH and ABTS inhibition).  
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Fig. 5 Antioxidant capacity (expressed as mmol of Trolox Equivalent 
Antioxidant Capacity, TEAC, per kg) of four microalgal strains (a) and in 
cookies enriched with different levels of microalgae (b) (Ap – A. platensis, Cv – 
C. vulgaris, Ts – T. suecica, Pt – P. tricornutum). 
 
3.5 In vitro digestibility 
As far as digestibility of microalgae is concerned, most of the literature deals 
with tests for macroalgae (Fleurence, 1999; Paiva et al., 2014; Tibbets et al., 
2016) and only few studies focus on the digestibility of microalgae (Mišurcová 
et al., 2010; Machů et al., 2014; Tibbets et al., 2012). To our knowledge, no 
literature is available concerning in vitro digestibility of microalgae-based 
cookies. 
        Ap                  Cv                  Ts                   Pt          Control 
         Ap                       Cv                       Ts                        Pt 
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The in vitro digestibility (IVD) results are presented in Fig. 6. T. suecica and P. 
tricornutum microalgae biomass presented the lowest IVD (around 50%). The 
differences in IVD values between the different microalgae could be related to 
the different structure of microalgae cell walls (Mišurcová, 2011). As expected, 
cookies added with 6% Chlorophyceae biomass exhibited the lowest 
digestibility (87%), although no significant difference in IVD between 
microalgae cookies and the control (IVD 95%) were found. 
 
 
Fig. 6 In vitro digestibility (%) of four microalgal strains (a) and in cookies 
enriched with different levels of microalgae (b) (Ap – A. platensis, Cv – C. 
vulgaris, Ts – T. suecica, Pt – P. tricornutum). 
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4. Conclusions 
The addition of microalgal biomass as natural ingredient resulted in cookies 
with an attractive and innovative appearance. Innovative and stable green 
tonalities varied, depending on the microalga used, from a blueish-green (A. 
platensis) to a brownish-green (P. tricornutum). A. platensis provided a 
significant structuring effect, in terms of cookies texture. In general, increasing 
microalgae content from 2% to 6% resulted in a significant increase in the 
cookies TPC (on average +115%) and AC (on average +66%), while 
digestibility was slightly lower (-5.9% on average).  
From this study, there are prospects for considering microalgae-based cookies 
functional nutrient foods, which could be widely consumed on a daily basis by 
European citizens from all age groups. 
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Abstract 
The first objective of this study was to evaluate the cyanobacterium Arthrospira 
platensis F&M-C256 and the green alga Tetraselmis suecica F&M-M33 
(lyophilised and frozen biomasses) as substrates for lactic acid fermentation 
using Lactobacillus plantarum ATCC 8014. Within 48 h of the fermentation 
process, 10 and 9 log CFU mL
-1
 concentration for the lyophilised and frozen 
substrates, respectively, were reached. Microalgal biomass appears as a suitable 
substrate for L. plantarum growth in both forms. Considering that most of the 
photosynthetic microorganisms of commercial importance (mainly 
Chlorophyceae, such as T. suecica) have rigid cell walls that reduce their 
digestibility, the second objective was to investigate if fermentation was able to 
enhance in vitro digestibility of the two examined microalgae. Fermentation 
increased digestibility of both microalgae, but only in the frozen form (+10.5% 
for A. platensis and +11.1% for T. suecica). Lactic acid fermentation increased 
the antioxidant activity and the total phenolic content in the broths with A. 
platensis biomass (both frozen and lyophilised). Even if the characteristics of 
both lyophilised and frozen biomasses improved after fermentation, it is worth 
noting that the freezing process is significantly more economically viable than 
lyophilisation on an industrial scale. This study highlighted the potential of A. 
platensis and T. suecica biomasses for the production of economically valuable 
functional food products. 
Keywords: Fermentation; Digestibility; Microalgae; Arthrospira; Tetraselmis, 
Food 
 
 
1. Introduction 
A number of technologies are employed to improve the organoleptic properties, 
nutritional profile, and shelf life of raw vegetable products while maintaining 
safe microbial levels (Jaiswal and Abu-Ghannam, 2013). Fermentation by lactic 
acid-producing bacteria is one such technology commonly used. Lactic acid 
fermented products from milk are well known, but a demand for dairy-free 
alternatives has arisen. This is driven by increasing intolerance to lactose, and 
concerns regarding the saturated fat content of dairy products and their effect on 
LDL cholesterol (Luckow and Delahunty, 2004). Plants, mainly vegetables, and 
macroalgae, therefore, represent a viable alternative for the production of 
fermented foods due to their availability and high nutritional value (Gupta et al., 
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substrates for the production of new fermented foods. Carbohydrates in 
microalgae are allocated in different compartments of the cells mainly as 
reserve polymers (in the cytoplasm in cyanobacteria and in the plastids in 
microalgae), and structural components of the cell wall (Domozych et al., 2007; 
Xia et al., 2001), providing an excellent substrate for fermentation (Ho et al., 
2012). Cyanobacteria synthesize glycogen as their primary energy reserve, and 
peptidoglycan as the major cell wall component (Tomaselli, 1997), while in 
green microalgae starch is the storage carbohydrate (Rismani-Yazdi et al., 2011) 
and cellulose the major component of the cell wall (Domozych et al., 2007). 
Microalgal polysaccharides have the potential to be effectively fermented 
(Gupta et al., 2011), thus possibly leading to the development of fermented 
functional foods. Reports of functional foods produced from fermented 
microalgae are limited in comparison to those relating to terrestrial plants 
(Gupta et al., 2011). These few studies focus particularly on the cyanobacterium 
Arthrospira platensis (commonly called spirulina) (Bhowmik et al., 2009). 
Microalgal matrices can be provided for the fermentation process in different 
forms: dry (e.g. sun-dried, spray-dried, lyophilised) or frozen. The form in 
which microalgal matrix is presented could affect the fermentation process. 
From several decades, freezing and lyophilisation are two among the best 
known conservation processes for microalgae. The lyophilisation process 
ensures the best product preservation although it is economically 
disadvantageous and time-consuming compared to the freezing process (Ratti, 
2001). Lyophilisation may negatively affect the antioxidant potential of organic 
matrices (Michalczyk et al., 2009). On the other hand, the freezing process 
followed by the thawing phase can damage cells, thus probably improving 
digestibility. 
Besides the presence of fermentable carbohydrates, a balanced biochemical 
composition along with the high nutritional value, makes microalgae new 
functional food candidates (Tredici et al., 2009). Microalgae can contain high 
levels of proteins (50–70% dry mass), vitamins, and minerals (Becker, 2007). 
The nutritive value of microalgal proteins is of particular interest, due to the 
presence of all the essential amino acids such as leucine, isoleucine, and valine 
(Becker, 2007). Microalgae may also contain high levels of carotenoids (Del 
Campo et al., 2000), short-chain (Chacón-Lee et al., 2010) and long-chain 
polyunsaturated fatty acids (Becker, 2013). The cyanobacterium A. platensis is 
one of the microorganisms already approved under Regulation (EC) No 258/97 
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of the European Union concerning novel foods and novel food ingredients, due 
to its consumption prior to May 1997 (European Union, 1997). The green 
microalga T. suecica, not being consumed prior to May 1997, requires approval 
as novel food before commercialization. However, another species within this 
genus, T. chuii, has been approved (AECOSAN 2014). Thus, Tetraselmis and 
Arthrospira represent two of the most promising microalgal genera for the 
development of functional foods (Niccolai et al., 2016). 
When the potential application of new matrices for the production of functional 
foods is studied, in vitro evaluation of digestibility is a fundamental analysis to 
provide information on their nutritional bioavailability (Boisen and Eggum, 
1991). Microalgae can have high digestibility, as in the case of Arthrospira that 
being a cyanobacterium present a cell wall of easy breakage (Becker, 2007). In 
other cases, mainly green algae, such as Tetraselmis, the digestibility is 
generally low due to the robust cell wall which restricts the access of the gut 
enzymes to the cell components (Janczyk et al., 2005). In this case, an increase 
of enzyme accessibility to the cell content is necessary to improve digestibility 
(Doucha and Lìvansky, 2008) and this could be achieved through lactic acid 
fermentation (Harun et al., 2010). Fermentation process could also favour the 
release of a higher amount of intracellular proteins most likely as a result of 
disruption of the cell walls, dissociation of the nutrient-matrix complexes, or 
transformation into more active molecular structures (Parada and Aguilera, 
2007). In accordance to Windey et al. (2012), the process can also break the 
amino acid chains increasing protein bioavailability. 
Microalgae have potent antioxidant activity, due to the presence of compounds 
such as polyphenols and pigments (Tredici et al., 2009; Liu et al., 2011). This 
property is highly valuable for the production of functional foods. The radical 
scavenging abilities of Arthrospira and Tetraselmis have been evaluated in 
recent years (Liu et al., 2011; Ulloa et al., 2012). Liu et al. (2011) found that 
DPPH radical scavenging ability and total phenolic content of Arthrospira 
increased significantly after fermentation with lactic acid bacteria. This was 
attributed to the lysis of the cell wall during fermentation, which released 
unidentified phenolics which increase antioxidant capacities (Liu et al., 2011). 
Findings such as these show the potential of fermentation to improve the 
bioactivity of microalgae-based foods. 
This study was designed to investigate one cyanobacterium (A. platensis F&M-
C256) and one Chlorophyta (T. suecica F&M-M33) as substrates for 
Lactobacillus plantarum fermentation and the fermented products were 
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phenolic content. These parameters are important attributes for the development 
of functional food products for which microalgae could be considered as 
interesting candidates. 
 
2. Materials and methods 
2.1 Microalgal material 
Biomasses of the green microalga Tetraselmis suecica F&M-M33 and of the 
cyanobacterium Arthrospira platensis F&M-C256 were provided by Archimede 
Ricerche S.r.l., Camporosso, Imperia, Italy. Both strains were cultivated in 
GWP
®
-I photobioreactors (Tredici et al., 2004) in semi-batch mode. A. platensis 
was cultivated in Zarrouk medium (Zarrouk, 1966), harvested by filtration while 
the biomass was washed with saline solution to remove excess bicarbonate 
before being frozen. T. suecica was cultivated in F medium (Guillard and 
Ryther, 1962), harvested by centrifugation, and the algae paste obtained frozen. 
Aliquots of each biomass were lyophilised and powdered. The frozen and 
powdered biomasses were stored at -20 °C until use. In the literature, A. 
platensis is often incorrectly reported with the name Spirulina platensis. To 
avoid confusion with the true Spirulina genus, we have always adopted the 
correct denomination A. platensis. 
2.2 Bacterial inoculum preparation  
Lactobacillus plantarum ATCC 8014 was purchased from Cruinn Diagnostics 
Ltd, Dublin, Ireland. The culture was maintained at -80 °C (Thermo Scientific 
Revco Elite PLUS Freezer ULT2586-10-A, Massachusetts, U.S.A.) in 20% 
glycerol stocks. 
For the preparation of the inoculum, de Man, Rogosa and Sharpe (MRS) broth 
(Scharlau Chemie, Spain) was autoclaved (15 min, 121 °C) (Tomy SS-325, 
Tomy Seiko Co. Ltd, Japan). 25 mL of the cooled, sterile broth were inoculated 
with 1 mL of thawed L. plantarum stock culture and incubated at 37 °C for 24 h 
(Gallenkamp, Weiss Technik, U.K.). This inoculum was then serially diluted 
one hundred times to obtain a working culture containing 6-7 log CFU mL
-1
 as 
determined by plate counts. 
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2.3 Fermentation 
In order to determine the applicability of A. platensis and T. suecica as growth 
substrate for L. plantarum, lyophilised and frozen biomasses of each species 
were tested according to a modified method by Gupta et al. (2011). 5 g of each 
frozen or lyophilised T. suecica and A. platensis biomasses were transferred in a 
100 mL Erlenmeyer flask and 48 mL deionised water was added. Under sterile 
conditions, the water and biomass broths were inoculated with 2 mL of L. 
plantarum culture. The flasks were incubated at 37 °C and 100 rpm in an orbital 
shaker (Innova 42, Mason Technology, Ireland). Samples were taken at 0, 24, 
48, and 72 h for microbiological analysis. According to Gupta et al. (2011), a 
total of 72 h of fermentation was considered a sufficient time to observe the 
responses of the investigated fermentation parameters. 
The pH of fermented samples was measured (Orion
TM
 2 Star
TM
 pH meter 
Benchtop, Singapore) at 0 and 72 h. 
To evaluate the post-fermented in vitro digestibility, antioxidant capacity and 
total phenolic content of each sample, aliquots (15 mL) were taken after 72 h of 
incubation and stored at 4 °C (Lec AC150, 119 L, U.K.) until analysis. 
2.4 Analytical methods 
2.4.1 Microbiological analysis 
Viable cell counts in the microalgal broth (log CFU mL
-1
) were performed by 
the standard plate method with MRS agar (Scharlau Chemie, Spain). 
Fermentation broth was serially diluted (1:10) in Maximal Recovery Diluent 
(Sigma–Aldrich, Germany) before plating . The plates were incubated at 37 °C 
for 36-48 h for cell enumeration. Viable cell counts were carried out at the start 
and after 24, 48, and 72 h of incubation. 
2.4.2 HPLC analysis of lactic acid 
Samples were collected from the fermented broths at the start and after 24, 48, 
and 72 h, diluted 1:10 with water and centrifuged at 16,211 x g for 15 min at 4 
°C (ROTANTA 460 R centrifuge, Hettich Zentrifugen, Germany). Cell-free 
supernatant was used to quantify the lactic acid content. Analyses of lactic acid 
content were carried out with a high performance liquid chromatography 
(HPLC) system (Waters Alliance, e2695 Separation module, Massachusetts, 
U.S.A.) equipped with an auto sampler and dual pump controller. The detection 
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refractometer (Waters-410) connected in series. The column (Rezex ROA-
Organic acid 5 H+ (8%) 350.0 mm x 7.8 mm; Phenomenex, U.K.) was 
maintained at a temperature of 65 °C and preceded by a guard column (50.0 mm 
7.8 mm; Phenomenex, U.K.). An isocratic programme was used with a flow rate 
of 0.9 mL min
-1
 with a mobile phase of ammonium phosphate monobasic (0.05 
M) (NH4H2PO4) (Sigma–Aldrich, Germany) adjusted to pH 2.4 with 
concentrated phosphoric acid (H3PO4) (Sigma–Aldrich, Germany). An injection 
volume of 20 µL was used. Each sample was injected twice. Samples and 
mobile phases were pre-filtered using a 0.22 µm Millipore filter (Millipore, 
Massachusetts, USA). Data acquisition and integration were performed using 
Empower
TM
 4.0 software. Sodium lactate standards (Sigma-Aldrich, Germany) 
were used to identify and quantify lactic acid in the samples. 
2.4.3 Total carbohydrates 
Samples were collected from the fermented broths and centrifuged as per 
Section 2.4.2. Total carbohydrates of the solid and liquid phases were 
determined in the pellet and supernatant fractions, respectively, of the 
centrifuged broth. Total carbohydrates were estimated by the phenolsulphuric 
acid method (Dubois et al., 1956) and compared to a glucose (Sigma–Aldrich, 
Germany) standard curve.  
2.4.4 In vitro digestibility 
The in vitro digestibility was performed on the unfermented and fermented 
biomass after 72 h of incubation. An adapted method developed by Boisen and 
Fernández (1997) was used to evaluate in vitro digestibility. The in vitro 
analysis reproduces the chemical-enzymatic catalysis (gastric and pancreatic 
juice) that occurs in the proximal tract of the monogastric digestive system. 
After 72 h of fermentation, the collected samples were lyophilised for 24 h and 
carefully powdered before analysis. Samples of 1 g of finely ground material 
(particle size ≤1 mm) were weighed and transferred in 250 mL conical flasks. 
To each flask, phosphate buffer (25 mL, 0.1 M, pH 6.0) was added and mixed, 
followed by HCl (10 mL, 0.2 M). The pH was adjusted to 2.0 by the addition of 
HCl (1 M) or NaOH (1 M). A freshly prepared pepsin water solution (3 mL; 
Applichem, Germany) containing 30 mg of porcine pepsin with an activity of 
0.8 FIP-U/mg was added. The flasks were closed with a rubber stopper and 
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placed on multipoint stirrers at 150 rpm for 6 h in a thermostatically-controlled 
heating chamber (Innova
®
 42 Incubator shaker, Mason Technology, Ireland) at 
39 °C. Following incubation, phosphate buffer (10 mL, 0.2 M, pH 6.8) and 
NaOH solution (5 mL, 0.6 M) were added to each sample. The pH was adjusted 
to 6.8 by addition of HCl (1 M) or NaOH (1 M). A freshly prepared pancreatin 
ethanol : water solution (10 mL, 50:50 v/v) containing 500 mg of porcine 
pancreatin with an activity of 42362 FIP-U/g (Applichem, Germany) was added 
to each sample. After closing with a rubber stopper, the flasks were again 
incubated for 18 h at 39 °C, 4 x g. A reagent blank without biomass was also 
prepared. 
The undigested residues were collected by centrifugation (ROTANTA 460 R 
centrifuge, Hettich Zentrifugen, Germany) at 10,375 x g for 30 minutes. The 
undigested material (sedimentation pellet) was washed with deionised water to 
remove any salts from the buffer, and then centrifuged as per the parameters 
above. 
The supernatant was removed after the second centrifugation, and filtered on 47 
mm glass-fiber membranes with a pore diameter of 1.2 μm (FILTER-LAB, 
Spain). The pellet and filter papers were dried at 80 °C for 6 h, and then at 45 
°C until a constant mass was reached. To account for any residual biomass or 
undissolved reagent not sedimented during centrifugation, the mass of the dried 
residue on each filter paper was added to the mass of the undigested material 
(pellet). The reagent blank was processed in the same manner. The percentage 
in vitro digestibility of dry matter was calculated according to Boisen and 
Fernández (1997): 
 
       
                 
  
       
 
where: 
D is the in vitro digestibility of dry matter expressed as percentage 
SW is the mass of the starting material expressed in grams 
UW is the mass of the undigested material expressed in grams 
RP is the residual particulate, any residual biomass and/or undissolved reagent 
re-suspended from the pellet or not sedimented expressed in grams 
B is the blank (all reagents without biomass) expressed in grams 
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In order to evaluate enhancements in radical scavenging abilities due to a 
release of antioxidant components after fermentation for both frozen and 
lyophilised A. platensis and T. suecica, the 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) radical scavenging assay was carried out according to Rajauria et al. 
(2013).  
Briefly, the assay was performed in a 96-well (non-sterile) round-bottom 
microtiter plate (Greiner Bio-One International GmbH, Germany) with 1:1 ratio 
of 100 µL of DPPH radical solution (165 µM, in methanol, Aldrich, Ireland) 
and 100 µL of sample (equal to a final extract concentration of 0.2 mg mL
-1
 
methanol:water 1:5). The reaction mixtures were incubated in darkness at 30 °C 
for 30 min. The absorbances were measured at 517 nm using a UV-Vis 
spectrophotometric plate reader (BioTek PowerWave with Gen5 Data Analysis 
software, Vermont, U.S.A.). The following equation was used to calculate the 
DPPH radical scavenging capacity: 
 
                            
                     
        
   
 
where Acontrol is the absorbance of the control (DPPH solution without sample), 
Asample is the absorbance of the test sample (DPPH solution plus test sample) and 
Asample blank is the absorbance of the sample only (sample without DPPH 
addition). 
 
Results were expressed as DPPH radical-scavenging capacity (%). 
2.4.6 Total phenolic content assay 
The total phenolic content assay was carried out according to Rajauria et al., 
2013 using the Folin Ciocalteu assay. 0.1 g of lyophilised or frozen A. platensis 
and T. suecica samples were dissolved in 10 mL of deionised water. To an 
aliquot of each sample (100 μL), 2% sodium carbonate (2 mL; Sigma-Aldrich, 
Ireland) was added. After 2 min, 50% Folin Ciocalteu reagent (100 μL; Sigma-
Aldrich, Ireland) was added. The reaction mixture was incubated in darkness at 
25 °C for 30 min. The absorbance of each sample was measured at 720 nm 
using a UV-Vis spectrophotometric microplate reader (BioTek PowerWave 
with Gen5 Data Analysis software, Vermont, U.S.A.). Results were expressed 
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in gallic acid equivalents (mg GAE g
-1
) of A. platensis or T. suecica biomass, 
through a calibration curve of gallic acid (0 to 500 μg mL-1, Sigma, Ireland). 
 
3. Statistical analysis 
All analyses were conducted in triplicate. The results were expressed as mean ± 
SD (standard deviation). All statistical analyses were carried out using 
Statgraphics Centurion XV (StatPoint Technologies Inc., Virgina, U.S.A.). 
Statistical differences between different fermented broths were determined 
using ANOVA followed by multiple range tests to determine the least 
significant difference (LSD). Differences were considered statistically 
significant when P <0.05. 
 
4. Results and discussion 
4.1 Suitability of A. platensis and T. suecica for lactic acid fermentation  
The growth curves of L. plantarum upon the utilization of A. platensis and T. 
suecica biomass that have been either lyophilized or frozen prior to the 
fermentation process are shown in Fig. 1. At the start of the process, an average 
bacterial concentration of 5.1 ± 0.2 log CFU mL
-1
 was found. Within 48 h of the 
fermentation process, a concentration of 10 log CFU mL
-1
 for the lyophilised 
substrates and 9 log CFU mL
-1
 for the frozen substrates was reached. Significant 
differences in L. plantarum growth (P<0.05) were seen for lyophilized and 
frozen biomasses. It is worth noting that the substrate in the frozen biomass 
broths was, in terms of dry material available, one-fourth (T. suecica) or one-
fifth (A. platensis) of that in the lyophilised broths. With one gram of dry 
substrate from 11.4 to 11.6 log CFU were produced with either lyophilised or 
frozen biomasses; lyophilised substrates were able to produce only 1.2 (T. 
suecica) to 1.5 (A. platensis) times more growth than frozen biomasses. 
Microalgal biomass appears as a suitable substrate for L. plantarum growth in 
both forms, although frozen biomass appears more effective. 
Several authors (Bergqvist et al., 2005; Gardner et al., 2001; Yoon et al., 2006) 
have studied the growth curves of lactic acid bacteria on conventional organic 
matrices, as beet, onion, carrot and cabbage. From these studies the maximum 
concentration reached by various species of Lactobacillus ranged from 9 log 
CFU mL
-1
 after 48 h on cabbage juice (Yoon et al., 2006) or 72 h on a vegetable 
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(Bergqvist et al., 2005). However, it must be considered that in these studies 
Lactobacillus initial concentration was always higher than in our study. The 
results of Fig. 1 indicates that microalgae can be considered a competitive 
organic matrix compared to conventional fermentation substrates. 
 
 
Fig. 1. Growth curve (log CFU mL
-1
) of L. plantarum with lyophilised and 
frozen A. platensis and T. suecica biomass fermentation 
 
The suitability of microalgae for fermentation by lactic acid bacteria has been 
previously evidenced (Uchida and Miyoshi, 2013). The addition of A. platensis 
(up to10 g L
-1
) promoted the growth of different Lactobacillus strains up to a 
maximum of 7-9 log CFU mL
-1
 (according to the strain) after 10 h, starting from 
a concentration of about 2-3 log CFU mL
-1
 (Bhowmik et al., 2009). These 
values are comparable to those obtained in the present study. The positive 
effects of microalgae on the viability of lactic acid bacteria can be attributed to 
the highly nutritious substances they contain which stimulate bacterial growth 
and activity. These substances include exopolysaccharides, free amino acids, 
and essential vitamins and minerals (Parada et al., 1998). 
Substrate of Lactobacillus growth is carbohydrate. Fig. 2 illustrates the total 
carbohydrate concentration of the broths prepared with A. platensis and T. 
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suecica biomasses before inoculation with L. plantarum and its partitioning 
between the solid and liquid fractions of the fermentation broth at the start of 
the process. Before inoculation, the A. platensis broth showed a significantly 
higher total carbohydrate content (P <0.05), for both lyophilised and frozen 
biomasses, compared to T. suecica. Due to the lower initial dry biomass 
concentration, in the broths from frozen biomasses the total carbohydrate 
concentration was lower than in those from lyophilised biomasses. At the start 
of the fermentation (inoculation with L. plantarum) carbohydrates partitioned 
between the solid (biomass) and the liquid phase, with the larger fraction 
remaining within the solid phase. 
 
 
Fig. 2. Total carbohydrate concentration in the broths prepared with A. platensis 
and T. suecica biomasses before inoculation with L. plantarum and at the start 
of the fermentation process, when partitioning between solid phase (biomass) 
and liquid phase occurred. Values are expressed as mean ± SD. For the two 
lyophilised and the two frozen biomasses before inoculation, different letters 
denote a significant difference (P <0.05) 
 
A decrease in carbohydrate concentration (60-65% for A. platensis and 70-75% 
for T. suecica) in the liquid phase of the broths was observed as fermentation 
time increased. At the same time a decrease in carbohydrate content of the solid 
phase was detected (about 15% in A. plantesis and 25% in T. suecica). Thus, it 
seems that carbohydrate in the solid phase were released in the liquid phase 
with increasing difficulty as the fermentation proceeded. 
Lactic acid concentration in the fermentation broths during the process is 
reported in Fig. 3. Concentration in the two frozen biomass broths significantly 
increased (P <0.05) between 0 and 24 h with a production of about 0.7 g L
-1
 for 
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48 h. In both broths with lyophilised biomasses the highest lactic acid 
production (about 2.0 g L
-1
 for both biomasses) occurred in the first 24 h of 
fermentation. Also in this case maximum concentration was reached after 48 h 
(3.5-3.7 g L
-1
). The four tested broths followed overall a similar trend, however, 
as it emerges from Fig. 3, lyophilised biomasses were able to induce a higher 
lactic acid production compared to frozen biomasses. Nevertheless, when lactic 
acid production per unit substrate dry weight after 48 h of fermentation is 
considered, broths with frozen biomasses demonstrated to be the most 
productive, the best substrate being A. platensis (52.3 mg of lactic acid 
produced per gram of dry material, compared to 36.2 mg g
-1
 for T. suecica). The 
two lyophilized biomass broths showed lower and similar productions (about 27 
mg g
-1
). The trend observed for lactic acid concentration was similar to that of 
L. plantarum growth (Fig. 1). 
A significant decrease (P <0.05) in pH to values <6 was observed in both 
lyophilised biomass broths (-14% and -30% for A. platensis and T. suecica, 
respectively), and in frozen A. platensis broth (-13%) during fermentation. The 
pH of frozen T. suecica broth, instead, increased until 9 at the end of the 
fermentation; further tests are necessary to explain this increase.  
 
 
Fig. 3. Lactic acid production (g L
-1
) in broths with lyophilised and frozen A. 
platensis and T. suecica biomasses at different fermentation times. Values are 
expressed as means ± SD 
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Common cereal grains have been studied for their ability to support the growth 
of lactic acid bacteria. For example, Tanaka et al. (2006) found that L. 
delbrueckii IFO 3202 was able to produce 28 g L
-1
 lactic acid from 100 g L
-1
 of 
rice bran. Although an equal concentration of substrate (100 g L
-1
 of lyophilised 
Arthrospira or Tetraselmis) was used in the present study, a maximum lactic 
acid concentration of about 3.5 g L
-1
 was obtained after 48 h of fermentation. 
The greater yield of lactic acid attained with rice bran may be explained by the 
different carbohydrate content and profile, probably more suitable to sustain 
Lactobacillus metabolism in rice bran, which contained 11.3% cellulose + 
hemicellulose and 46.7% starch + dextrin, whereas lyophilised A. platensis 
F&M-C256 and T. suecica F&M-M33 contained 13.4% and 8.2% total 
carbohydrates, respectively. 
Also Gupta et al. (2011) for fermented seaweeds obtained lactic acid 
productions similar to those reached by fermenting microlagal biomasses in this 
work. Uchida and Miyoshi (2013) reported lactic acid production from 
microalgae such as Chlorella spp., Tetraselmis spp., and Nannochloropsis spp. 
in the range of 1.5 - 5.4 g L
-1
. In addition, pre-treatment of microalgae with 
enzymes (as macerozyme and lactase) increased lactic acid production from 5.4 
to 9.6 g L
-1
 for Chlorella spp., and from 1.5 to 4.3 g L
-1
 for Tetraselmis spp. 
Lactic acid production reported by these authors for Tetraselmis spp. is in good 
agreement with that obtained for lyophilised biomass in the present study, 
although our biomasses were not pre-treated. Degradation of the cell walls via 
enzymolysis could promote a greater production of lactic acid during 
fermentation. Moreover, the effect of this pre-treatment combined with further 
degradation occurring during fermentation could also increase the other 
investigated parameters (in vitro digestibility, antioxidant capacity and total 
phenolic content). 
4.2 In vitro digestibility 
A modified protocol based on the Boisen and Fernandez method (1997) was 
used to assess the in vitro digestibility of the unfermented and fermented (72 h) 
biomasses (Fig. 4). Before fermentation, lyophilised and frozen A. platensis 
biomasses had a significantly (P <0.05) greater digestibility, expressed as dry 
matter percentage, than T. suecica biomasses (+32% and +30%, respectively). 
The same situation (+45% and +42% for lyophilized and frozen biomass, 
respectively) was observed after fermentation, although with an increased 
difference. For frozen fermented biomasses a similar significant increase in 
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algae (from 77.3% to 85.4% and from 54.2% to 60.3% for A. platensis and T. 
suecica, respectively). Fermentation did not improve digestibility of lyophilised 
biomasses, as the small increases observed were not significant (P >0.05). 
 
 
Fig. 4. In vitro digestibility (expressed as percent of dry matter) of lyophilised 
and frozen A. platensis and T. suecica biomasses before and after fermentation 
(72 h). Values are expressed as mean ± SD. For each strain, a different letter 
denotes a significant difference (P <0.05) 
 
The cell wall (theca) of T. suecica is composed of polysaccharides made of 
acidic sugars, mainly unusual 2-keto sugars (comprising up to 65% of the theca 
dry matter), rather sensitive to acidic hydrolysis, and glycoproteins (Becker et 
al., 1994; Domozych et al., 2012). The breakage of the cell wall occurring, at 
last partially, during the thawing of the frozen biomasses (Mazur, 1984) resulted 
in an improvement in in vitro digestibility compared to the lyophilized biomass. 
A. platensis is a cyanobacterium, thus the cell wall structure is that of Gram 
negative bacteria with some modifications. The cell structure of Arthrospira has 
been well documented (Tomaselli, 1997). The low concentration (<1%) of β-
1,2-glucan (first layer), a polysaccharide with low digestibility, the small 
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thickness (12 nm) of the first layer, and the proteic and lipopolysaccharidic 
nature of the second layer resulted in a higher digestibility of this alga. The easy 
breakage of its cell walls allowed a higher accessibility to its intracellular 
content by enzymes, and for this reason chemical or physical processing steps 
are not required in order to make its biomass more digestible (Tomaselli, 1997). 
Mišurcová et al. (2010) evaluated the in vitro digestibility of unfermented 
lyophilized A. platensis and Spirulina Pacifica
®
 (registered mark of A. platensis 
by Cyanotech Corp, U.S.A.), finding a higher dry matter digestibility value 
(94.3%) both for A. platensis and Spirulina Pacifica
®
 (85.6%) compared to that 
obtained in the present study for A. platensis F&M-C256 (74.3%). To our 
knowledge, no literature is available concerning digestibility of T. suecica 
biomass (fermented and unfermented), as well as digestibility of fermented A. 
plantesis. 
With the exception of the cyanobacteria, many microalgae of commercial 
importance (among which several green algae, such as T. suecica) have rigid 
cell walls, thus making, in many cases, the adoption of mechanical and/or 
enzymatic methods to rupture cells necessary to improve digestibility. A high 
influence of different post-harvesting treatments on the digestibility of various 
algal species was demonstrated (Becker, 2013). The present study showed how 
the fermentation process led to a higher in vitro digestibility after fermentation 
for both frozen biomasses. 
4.3 Enhanced antioxidant capacity and phenolic content post-fermentation  
Arthrospira has in vitro and in vivo antioxidant, radical scavenging and anti-
inflammatory activity principally due to the presence of phycocyanin. 
Phycocyanin contains an open chain tetrapyrrole chromophore, 
phycocyanobilin, which is covalently attached to the apoprotein (Bhat and 
Madyastha, 2001). Liu et al. (2011) hypothesized that antioxidants or 
phycocyanobilin released from Arthrospira when fermented would have better 
biological activity. 
The comparative DPPH radical scavenging capacity of fermented and 
unfermented lyophilised and frozen A. platensis and T. suecica biomasses at 0.2 
g L
-1
 methanol : water (1:5) extract concentration are illustrated in Fig. 5 . 
Lyophilised A. platensis exhibited 20.5% DPPH inhibition before fermentation, 
increased to 36.6% after fermentation (+79%). A high increase (+69%) for 
frozen A. platensis was also observed. On the contrary, T. suecica exhibited a 
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which decreased to 34.4% and 36.4%, respectively, after fermentation (Fig. 5). 
 
 
Fig. 5. DPPH inhibition (%) by lyophilised and frozen A. platensis and T. 
suecica biomasses before and after fermentation. Values are expressed as means 
± SD. For each alga, different letters denote a significant difference (P <0.05) 
 
Similar to the results obtained in the present study, Liu et al. (2011) reported a 
radical scavenging capacity of A. platensis biomass between 15% and 20%, 
although at a higher broth concentration (20 g L
-1
). El-Baky and El-Baroty 
(2012) and Chu et al. (2010) found a radical scavenging ability of about 20% at 
concentrations from 0.005 to 2.510-5 g L-1 for phycocyanin extracted from 
Arthrospira maxima and A. platensis. Correlated with the trend observed in the 
present study, Liu et al. (2011) found an improvement (approximately +78%) in 
DPPH scavenging ability after fermentation of A. platensis biomass. 
Tetraselmis contains phenolic compounds (Goiris et al., 2012) and a high 
proportion of chlorophyll a as principal antioxidants (Pane et al., 1998). As 
reported by Lanfer-Marquez et al. (2005), chlorophylls are capable of inhibiting 
the DPPH radical. T. suecica also contains other antioxidant compounds, such 
as tocopherols (up to 125 µg g
-1
 dry weight, Chini Zittelli et al., 2006) and 
tocotrienols (Vismara et al., 2003; Liu et al., 2008). As a consequence, this 
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microalga has the potential to exert potent antioxidant effects. Some authors 
(Ulloa et al., 2012; Custódio et al., 2012; Jo et al. 2012) found a radical 
scavenging ability of 40%, 46% and 55% at higher concentrations compared to 
our study (30, 10 and 2 g L
-1
, respectively) for T. chuii and T. suecica. 
Unexpectedly, the fermented T. suecica F&M-M33 biomass showed a lower 
percentage of inhibition compared to the unfermented sample (Fig. 5). The 
simultaneous actions of enzymes, weak acids, oxygen, light, and heat can lead 
to the formation of a large number of degradation products, including those 
from chlorophylls (Mangos and Berger, 1997). Moreover, tocopherols are also 
subject to degradation by heat and light (Allwood and Martin, 2000). Since 
fermentation was carried out at 37 °C for 72 h in the present study, also 
temperature may have contributed to degrade chlorophylls and tocopherols in T. 
suecica F&M-M33, thus decreasing its antioxidant power. To the authors’ 
knowledge, no data has been published on DPPH inhibition of fermented T. 
suecica biomass. 
The total phenolic content of lyophilised and frozen A. platensis and T. suecica 
biomasses during fermentation is illustrated in Fig. 6. The broths from 
lyophilised biomasses showed a higher phenolic content compared to those 
from frozen biomasses until 48 h from the start of the fermentation for both 
species. Unexpectedly, after 48 h the broth from frozen A. platensis biomass 
showed a higher total phenolic content compared to that from lyophilised 
biomass. Observing the total phenolic content in the two T. suecica broths, in 
that with lyophilised biomass a maximum of 11.9 mg GAE g
-1
 at 24 h was 
reached and a decrease to 5.2 mg GAE g
-1
 at 72 h was observed. A similar trend 
was observed in the broth with frozen T. suecica biomass. In the broth with 
lyophilised A. platensis biomass total phenolic content increased from 0 h (4.2 
mg GAE g
-1
) to 48 h (17.4 mg GAE g
-1
) and then decreased at 72 h (10.0 mg 
GAE g
-1
) In the broth with frozen biomass a completely different trend was 
observed: although the maximum value reached was slightly lower compared to 
that measured in the lyophilised biomass broth, the total phenolic content 
continued to increase from the start (1.8 mg GAE g
-1
) to the end (11.8 mg GAE 
g
-1
) of the fermentation. 
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Fig. 6. Total phenolic content (expressed as gallic acid equivalents mg g
-1
 dry 
mass) in the broths with lyophilised and frozen A. platensis and T. suecica 
biomasses at different fermentation times. Values are expressed as means ± SD 
 
Only few studies have investigated the role of phenolic compounds in 
microalgae (Chaiklahan et al., 2013; Hajimahmoodi et al., 2010; Li et al., 2007). 
Phenolic compounds, synthesized as secondary metabolites, are considered the 
major contributors to antioxidant capacity (Abd El-Baky et al., 2009). Total 
phenolic content of Arthrospira reported in the literature varies from 2.4 to 49.8 
mg GAE g
-1
 depending on culture medium (Abd El-Baky et al., 2009), 
extraction methods (Chaiklahan et al., 2013) and culture conditions (Kepekçi 
and Saygideger, 2012). Liu et al. (2011) found that unfermented A. platensis 
powder contained 19.5 mg GAE g
-1
, and the broth with Arthrospira fermented 
with lactic acid bacteria after 48 h incubation contained 33.6 mg GAE g
-1
. The 
fermentation process could have released polyphenols such as gallic acid, or 
produced other metabolites (Liu et al., 2011). Since total phenols are, amongst 
other compounds, responsible for antioxidant activity (Abd El-Baky et al., 
2009; Liu et al., 2011), the greater quantity of total phenols in fermented A. 
platensis F&M-C256 may indicate a greater antioxidant activity than 
unfermented biomass, which is confirmed by the DPPH data (Fig. 5). 
Ahmed et al. (2014) and Custódio et al. (2014) found values for total phenolic 
content in Tetraselmis spp. aqueous extract of the hexane-extracted biomass and 
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in T. suecica ethyl acetate extract of 0.8 mg GAE g
-1
 and 1.1 mg GAE g
-1
, 
respectively. Goiris et al. (2012) measured phenolic contents of 3.74 mg GAE g
-
1
 and 1.71 mg GAE g
-1
 in ethanol/water extracts of Tetraselmis spp. and T. 
suecica, respectively. The results obtained in this work showed for T. suecica 
F&M-M33 aqueous extracts much higher total phenolic contents. To the 
authors' knowledge, no data on the total phenolic content of T. suecica after 
fermentation have been published to date. 
 
5. Conclusions 
At the end of lactic acid fermentation, cell growth of L. plantarum was good 
with both lyophilised and frozen biomasses and no differences were found 
between A. platensis and T. suecica, demonstrating that both lyophilised and 
frozen biomasses were excellent substrates. After fermentation, a significant 
increase in digestibility was observed for frozen but not for lyophylised 
biomasses. Moreover, an increase in the antioxidant activity was observed with 
A. platensis. Total phenolic content increased during fermentation, although 
biomass freezing had a negative impact, resulting in a lower content compared 
to broths from lyophilised biomasses. Frozen biomass, also considering the 
results per unit dry weight of substrate, appears to be a better fermentable 
substrate (higher lactic acid production, higher digestibility). Furthermore, it is 
more economically viable on an industrial scale because it obviates the need for 
a drying process (as lyophilisation or spray drying), that would be highly 
expensive in terms of energy costs, as well as time-consuming. 
In conclusion, fermentation of microalgae is a promising technology and 
remains open to future studies. Thanks to their excellent biochemical and 
nutritional profile, microalgae are good candidates for the production of 
functional food products through fermentation. 
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9.1 General discussion 
 
The world demand for foods is increasing and conventional agriculture shows a 
limited ability to face the increase in demand, especially under the changing 
climatic conditions and considering the increasing need of freshwater by urban 
areas. The problem of food scarcity and malnutrition is still unsolved today with 
a world population of 7 billion and expected to surpass 9 billion in 2050 (Antal 
and Van Den Bergh, 2016). Malnutrition occurs in people who are either 
undernourished or overnourished. Undernutrition is the condition that develops 
when the body does not get the right amount of the vitamins, minerals, and 
other nutrients it needs to maintain healthy tissues and organ function. While, 
overnutrition results from eating too much and eating too many unhealthy 
foods, or taking too many vitamins or other dietary replacements (Website 
FAO, glossary). 
Alternative food sources, like microalgae, appear a possible next generation of 
crops for the agro-industry. Indeed: i) many microalgae show a balanced 
biochemical composition, with a high protein content, vitamins, minerals, 
carotenoids, short-chain and long-chain polyunsaturated fatty acids; ii) their 
cultivation can be carried out in non-arable lands using saline or sea waters, so 
avoiding competition with traditional crops and with humans and animals for 
freshwater consumption; iii) they can grow on wastewaters, reducing the water 
pollution; iv) they do not need of pesticides or herbicides for their cultivation  
limiting pollution by these products (Tredici et al., 2009; Tredici, 2015). 
However, only few microalgal species have been selected for large-scale food 
production, among these Chlorella, Arthrospira and Dunaliella (Norsker et al., 
2011). 
The general aim of the research, reported in Chapter 2, was to evaluate the 
nutritional properties of some microalgal and cyanobacterial biomasses that 
might be proposed for the production of innovative foods and nutraceuticals. 
For the use of microalgal biomass for food and nutraceutical purposes, there is a 
need to determine certain characteristics: i) the nutritive value of the alga; ii) the 
presence of toxic substances; iii) its digestibility; iv) the acceptability of the 
product by the consumer (Becker, 2004). 
Chapter 3 reports the tests used to investigate the possible in vitro toxicity of 
selected microalgal and cyanobacterial strains. Methanolic and aqueous extracts 
of the microalgal biomasses were tested on human dermal fibroblasts and on 
Artemia salina models. Concerning the in vitro toxicity studies, most of the 
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9 literature focused on tests against cancer cell lines (Jaki et al. 1999; Carballo et 
al. 2002; Bechelli et al. 2011; Hisem et al. 2011) and only few studies, to our 
knowledge, evaluated the cytotoxic effects of microalgae on non-cancerous 
cells (Prestegard et al. 2009; Lopes et al. 2011; Goh et al. 2014). The use of 
normal human cell lines as human dermal fibroblasts, that present a non-
aberrant phenotype, is an added value with respect to the use of cancerous cells 
that typically show chromosome and phenotype aberrations (Jallepalli and 
Lengauer 2001; Fackenthal and Godley 2008). 
As found by Logrieco et al. (1996), that found that extracts from Fusarium 
subglutinans have a different pattern of toxicity on A. salina and human B 
lymphocytes, our data indicate that extracts from microalgae show different 
toxicity on A. salina and fibroblasts due to a different sensitivity and complexity 
between the two models. Moreover, the different toxicity patterns often 
observed in methanolic and aqueous extracts tested on A. salina may also derive 
from different molecules being extracted by the different solvents (Piccardi et 
al. 2000), or from the same component that is extracted by the solvents with a 
different efficiency (see the case of Nostoc sp. M1 in Chapter 3). Although in 
some cases the two models provided contrasting results, the work reported in 
Chapter 3 confirmed their validity for preliminary screening of toxicity. These 
in vitro models, especially in the case of methanolic extracts after 48 hours of 
incubation, are able to indicate organisms and substrates of potential toxicity 
and may well serve as guidelines for in vivo tests on mammals to be performed 
on the whole algal biomass, which are necessary to apply for novel food in the 
European Union (see Chapter 1, Subchapter 1.3.1, pp 21-24). 
The biochemical composition and the evaluation of digestibility are 
fundamental to provide information about the quality and bioavailability of 
microalgae constituents. In Chapter 4, the biochemical composition and the in 
vitro digestibility of some selected microalgal and cyanobacterial biomasses are 
reported. Despite similarities in  the  biochemical composition, each microalga 
presented a typical nutrient profile allowing the selection of desired 
physicochemical characteristics for food applications. Knowing their 
characteristics is essential for the selection of the most suitable microalgae for 
specific food technology applications and consequently successful novel foods 
development (Batista et al., 2013). 
Proteins are considered fundamental macroelements of microalgal and 
cyanobacterial biomass, which need to be characterized to evaluate these 
microorganisms as a new food source. The estimations of crude protein in 
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microalgae include other nitrogenous constituents like nucleic acids, 
glucosamides, amines, and cell wall materials (Becker, 2004). A. platensis 
F&M-C256, Klamath powder (a commercial product obtained from a natural 
bloom mainly composed of Aphanizomenon flos-aquae) and C. vulgaris Allma 
showed the highest values of crude protein content. It is interesting to note that, 
in our work, most of the marine microalgae fall in the same low range of protein 
content, instead, four freshwater microalgae and A. platensis F&M-C256, 
grown in alkaline media, showed higher values. The protein content of almost 
every microalga was always higher to the of reference indicated by FAO for 
other vegetable food proteins, such as lentils, faba beans, chickpeas, whole 
wheat, and rolled oats (25-30%) (FAO/WHO, 1991). Taking 5 g of A. platensis 
F&M-C256 or C. vulgaris Allma per day, the amount usually recommended by 
the nutrition facts for several Arthrospira and Chlorella-based products 
(Website Aurospirul; Website MyProtein; Website Bulk Powders; Website 
Health Ranger Store), a person can enrich the daily diet up to 3.5 or 2.8%, 
respectively of non-animal protein, with a low amount of lipids (only 0.5 and 
0.8%, respectively). These numbers indicate the great potential of microalgal 
and cyanobacterial biomasses as new protein sources of non-animal origin. 
Diets high in animal protein have been shown to increase the risk of kidney 
problems (Reddy et al., 2002; Knight et al., 2003) osteoporosis (Abelow et al., 
1992) and some types of cancer (Giovannucci et al., 1994; Willet et al., 1990) in 
humans. Furthermore, changes in demand for meat may increase the 
environmental negative impact of meat production. It has been estimated that 
global meat consumption may double in the period 2000 to 2050, mostly as a 
consequence of increasing world population, but also because of increased per 
capita meat consumption (FAO, 2006). In 2007, the global average meat 
consumption per capita per year was equal to 37.3 kg (Table 1). FAO illustrated 
(by forecast estimates) that emerging countries and developed countries will 
increase meat consumption by 1 kg per capita per year between 2016 and 2050 
(Alexandratos and Bruinsma, 2012). 
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Table 1 World meat consumption (kg) per capita per year  
Country  Meat consumption per capita per year 
Africa 11.3 
Emerging countries 17.1 
West Asia (including the Middle East) 19.7 
East and South Asia 40.8 
Latin America 53.6 
Developed countries 81.7 
Global average 37.3 
Adapted from McMichael et al., 2007 
 
Meat production is responsible for enormous environmental impacts, mainly 
attributable to: i) freshwater consumption; ii) negative effects on aquatic 
ecosystems due to the increased discharge of phosphates and nitrates, decreased 
dissolved oxygen, increased temperature and turbidity that cause eutrophication 
events (Belsky et al., 1999); iii) greenhouse gas emissions (Gerber et al., 2013); 
iv) energy consumption (Canning et al., 2010). 
Besides proteins, carbohydrates are fundamental macronutrients to provide the 
energy required by the body, for the correct functioning of the nervous system 
and red blood cells; and, more generally, for many of the metabolic reactions 
taking place inside an organism (Cummings and Englyst, 1995). Carbohydrates 
of microalgae can be found in the form of cellulose, starch, and other 
polysaccharides, as storage products or cell wall components (Becker, 2004). 
Carbohydrate in most of the studied microalgae were found always lower than 
20%, which were comparable to the values indicated by FAO/WHO (2003) for 
common foods such as corn, rice and beans. Based on the effects on risk of 
heart disease and obesity (Tighe et al., 2010), the Institute of Medicine 
recommends that American and Canadian adults should take between 45–65% 
of dietary energy from carbohydrates (Food and Nutrition Board, 2002/2005). 
While, the Food and Agriculture Organization and World Health Organization 
jointly recommend that national dietary guidelines set a goal of 55–75% of total 
energy from carbohydrates, but only 10% directly from sugars (FAO/WHO, 
2003). 
Concerning dietary fiber, it is recommended dietary intakes of 14 g/1000 kcal 
(both for children and adults) in order to have a positive effect on health 
(Anderson et al., 2009). In particular, this intake can stimulate the proliferation 
of intestinal flora and decrease cholesterol and glycemic levels (Beecher, 1999). 
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In studies of general populations, low fiber intake is associated with increased 
risk of colon cancer and other malignancies (World Cancer Research, 1997), 
heart disease (FAO/WHO, 2003) diabetes and constipation (Anderson et al., 
1995; Salmeron et al., 1997). Most of the marine algal strains showed values of 
total dietary fiber ≥ 13%, comparable to oat, bran, and whole wheat flour and 
much higher compared to fruits and vegetables (such as apricots and carrots) 
(Table 2). 
Studies of general populations consuming diets high in fat, particularly 
saturated fat, have shown increased risk of cancer (World Cancer Research, 
1997; Bingham et al., 2003; Cho et al., 2003) diabetes, and heart disease 
(FAO/WHO, 2003). In our study, only five strains (C. sorokiniana F&M-M49, 
C. sorokiniana IAM C-212, Tetraselmis suecica F&M-M33 grown in nutrient 
replete medium, Tisochrysis lutea F&M-M36 and Nannochloropsis oceanica 
F&M-M24) exhibited values of lipid from 23 to 29%. The other strains showed 
lipid content ≤ 22% (see Chapter 4, p. 84, Table 2), lower than common foods 
such as coconuts and peanuts, but higher compared to rice and vegetable such as 
row spinach (Table 2). 
 
Table 2 Content of lipids and total dietary fiber in frequently consumed foods 
Lipid  Total dietary fiber  
Food Content (%) Food Content (%) 
Coconut 45.6 Apricots 7.7 
Spinach (raw) 0.4  Carrots (raw) 2.9 
Rice 0.9 Oat bran 15.7 
Roasted peanuts 49.5 Whole wheat flour 12.4 
Biscuits 11.9 White bread 3.2 
Adapted from Anderson and Bridges, 1988; Marlett, 1992; Rocquelin et al., 
1998; Li et al., 2002 
 
In Chapter 4, the nutritional quality of lipid profiles observed in the algae 
species was also evaluated by different indexes (p. 90, Table 4). Foods with 
polyunsaturated/saturated fatty acids ratio (P/S) below 0.45 are considered by 
the FAO/WHO to be undesirable in the human diet (FAO/WHO, 2008), due to 
their potential to induce increases in blood cholesterol. The P/S ratio of beef is 
typically about 0.1, and this ratio decreases with an increase of meat fatness 
(Scollan et al., 2006). The P/S ratio in all studied microalgae varied from 0.48 
(N. oceanica F&M-M24) to 4.13 (C. sorokiniana IAM C-212), with  
presumable beneficial health effects. The ratio hypocholesterolemic 
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9 /hypercholesterolemic fatty acids (H/H) is an index based on current knowledge 
of the effects of individual fatty acids on cholesterol metabolism (Santos-Silva 
et al., 2002; Simat et al., 2015). Nutritionally, higher H/H values are considered 
more beneficial for human health because directly proportional to a high PUFA 
content. The result obtained for T. lutea F&M-M36 is quite in agreement with 
H/H values for marine fish such as sardine and mackerel (2.46) reported by 
Fernandes et al. (2014). The fatty acids from microalgae (such as T. lutea) that 
are highly polyunsaturated could have beneficial effects on cholesterol. Two 
other indexes are used to evaluate the potential for stimulating platelet 
aggregation, the atherogenicity index (AI) and thrombogenicity index (TI) 
(Turan et al., 2007). Lower AI and TI values indicate a greater potential to 
protect against coronary artery disease (Turan et al., 2007). Very interestingly, 
the lowest TI value was observed in the marine N. oceanica F&M-M24 (0.91), 
which is still higher compared to the value of TI found for sardine (0.20) by 
Fernandes et al (2014). 
Fatty acids (provided either by ingestion or by triglycerides stored in fatty 
tissues) are distributed to cells to serve as energy for muscular contraction and 
general metabolism (Simopoulos, 1991). Regarding MUFA, for all 
Chlorophytes a general presence of oleic acid (C18:1 ω9) was found. Oleic acid 
(in triglyceride form) is included in the normal human diet as a part of animal 
fats and vegetable oils. Monounsaturated fat consumption has been associated 
with decreased low-density lipoprotein (LDL) cholesterol, and possibly 
increased high-density lipoprotein (HDL) cholesterol (Appel et al., 2005). In 
particular, oleic acid may be responsible for the hypotensive effects (Pitozzi et 
al., 2010). Concerning PUFA, A. platensis F&M-C256 showed a larger 
proportion of γ-linolenic acid (GLA C18:3 ω6, 1.7%). GLA has several 
beneficial health effects and GLA oils are mainly used for their 
antiinflammatory effects (Van Hoorn et al., 2008). GLA is also shown to 
stimulate apoptosis of cancer cells without affecting healthy cells and can 
prevent weight regain after weight loss (Van Hoorn et al., 2008). Besides          
γ-linolenic acid, A. platensis F&M-C256 was rich in linolenic acid (C18:2 ω6, 
1.2%). Over the past two decades, numerous health benefits have been 
attributed to linoleic acid in experimental animal models including actions to 
reduce carcinogenesis, atherosclerosis, onset of diabetes, and body fat mass 
(Belury, 2002). Concerning N. sphaeroides F&M-C117, a higher amount in 
C16:0 and α-linolenic acids (ALA C18:3 ω3) than other fatty acids were found 
(3 and 2.1%, respectively). ALA plays an important role reducing the level of 
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platelets stickiness due to the alteration of the aggregating potential. This 
determines a decrease of the probability of thrombotic occlusion and a reduction 
of the atherosclerotic process (Connor, 1999). For Porphyridium purpureum 
F&M-M46, a high proportion of PUFA (3.4%), mainly eicosapentaenoic acid 
(EPA C20:5 ω3) and arachidonic acid (ARA C20:4 ω6) was found. ARA is the 
main precursor of eicosanoids, that are involved in the control and regulation of 
the inflammatory process (Kuehl and Egan, 1980). In our study, N. oceanica 
F&M-M24 and Phaeodactylum tricornutum F&M-M40 showed the highest 
proportion of PUFA (4 and 5%, respectively) compared to the other microalgae, 
mainly EPA (3 and 4%, respectively). It is worth noting that T. lutea F&M-M36 
was the only alga  which showed the presence of docosahexaenoic acid (DHA 
C22:6 ω3). EPA and DHA support cardiovascular health, have a beneficial 
effect in several forms of cancer and also in inflammatory and autoimmune 
disorders, and play an essential role in the brain and retina development (Bucy 
et al., 2012). Women during pregnancy and lactation could satisfy their 
recommended intake of EPA (100 mg/day, FAO, 2010), assuming around 2.5 g 
per day of P. tricornutum F&M-M40 or 3.2 g per day of N. oceanica F&M-
M24. Microalgae (including cyanobacteria) represent one of the most attractive 
resources for the production of PUFAs because: i) they are primary producers in 
the marine food chain; ii) it is possible to change fatty acid content and profile 
by simply varying culture conditions; iii) PUFAs production does not suffer 
from the fluctuations (qualitative and quantitative) typical of that from fish oil; 
iv) microalgal biomass with standard content of PUFAs can be obtained in 
strictly controlled culture systems avoiding contamination by heavy metals; v) 
microalgal PUFAs are of non-animal origin (Chini Zittelli, 2013). 
Thanks to the health benefits related to the fatty acids found in all investigated 
microalgal and cyanobacterial biomasses, these microorganisms have a great 
potential for the development of healthy food products and nutraceuticals.  
A well-balanced ratio between the ω3/ω6 is advantageous for human health and 
1:4 is considered the recommended ratio to prevent cardiovascular diseases 
(Simopoulos, 2002). Except for A. platensis F&M-C256 and T. suecica F&M-
M33 grown in nutrient replete medium all the other microalgae studied 
presented a ω3/ω6 ratio higher than 1 (see Chapter 4, pp 88-89, Table 3). 
Indeed, in cyanobacteria the unsaturated double bounds are principally in ω6 
position while, in marine species are mainly in ω3 position (Batista et al., 2013). 
Some foods or food ingredients of wide consumption, especially in the Western 
diet, contain a high amount of saturated fatty acids and high quantity of total 
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9 cholesterol (Table 3). In particular, coconut oil contains a high amount of 
saturated fatty acids (85%) and sunflower oil and palm oil contain a large 
amount of total cholesterol (up to 49%). High quantities of positive 
monounsaturated fatty acids for human health are identified for canola/rapeseed 
oil and olive oil (64 and 70%, respectively) (Website USDA, 2010). Sunflower 
oil and hemp oil can contain up to 75% of polyunsaturated fatty acids (FSA, 
1991) (Table 3). 
 
Table 3 Fatty acids and cholesterol composition (g/100 g) of some common 
dietary fats 
 Saturated Monounsaturated Polyunsaturated Cholesterol 
Animal fats     
Lard 40.8 43.8 9.6 0.6 
Butter 54.0 19.8 2.6 2.0 
Vegetable fats     
Coconut oil 85.2 6.6 1.7 0.66 
Cocoa butter 60.0 32.9 3.0 1.8 
Palm oil 45.3 41.6 8.3 33.1 
Soybean oil 14.5 23.2 56.5 16.3 
Olive oil 14.0 69.7 11.2 5.1 
Corn oil 12.7 24.7 57.8 17.2 
Sunflower oil 11.9 20.2 63.0 49.0 
Hemp oil 10.0 15.0 75.0 12.3 
Canola/Rapeseed oil 5.3 64.3 24.8 22.2 
Adapted from FSA, 1991; Website USDA, 2010 
 
The Italian Society of human nutrition, about dietary reference intakes for fatty 
acids, recommended in the case of i) an adult man, 6 g per day of ω6 and 1.5 g 
per day of ω3 fatty acids, ii) an adult woman, 4.5 g per day of ω6 and 1 g per 
day of ω3 fatty acids, and iii) children (4-10 years), 4 g per day of ω6 and 1 g 
per day of ω3 fatty acids (Website SINU, 2012). The low quantity of saturated 
fatty acids and the high quantity of polyunsaturated fatty acids, and, in 
particular of essential fatty acids found in our work, allows considering 
microalgae an innovative food source useful to improve the quality of the diet 
of many people, especially those of Western countries. 
Phenolic compounds, including simple phenols, flavonoids, tannins, lignins, 
phenolic acids, and their derivatives, synthesized as secondary metabolites are 
considered the major contributors to antioxidant capacity (Abd El-Baky et al., 
2009). Cyanobacteria exhibited higher total phenolic contents (TPC) compared 
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to the other microalgae. In particular, A. platensis F&M-C256 showed the 
highest TPC (19 mg GAE g
-1
) (see Chapter 4, p. 92, Fig. 1). Therefore 
microalgae, especially cyanobacteria, would be able not only to enrich a diet of 
micro and macronutrients but also in antioxidants. 
In vitro digestibility test is of utmost importance to understand microalgae 
nutritional bioavailability. Most of the literature deals with macroalgae in vitro 
digestibility tests (Fleurence, 1999; Paiva et al., 2014; Tibbets et al., 2016) and 
only few studies, to our knowledge, focus on the digestibility of microalgae 
(Mišurcová et al., 2010; Machů et al., 2014; Tibbets et al., 2012). None of the 
strains exhibited digestibility values lower than 45%. The differences in dry 
matter digestibility values between microalgal and cyanobacterial samples could 
be related to the different structure of their cell walls (Mišurcová, 2011). 
Concerning crude protein digestibility (CPD), C. vulgaris Allma, A. platensis 
F&M-C256, and N. sphaeroides F&M-C117 were the most digestible strains 
(76, 81, 82%, respectively), which compares favourably with the true protein 
digestibility values found for beans (78%), millet (79%), wheat (77%), and rice 
(75%) in man (Hopkins, 1981; FAO, 1985). Many authors reported very diverse 
CPD values for different species of Chlorella (Janczyk et al., 2005; Morris et 
al., 2008; Mišurcova et al., 2010), Arthrospira (Devi et al., 1981; Becker, 2004), 
and Nostoc (Hori et al. 1990). This large variability may be related to species 
differences but more likely due to differences in methods used (such as different 
enzyme mixtures, sample processing, assay conditions, and the extent of algal 
cell wall disruption) (Mišurcova, 2011). Despite no significant correlation 
between CPD and dietary fiber was found (R
2
 = 0.10), reduced CPD of algae 
can also be attributed to relatively high levels of fiber that can entrap proteins in 
the cellular matrix, rendering them less bioavailable to enzymatic hydrolysis 
(Marrion et al. 2005). 
Some microalgae of commercial importance (mainly Chlorophyceae) have rigid 
indigestible cell walls and many authors consider sonication as an efficient 
method to open microalgal cell (McMillan et al., 2013; Safi et al., 2014; Wang 
et al., 2014). Although the sonication pre-treatment led to an increase of dry 
matter digestibility for both C. sorokiniana F&M-M49 and C. vulgaris Allma 
compared to those of the untreated samples (see Chapter 4, p. 97, Table 5), 
these values were not significantly different. The data obtained in this study 
confirm the positive effect of the sonication pretreatment and of the continuous 
stirring on cell dispersibility and consequently on the efficiency of enzyme 
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significant improvement in digestibility of these Chlorella strains. 
Over the past 20 years, the interest in microalgae applications has grown 
increasingly and several authors investigated the role of microalgae in rats diet 
for many purposes, such as effect on serum cholesterol (Dvir et at., 2000), on 
oxidative stress (Carfagna et al., 2015), to prevent cardiovascular disease (Ku et 
al., 2013) or for other purposes, including safety assessment (Hammond et al., 
2001; Cherng and Shih, 2005; Stewart et al., 2008). In Chapters 5 and 6 a 
safety evaluation and the potential health effects of A. platensis F&M-C256 and 
T. lutea F&M-M36 in rats are described. Overall, the results shown in Chapter 
5 indicate that diets supplemented with 20% A. platensis F&M-C256 was well-
tolerated during the 30 days feeding period and the general health status of the 
animal was not affected. The A. platensis F&M-C256 supplemented diet results 
in a daily dose of 12 g/kg. This amount, that mimics the potential use of 
microalgae as foods or food components for human consumption, showed no 
significant adverse effects (see Chapter 5, pp 121-122). The nucleic acid content 
is an important toxicological concern since the biochemical degradation of their 
component purines ends by producing uric acid which can produce kidney 
stones and gout attacks in the long term (Curhan and Taylor, 2008). The World 
Health Organization recommends that the daily total nucleic acid consumption 
should not exceed 4 g, which represent the nucleic acid content of about 80 g of 
dry biomass (World Health Organization, 2007). In our study, feeding a diet 
containing 20% of A. platensis F&M-C256 in rats corresponds to feeding 3 g of 
biomass/day. From our analysis, the DNA content of A. platensis F&M-C256 is 
4%, then we can estimate that the total content of DNA+RNA nucleic acids is 
around 10%, which translates into 0.3 g of nucleic acid/day. It is, therefore, 
reasonable to consider that the nucleic acid content of A. platensis F&M-C256 
does not pose health problems, even at high dosage.  
In the experimental settings, treatment with fibrates, a widely used class of 
lipid-modifying agents, results in a substantial decrease in plasma triglycerides 
and is usually associated with an increase in HDL cholesterol concentrations 
through the activation of the peroxisome proliferator-activated receptors 
(PPAR-α). Very interestingly, our results demonstrate for the first time that 
feeding a diet containing A. platensis F&M-C256 for one month is able to 
induce the expression of PPAR-α in the liver, thus providing a mechanistic 
explanation of the observed hypolipidemic effect (see Chapter 5, p. 120, Table 
2). As found by some authors (Singh et al., 2005; Ku et al., 2013; Vo and Kim, 
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2013), our results demonstrated that spirulina is able to reduce risk factors for 
cardiovascular diseases even in a well-balanced dietary regimen. The active 
ingredients responsible for this hypolipidaemic activity remain to be identified 
but C-phycocyanin has been suggested (Nagaoka et al., 2005). In the United 
States, 38% of adults (according to the National Center for Complementary and 
Alternative Medicine) opted for complementary and alternative medicine over 
conventional drugs, and herbal products are the most frequently used 
complementary and alternative medicine agents among patients with 
cardiovascular disease (Yeh et al., 2006; Nahin et al., 2007). A. platensis F&M-
C256 might thus represent a natural functional food to be used as 
complementary and alternative medicine agent for the prevention of 
dyslipidemias. 
The content in saturated fats, cholesterol, and trans fat of frequently consumed 
food in the United States is high (Table 4) and a drastic reduction of these 
components in a daily diet is fundamental to avoid serious illness. The 
American Heart Association suggests total blood cholesterol level for the 
population should be: < 200 mg/dL to be considered “normal blood 
cholesterol”; 200–239 mg/dL “borderline-high”; > 240 mg/dL “high 
cholesterol”. Furthermore, the trans and saturated fats should not exceed 5 
g/day and 10% of the energy of the diet, respectively (Website American Heart 
Association, 2009). In this respect, A. platensis F&M-C256 could also represent 
an interesting ingredient in a daily diet, not only by providing important 
nutrients, but also helping to reduce total cholesterol from foods high in 
saturated fat. 
 
Table 4. Lipids contents of selected food products for usual portions 
Food products Saturated (g) Cholesterol (mg) Trans (g) 
Fried potatoes (100 g) 12.9 - 2.5 
Steak (100 g) 13.2 92.9 0.65 
Sweet biscuit (50 g)  2.1 - 1.41 
Cracker (50 g) 1.8 - 2.8 
Pies and cakes (60 g) 4.7 - 1.0 
Whole milk (200 mL) 2.4 15.0 0.19 
Hamburger (100 g) 5.9 78.5 0.67 
Butter 10 g) 5.0 22.0 - 
Margarine (10 g) 5.3 6.8 1.0 
Cheese (50 g) 10.4 52.5 0.9 
Sausage (30 g) 3.2 78.5 0.1 
Total 67.0 346.2 11.2 
Adapted from Pennington, 1989; Chiara and Sichieri, 2001 
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accessory pigment present in the chloroplasts of brown algae (Kim et al., 2012). 
Lee et al. (2013) have shown that fucoxanthin has anti-inflammatory, 
antinociceptive, and anti-cancer effects. In addition, some metabolic and 
nutritional studies carried out on rats and mice indicate that fucoxanthin 
promotes fat burning within fat cells in white adipose tissue by increasing the 
expression of thermogenin (Maeda et al., 2005). The results reported in 
Chapter 6 indicate that a diet supplemented with 20% T. lutea F&M-M36 was 
well-tolerated during the 30 days feeding period and no treatment-related 
mortality was detected. However, rats fed T. lutea F&M-M36 showed a 
tendency to a reduction in body weight gain compared to controls. These 
observations are limited to the 30 days feeding but we cannot exclude 
significant effects in longer feeding periods. Nuño et al. (2013) evaluated the 
effects of the microalgae I. galbana in a diabetic rat model and found that from 
an average initial body weight of around 220 g, rats grew up to >300 g at eight 
weeks with differences in body weight. In contrast, body weight remained 
unchanged between weeks in the untreated diabetic group and I. galbana 
diabetic group. The lower body mass of the hyperglycemic and healthy rats 
administered I. galbana compared to those that did not receive a microalgae 
treatment suggests the effect of its polysaccharides are shaped by different 
monomers acting as dietary fiber in the gastrointestinal tract (Zeng et al., 2004). 
Dietary fiber affects satiety, energy, and body composition, reducing appetite 
and energy intake up to 10%, consequently leading to weight reduction (Nuño 
et al., 2013). As found by Maeda et al. (2005), also fucoxanthin may have 
contributed to the reduction in body weight. 
Given the relevant issue of T. lutea F&M-M36 salt content (6%), our study 
specifically focused on the hydro saline balance, blood pressure and renal 
damage. The hydro saline imbalance was supported by an increased water 
consumption, accompanied by increased urinary excretion. Blood pressure was 
not affected over one-month feeding but, as expressed above, it is not possible 
to exclude long term effects. Therefore, high biomass salinity is an issue which 
must be solved by using strategies to reduce its content (e.g. washing of the 
biomass after the harvest) or by using lower doses of this microalga. The 
amorphous neo-formation found in the bladder of both microalgae fed rats was 
interpreted as a uric acid crystal of sporadic occurrence and possibly related to 
the DNA content of microalgae.  
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Our observations indicate that the use of A. platensis F&M-C256 and T. lutea 
F&M-M36 did not have adverse effects in rats within 30 days feeding period 
and exerted positive health effects. Thus, the two microalgae represent 
promising functional foods and nutraceuticals. 
Traditional foods, like biscuits, pasta, gelled desserts, mayonnaises, and 
breakfast cereals, largely consumed on daily basis in different European diets, 
can be used as vehicles of nutraceuticals (Gouveia et al., 2008). Numerous 
combinations of microalgae or mixtures with other health foods can be found in 
the market in the form of tablets, powders, capsules, pastilles and liquids, as 
nutritional supplements. They can also be incorporated into food products (e.g. 
pastas, biscuits, bread, snack foods, candies, yoghurts, and soft drinks), 
providing the health promoting effects that are associated with microalgal 
biomass, probably related to a general immune-modulating effect (Belay, 1993). 
A. platensis, C. luteoviridis, C. pyrenoidosa, and C. vulgaris are microalgae 
already accepted as food, because used prior to May 1997 in Europe (Website 
European Union, Novel Food catalogue). Foods supplemented with these 
microalgae are widely spread in the food market. Besides Chlorella tagliatelle 
and noodles, already available in retail stores, Chlorella powder has been 
studied also as an additive to wheat flower to prepare bakery products (Guoveia 
et al., 2008). Gouveia et al. (2008) reports that the addition of increasing 
amount of C. vulgaris dry powder to cookies brought, besides an increasing 
green colour, a higher firmness of the pastry. A subsequent study by Fradique et 
al. (2010), reports the incorporation of C. vulgaris and A. maxima biomass in 
pasta products. In Chapter 7, to explore the potential food application of 
microalgae as functional ingredients within conventional foods, A. platensis 
F&M-C256-, C. vulgaris Allma-, T. suecica F&M-M33-, and P. tricornutum 
F&M-M40-based cookies are analysed for their sensory and physical properties, 
bioactivity and in vitro digestibility. Two biomass levels were tested: 2% (w/w) 
typically used in algal-based products and a significantly higher content, 6% 
(w/w), to provide additional algal-bioactives. The texture profile of the biscuits 
was also evaluated in our work, and a significant increase of their firmness was 
evidenced with an increase of added microalgal biomass. These results evidence 
the positive effect of the alga in the biscuit structure, reinforcing the short dough 
system. Biscuits are considered solid emulsions of sucrose, lipids and non-
gelatinized starch (Hoseney et al., 1988), being this mix of components 
responsible for the biscuits structure and texture. The replacement of a small 
amount of flour by microalgae biomass, resulted in the inclusion of a complex 
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9 biomaterial, rich in different proteins and polysaccharides. These molecules 
have an important role on the water absorption process, which promote the 
increase of biscuits firmness, resulting in more compact structures (Gouveia et 
al, 2008). A similar study was performed using I. galbana biomass (Gouveia et 
al., 2007). The main interest in using I. galbana biomass is due to its high levels 
of long chain ω-3 polyunsaturated fatty acids, especially EPA and DHA 
(Bandarra et al., 2003). As found in this study, in spite of the drastic thermal 
processing (high temperatures) during biscuits manufacturing, the addition of 
microalgal biomass leads to the presence of ω3 fatty acids (higher than control 
biscuits) (see Chapter 7, p. 175, Table 5). The thermal resistance of fatty acids 
should be due to their presence in an encapsulated form, inside the microalgal 
cell (Gouveia et al., 2008). These fatty acids contents indicate an important 
source of ω3 PUFA with a moderate biscuit consumption, as the 
recommendations for dietary intake in healthy adults is 500 mg/day (ISSFAL, 
2004). 
Very few papers (e.g. Fradique et al., 2013) deal with the bioactive compounds 
of microalgae foods and their resistance to different processing steps. In our 
study, all microalgae-based cookies showed significantly higher total phenolic 
content (TPC) compared to the control. P. tricornutum F&M-M40 cookies 
exhibited the highest TPC. Moreover, microalgae cookies presented 
significantly higher in vitro antioxidant capacity (AC) compared to the control 
(from +45% to +307%). The microalgal cookies in vitro digestibility were also 
assessed. As expected, cookies added with 6% Chlorophyceae biomass 
exhibited the lowest digestibility. From this study, A. platensis F&M-C256 C. 
vulgaris Allma, T. suecica F&M-M33, and P. tricornutum F&M-M40 cookies 
presented significantly higher in vitro antioxidant capacity and total phenolic 
content than the control, whilst not compromising the digestibility. Therefore, 
there are prospects for considering microalgae-based cookies functional nutrient 
foods that could be widely consumed on a daily basis worldwide from all age 
groups. 
In recent years, consumer demand for non-dairy-based probiotics has increased 
(Luckow and Delahunty, 2004) due to lactose intolerance and cholesterol 
content associated with the consumption of fermented dairy products (Gupta et 
al., 2011). In this respect, several reports are available on the use of terrestrial 
vegetables for lactic acid fermentation such as artichokes (Ge et al., 2009), 
carrot (Kun et al., 2008), cabbage (Kohajdová et al., 2006), and beet root (Yoon 
et al., 2005). Ariahu et al. (1999) adopted natural lactic fermentation process to 
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enhance the organoleptic quality of one of the most frequently consumed food 
commodities in the world such as soybean. Beyond nutritional and sensory 
properties, lactic acid fermentation can also improve the shelf life of vegetables 
(Karovicová and Kohajdová, 2003). 
During fermentation, an improvement in digestibility can be obtained due to the 
partial degradation of compounds such as non-starch polysaccharides, in 
particular cellulose, by Lactobacillus plantarum (Moraïs et al., 2014). L. 
plantarum is an attractive candidate for the degradation of cellulose due to its 
ability to metabolise the major polysaccharide constituents of cellulosic 
biomasses (Moraïs et al., 2014). In Chapter 8, in order to improve the 
acceptability of a microalgae-based product by consumers in terms of 
organoleptic quality and digestibility, L. plantarum was used to ferment frozen 
and lyophilised A. platensis F&M-C256 and T. suecica F&M-M33 biomasses. 
Microalgal biomass appears as a suitable substrate for L. plantarum in both 
forms, although frozen biomass appears more effective (see Chapter 8, p. 203, 
Fig. 1). Microalgae can be considered a suitable substrates for lactic 
fermentation compared to conventional foods, such as carrot, cabbage, and 
other vegetables (Gardner et al., 2001; Bergqvist et al., 2005; Yoon et al., 2006) 
(Table 5). The positive effects of microalgae on the viability of lactic acid 
bacteria found in our study can be attributed to the highly nutritious substances 
they contain which stimulate bacterial growth and activity (Parada et al., 1998). 
 
Table 5 Comparison between the growth (log CFU mL
-1
) of Lactobacillus with 
conventional foods and algal biomasses after 24 h of fermentation 
Algae biomasses Lactobacillus growth (log CFU mL
-1
)  
A. platensis F&M-C256 (frozen) 8.0
1
 
T. suecica F&M-M33 (frozen) 8.1
1
 
Laminaria saccharina 7.7
2
 
Conventional foods Lactobacillus growth (log CFU mL
-1
) 
Carrot juice 9.0
3
 
Cabbage juice 8.8
4
 
Vegetable mixtures 8.0
5
 
Sources: 
1
Data by the authors; 
2
Gupta et al., 2011;
 3
Bergqvist et al., 2005; 
4
Yoon 
et al., 2006; 
5
Gardner et al., 2001 
 
Despite the use of algal materials for the production of edible fermented 
products has been limited, a spirulina-based fermented drink is already in the 
market (Website Your Digestion).  
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the unfermented biomasses was observed for both algae; while, fermentation 
did not improve digestibility of lyophilised biomasses (see Chapter 8, p. 207, 
Fig. 4). The breakage of the cell wall occurring during thawing (Mazur, 1984) 
could result in an improvement of in vitro digestibility compared to the 
lyophilized biomass. Arthrospira has in vitro and in vivo antioxidant, radical 
scavenging and anti-inflammatory activity principally due to the presence of 
phycocyanin (El-Baky and El-Baroty, 2012). As found by Liu et al. (2011) an 
improvement in DPPH scavenging ability of lyophilised and frozen A. platensis 
F&M-C256 after fermentation was found. Similar to the results obtained in the 
present study, other authors (Liu et al., 2011; El-Baky and El-Baroty, 2012; Chu 
et al., 2010) reported a similar radical scavenging capacity with A. platensis or 
with phycocyanin extracted from A. maxima and A. platensis. Phenolic 
compounds are considered the major contributors to antioxidant capacity (Abd 
El-Baky et al., 2009). Similar to the trend observed in our study before and after 
fermentation, Liu et al. (2011) found that A. platensis fermented with lactic acid 
bacteria showed higher phenolic content compared to unfermented biomass. 
The fermentation process could have released polyphenols such as gallic acid, 
or produced other metabolites (Liu et al., 2011). Since total phenols are, 
amongst other compounds, responsible for antioxidant activity (Liu et al., 
2011), the greater quantity of total phenols in fermented A. platensis F&M-
C256 may indicate a greater antioxidant activity than unfermented biomass, 
which is confirmed by the DPPH results (see Chapter 8, pp 208-210). 
Frozen biomass appears to be a better fermentable substrate (higher lactic acid 
production, higher digestibility). Furthermore, it is more economically viable on 
an industrial scale because it obviates the need for a drying process (as 
lyophilisation or spray drying), that would be highly expensive in terms of 
energy costs, as well as time-consuming.  
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9.2 Concluding remarks  
Microalgae, as a potential source of functional foods and nutraceuticals, are a 
fast growing segment of the health and nutrition industry today, although well 
known cases of historical use of cyanobacteria as food do exist. 
An accurate selection of the best microalgae and cyanobacteria is the starting 
point for the future development of microalgae- and cyanobacteria-based 
functional products. The large biodiversity of microalgae in nature and in 
culture collections still needs accurate evaluation and exploration of microalgae 
in terms of quality and safety before exploitation.  
In conclusion, from the results of this research A. platensis F&M-C256 has 
proved to be one of the best strains, due to the absence of in vitro and in vivo 
toxicity, the balanced biochemical composition (especially the high amount of 
high quality proteins and the low amount of lipids), the high in vitro and in vivo 
digestibility and the high potential for the prevention of dyslipidemias. The high 
quality of A. platensis F&M-C256 biomass can provide valuable functional 
foods and nutraceuticals. Beside A. platensis F&M-C256, also C. vulgaris 
Allma, T. suecica F&M-M33 and P. tricornutum F&M-M46 have been found 
as suitable for the development of functional microalgae-based products. Lactic 
acid fermentation enhanced the quality of A. platensis F&M-C256 and T. 
suecica F&M-M33 biomasses in terms of organoleptic quality and digestibility, 
and we expect that also other microalgae could provide suitable fermentation 
substrates.  
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Abstract The general objective of the present work was to
evaluate the toxicity of 11 microalgal strains and one natural
bloom, selected as potential food or food ingredients due to
their nutritional quality, in two models, human dermal fibro-
blasts and Artemia salina. Methanolic and aqueous extracts of
the biomasses were tested on A. salina for 24 and 48 h at
concentrations up to 12.5 g L−1 of extracted biomass. Only
aqueous extracts were tested on fibroblasts for 24 h. Chlorella
vulgaris Roquette, C. vulgaris Allma, Tetraselmis suecica
F&M-M33, and Porphyridium purpureum F&M-M46
showed no toxicity towards A. salina and fibroblasts. Only
Klamath powder was toxic to both models with all types of
extracts. Tisochrysis lutea (T-ISO) F&M-M36, Chlorella
sorokiniana F&M-M49 grown in BG11, and C. sorokinina
IAM C-212 showed toxicity, even if to different extents, to
fibroblasts and, only with the methanolic extract, to A. salina.
The remaining strains showed no toxicity towards A. salina,
but were toxic to fibroblasts: Arthrospira platensis F&M-
C256 and Nannochloropsis oceanica F&M-M24 exhibited
low toxicity,Nostoc sphaeroides F&M-C117medium toxicity
and Phaeodactylum tricornutum F&M-M40 high toxicity.
Although in some cases the two models provided contrasting
results, this work confirms their validity for preliminary
screening of toxicity. The models are able to indicate
organisms and substrates of potential toxicity and may well
serve as guidelines for in vivo tests on mammals, which are
necessary to apply for novel food in the EU.
Keywords Brine shrimp bioassay . Fibroblasts . Toxicity .
Microalgae . Food
Introduction
Microalgae (including cyanobacteria) are oxygenic photosyn-
thetic microorganisms that have long been recognized as a
potential source of food. The high potential of microalgae as
food is due to their balanced biochemical composition and
high nutritional value (Tredici et al. 2009). They can have a
high protein content with a balanced amino acid composition
(Becker 2007), a good content of vitamins, minerals, short-
chain polyunsaturated fatty acids, including linoleic and
linolenic acids, and long-chain polyunsaturated fatty acids
such as docosahexaenoic (DHA) and eicosapentaenoic
(EPA) acids (Bishop and Zubeck 2012; Batista et al. 2013).
Some strains are also good sources of carotenoids like lutein,
astaxanthin, and β-carotene (Del Campo et al. 2007).
Chlorella, Arthrospira, Dunaliella, and Haematococcus are
microalgae largely employed for human consumption
(Tredici et al. 2009; Ibañez and Cifuentes 2013).
In the EU, novel foods and food ingredients are defined as
those that Bhave not been used to a significant degree for
human consumption within the Union before 15th
May 1997^ (European Union 1997). With the Regulation
(EC) No 258/97, the European Union, through the European
Food Safety Authority (EFSA), guarantees that novel foods
and food ingredients are subject to a single safety assessment
through a unified procedure in order to protect public health.
Foods and food ingredients to be authorized must not present
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a danger for the consumer, mislead the consumer, and differ
from foods that they are intended to replace to such an extent
that their normal consumption would be nutritionally disad-
vantageous for the consumer (European Union 1997). In the
USA, the term Bfood additive means any substance the
intended use of which results…, directly or indirectly, in its
becoming a component or otherwise affecting the characteris-
tics of… food^ (Federal Food, Drug, And Cosmetic Act,
Section 201). Food additives (that do not include substances
generally recognized as safe (GRAS), substances used prior to
January 1958, and those included in the exemptions of the
Federal Food, Drug, and Cosmetic Act), require pre-market
approval aimed at demonstrating safety under the intended
conditions of use. The Food and Drug Administration
(FDA) issues regulations, based on data submitted through
petitions or obtained by its own initiative, specifying the con-
ditions under which an additive has been demonstrated to be
safe and, therefore, may be lawfully used (FDA 2014). The
GRAS standard requires the industry to provide scientific ev-
idence that the substance is not harmful under its intended
conditions of use and once certified exempts the substance
from pre-market approval (FDA 2014). The Food Standards
Australia New Zealand (FSANZ) considers as novel food all
non-traditional food or its derivatives and requires safety as-
sessment (Commonwealth of Australia Gazette 2007).
Currently, FSANZ is reviewing the requirements for novel
food applications (Standards 1.5.1). Algae that are not listed
in the Standards need approval as novel food and thus safety
assessment (FSANZ, Proposal P1024).
The microalgae used prior to May 1997 in Europe and thus
authorized as food in the EU are Aphanizomenon flos-aquae
from Klamath Lake, Arthrospira platensis, Chlorella
luteoviridis, Chlorella pyrenoidosa, and Chlorella vulgaris
(European Union, Novel Food catalogue). The diatom
Odontella aurita was authorized later (European Union
2005), and, in 2014, also Tetraselmis chuii was approved as
food, following the application by the Spanish company
Fitoplancton Marino S.L. (AESAN 2013; AECOSAN
2014). Astaxanthin from Haematococcus pluvialis was also
recently authorized (EFSA 2014). To be used as food, with the
exception of the species mentioned above, microalgae have to
follow the novel food regulation (European Union 2015). In
the USA, Chlorella protothecoides, A. platensis, Dunaliella
bardawil, and astaxanthin from Haematococcus are included
in the GRAS list (FDA, GRAS Notices). In Australia, all
Chlorella (including Chlorella sorokiniana) and Arthrospira
species and derivatives for which a novel food application was
submitted have been so far considered as traditional food,
whereas A. flos-aquaewas considered as novel food and safe-
ty assessment was required due to the potential presence of
cyanobacterial toxins such as microcystins and nodularin
(FSANZ 2016). These approved microalgae (and microalgal
products) represent a very small number of species compared
to the high number present in nature, from 30,000 to 1 million
according to different sources (Guiry 2012).
In this work, we tested three strains/products belonging to
species already approved as food in the EU (C. vulgaris,
A. flos-aquae from Klamath Lake blooms, A. platensis), and
two species not approved at present (C. sorokiniana and
Tetraselmis suecica), but belonging to genera of approved
species. Five other microalgae were also tested: Nostoc
sphaeroides, an edible cyanobacterium consumed in China
and other Asian countries (Han et al. 2013), Tisochrysis lutea,
Nannochloropsis oceanica, and Phaeodactylum tricornutum,
widely used (as well as Tetraselmis spp.) in aquaculture
(Tredici et al. 2009; Muller-Feuga 2013), and Porphyridium
purpureum, rich in EPA, but to date used only in cosmetics
(Arad and Levy-Ontman 2010; Rajasulochana and Preethy
2015). These strains as well as the natural bloom were chosen
for their high potential as food sources thanks to a high protein
content (A. platensisF&M-C256, Klamath powder,
N. sphaeroides F&M-C117, T. suecica F&M-M33,
C. sorokiniana F&M-M49 and IAM C-212, C. vulgaris
Allma and Roquette) or for their ability to produce high
amounts of polyunsaturated fatty acids (N. oceanica F&M-
M24, P. tricornutum F&M-M40, P. purpureum F&M-M46,
T. lutea F&M-M36), besides having interesting amounts of
protein.
The first concern when proposing microalgae as food or
food ingredients is to establish their lack of toxicity towards
the consumer. In this regard, several species of different algal
groups have been reported to produce neurotoxins,
hepatotoxins, diarrheic toxins, dermotoxins, etc., which are
usually active at very low doses (Landsberg 2002). Besides
biotoxins, microalgae and cyanobacteria are able to produce
other secondary metabolites (cytotoxins) that may have nox-
ious effects on human health (Carmichael 1992; Tredici et al.
2009). Finally, it is to consider that also molecules that do not
enter in the category of toxins (Carmichael 1992) can have
toxic effects if provided at excessively high dosages. This
concept provides the rational behind legislation, which re-
quires that the toxicity data provided be related to the dose
of the biomass/extract/component that is intended for use.
Toxicity tests for novel food applications require time-
consuming and expensive procedures. Moreover, the EU
strongly encourages the B3Rs^ (replacement, reduction, and
refinement) principle for sparing animals used for scientific
purposes (European Union 2010). In vitro tests and bioassays
on invertebrates have the advantage of being less expensive
and shorter in duration, offering a simplified model for a pre-
liminary screening to be used as a guideline for further in vivo
studies. To determine microalgal toxicity (intended in all the
meanings reported above), model organisms such as crusta-
ceans (Artemia or Daphnia) are often used (Vezie et al. 1996;
Guilhermino et al. 2000; Biondi et al. 2004). In this study, we
adopted the brine shrimp (Artemia salina) assay, an easy and
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low-cost toxicity test (Solis et al. 1993; Piccardi et al. 2000). It
is to note that, despite it targets a whole organism, the brine
shrimp assay is considered by several authors as an in vitro
test (Sleet and Brendel 1985; Lagarto Parra et al. 2001;
Carballo et al. 2002). Besides invertebrates, toxicity is often
evaluated on mammalian cells, mainly cancer cell lines (Jaki
et al. 1999; Carballo et al. 2002; Hisem et al. 2011). Some
authors report a good correlation between the toxic activity
measured with brine shrimp and that observed with tumor cell
lines (Anderson et al. 1991). Here, we report the toxicity of 13
microalgal extracts on A. salina and on human fibroblasts in
order to evaluate the potential health risks of these microbial
strains if used as food or food ingredients.
Materials and methods
Experimental plan
Microalgal biomasses were extracted in methanol and/or wa-
ter and tested against normal human dermal fibroblasts
(NHDF) and the nauplii of the crustacean A. salina to evaluate
their potential toxicity. The experimental design is reported in
Table 1.
Microalgal strains and biomass production
The algae tested are listed in Table 2. A positive reference
extract was prepared from Nostoc sp. M1, known from previ-
ous experiments carried out in our laboratory to be strongly
cytotoxic. A negative reference extract was also prepared
using organic lettuce (Lactuca sativa var. capitata).
Most of the tested microalgae were produced at the facili-
ties of Fotosintetica & Microbiologica S.r.l. or of the Institute
of Ecosystem Study of the CNR, both in Sesto Fiorentino,
Florence. The algae were produced in GWP®-II
photobioreactors (Tredici et al. 2011; Chini Zittelli et al.
2013) in semi-batch mode, and the biomasses were harvested
by centrifugation, frozen, lyophilized, and powdered. The
powdered biomasses were stored at −20 °C until use. Only
A. plantesis F&M-C256 biomass was washed with physiolog-
ical saline solution to remove extracellular sodium bicarbon-
ate and carbonate before freezing. All the freshwater strains
were cultivated in BG11 (Rippka et al. 1979) and all the
marine strains in F (Guillard and Ryther 1962) medium, while
A. platensis was cultivated in Zarrouk medium (Zarrouk
1966). C. sorokiniana F&M-M49 was cultivated in both
BG11 and F medium (Guccione et al. 2014). The F
medium-grown biomass (unwashed) was used to test the ef-
fect on fibroblasts of sea salt residues (see below).
Chlorella vulgaris Allma (Allma Microalgae, Lisbon,
Portugal), C. vulgaris Roquette (Roquette Frères, Lestrem,
France), and Klamath powder (Erbologica SAS, Serina,
Bergamo, Italy) are commercial products. Klamath powder is
obtained from a natural bloom mainly composed of A. flos-
aquae, harvested from Upper Klamath Lake (OR, USA).
In vitro cytotoxicity on human fibroblasts
Preparation of microalgal extracts Lyophilized microalgae
were suspended (25 g L−1) in Dulbecco’s Modified Eagle
Medium (DMEM)without phenol red and sonicated for 2 cycles
of 3 min in ice, followed by a 3-min resting interval by using an
ultrasonic homogenizer (Sonopuls HD 2070, Bandelin
Electronic, Germany), set at 100 % power. Microalgal suspen-
sions were then centrifuged for 15 min at 15,000 × g at 4 °C,
filtered through a 0.2-μm filter and stored at −20 °C.
Cell culturesHuman dermal fibroblasts (N°CC-2509), kindly
provided by Prof. Lisa Giovannelli (NEUROFARBA,
University of Florence), were maintained in DMEM without
phenol red, supplemented with 10 % fetal bovine serum
(FBS), glutamine (2 mM), penicillin (100 IU mL−1), and
streptomycin (100 μg mL−1) in a humidified incubator at
37 °C under a 5 % CO2 atmosphere.
Determination of cytotoxic activity of microalgal aqueous
extracts on human fibroblasts NHDF cells of passages 12–
14 were seeded in 96-well plates (5 × 103 per well), kept for
24 h, and then treated with microalgal extracts for 24 h. The
concentrations tested were 12.5, 5.0, 2.5, and 0.5 g of extract-
ed biomass per liter for 24 h. Viability analysis was performed
using Cell Titer 96 Aqueous One solution cell proliferation
assay kit (Promega, USA). At the end of the incubation peri-
od, the treated cells were exposed to Aqueous One solution
(Giovannelli et al. 2014) and incubated for 2 h at 37 °C. The
product of the reaction was measured at 490 nm using a
spectrophotometer.
Effect of salt interference
To evaluate the interference of marine salts on fibroblast via-
bility, artificial seawater (Tropic Marine, Adriatic Sea
Equipment & Co, Rimini, Italy) at a salinity of 60 g L−1 was
used to prepare culture media for NHDF at different salinities,
from 30 to 0.6 g L−1. The experiment was set up and per-
formed as reported above for the algal extracts. To further
Table 1 Plan of the experiments
Extracts Effect of salt
MeOH H2O
Fibroblasts (NHDF) ✓ ✓
Artemia salina ✓ ✓
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verify the effect of the salts that may remain in the algal bio-
mass after centrifugation,C. sorokiniana F&M-M49 grown in
freshwater and in seawater was extracted and tested as previ-
ously described.
To quantify the salt content of the biomass, ash was deter-
mined by incineration in a muffle furnace at 450 °C.
Determination of cytotoxic activity of microalgal extracts
on A. salina
Extraction of biomasses Biomass extraction for A. salina
tests was performed following two different protocols. One
set of experiments was performed on methanolic extracts.
For each algal strain, as well as for the negative reference
lettuce, an aliquot of 0.5 g of dry biomass was extracted in
60 mL of methanol overnight at room temperature. The sol-
vent was then separated from biomass by filtration on paper.
The biomass residue was extracted again with 30 mL of meth-
anol at 37 °C for 4 h, then the exhausted biomass was removed
by filtration on paper. The two extracts (60 + 30 mL) were
mixed and then evaporated under vacuum. The dry residues
were suspended in 2.5 mL of methanol to obtain a final con-
centration of the extracts of 200 g L−1 of extracted biomass.
Glassware and plastic- ware were kept in 0.27MNaOH in 9:1
ethanol/water for 24 h before use, to prevent cross-
contamination (Golakoti et al. 1995), and then washed with
deionized water.
Another set of experiments on A. salina was performed on
aqueous extracts of microalgae and lettuce. Aliquots of the dry
biomasses (0.2 g) were dispersed in 1.5 mL of sterile water
and sonicated for 3 min, and then the probe was washed with
0.3 mL of sterile water. The sonicated material was frozen at
−20 °C. As soon as the material was taken out of the freezer,
0.2 mL of an antibiotic solution containing 3200 μg mL−1 of
streptomycin sulfate (chemist’s preparat ion) and
6000 μg mL−1 of ampicillin (Amplital, Pfizer) were added
to each sonicated biomass to prevent bacterial growth. After
thawing, each sonicated biomass was homogenized, and an
aliquot was transferred into a sterile 1.5 mL test tube and
centrifuged for 15 min at 18,000 × g at 4 °C. The supernatant
was finally transferred to a new sterile test tube. The final
extract concentration was of 100 g L−1 of extracted biomass.
For this type of extraction, only disposable material was used.
Lethality tests on A. salina Cysts of A. salina (Premium,
SHG, Ovada, Alessandria, Italy) were transferred for hatching
in a glass bottle containing sterile artificial seawater (Tropic
Marine) at 30 g L−1 salinity. The inoculated seawater was
bubbled with air sterilized through 0.2 μm porosity filters.
The incubation was carried out under constant illumination
of 80 μmol photons m−2 s−1 at 25–27 °C. Once the cysts
hatched, the nauplii were used to set up the experiments.
The experiments were performed in 96-well microtiter
plates on a final test volume of 100 μL. For methanolic ex-
tracts, the concentrations tested varied from 12.5 to 0.1 g L−1
Table 2 Algae and algal products selected for toxicity screening
Strain Type of culture medium Biomass obtention
Cyanobacteria
Arthrospira platensis F&M-C256 Alkaline In-house cultivation
Klamath powder Fresh Commercial product (Erbologica SAS)
Nostoc sphaeroides F&M-C117 Fresh In-house cultivation
Nostoc sp. M1 Fresh In-house cultivation
Chlorophytes
Chlorella sorokiniana F&M-M49 Fresh/marine In-house cultivation
Chlorella sorokiniana IAM C-212 Fresh In-house cultivation
Chlorella vulgaris Roquette Fresh Commercial product (Roquette Frerès)
Chlorella vulgaris Allma Fresh Commercial product (Allma Microalgae)
Tetraselmis suecica F&M-M33 Marine In-house cultivation
Rhodophytes
Porphyridium purpureum F&M-M46 Marine In-house cultivation
Diatoms
Phaeodactylum tricornutum F&M-M40 Marine In-house cultivation
Haptophytes
Tisochrysis lutea (T-ISO) F&M-M36 Marine In-house cultivation
Eustigmatophytes
Nannochloropsis oceanica F&M-M24 Marine In-house cultivation
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of extracted biomass. An aliquot (12.5 μL) of the extract was
transferred into the first well, and the solvent let to evaporate.
After evaporation, 20 μL of pure DMSO:water 1:10 was
added to prepare the final extract, that was then diluted in
the other wells 1:2 in 10 μL of DMSO:water 1:10 till the last
concentration to be tested. Controls were prepared with 10 μL
of DMSO:water 1:10. Each extract concentration and the con-
trol were tested in six replicates. Reference extracts were set
up with biomasses expected to produce a positive (Nostoc sp.
M1) and a negative (lettuce) response in the test.
For aqueous extracts, the concentrations tested were from
12.5 to 0.1 g L−1 of extracted biomass. An aliquot (25 μL) of
the extract was transferred into the first well of the microtiter
plate and diluted 1:2 in the other wells in 50 μL of artificial
seawater (30 g L−1 salinity) containing antibiotics. The final
concentration of antibiotics in each well was 160 μg mL−1 of
streptomycin and 300 μg mL−1 of ampicillin. Control was
prepared with sterile artificial seawater (30 g L−1 salinity)
containing antibiotics at the same concentrations as in the test
wells. Each extract concentration and the control were tested
in three replicates. Reference extracts were set up with Nostoc
sp. M1 and lettuce that were treated in the same way as the test
extracts.
After the test and reference extract dilutions and the control
were prepared in the microtiter plates, 90 μL of seawater con-
taining five nauplii were added to each well to reach the final
test volume of 100μL. The plates were then incubated at room
temperature, and the number of dead nauplii was counted
under a direct light microscope (Nikon Eclipse E200, Nikon,
Tokyo, Japan) at 40 magnifications after 24 and 48 h of
incubation.
Nauplii were considered as dead when no movement was
observed in the reasonable time of the observation (Carballo
et al. 2002; Lopes et al. 2011). Mortality was calculated ac-
cording to Abbott (1987):
M % vs controlð Þ ¼ LC−LTð Þ
LT
 100
whereM is mortality; LC, living nauplii in the control after 24
or 48 h; LT, living nauplii in the test or reference extract after
24 or 48 h.
Calculation of IC50 values
For all microalgal extracts tested against NHDF and A. salina,
dose-response curves were obtained. The concentration
(expressed as gram of extracted biomass per liter) which in-
hibits 50 % of the population (IC50) was calculated by a linear
regression model using log transformed data when necessary.
When the experimental data did not include the 50 % inhibi-
tion, IC50 values were estimated, still through linear regres-
sion. For some extracts (indicated as Bnot calculable^), it was
not possible to calculate an IC50 value because no toxicity was
detected at the concentrations tested. IC50 values higher than
15 g L−1 were not indicated in extenso, as this amount was
considered the threshold of non-toxicity.
The extracts were divided into four toxicity categories ac-
cording to their IC50 value: high toxicity (IC50≤5 g L−1), me-
d ium toxic i ty (5<IC50≤10 g L−1 ) , low toxic i ty
(10<IC50≤15 g L−1), and no toxicity (IC50>15 g L−1). The
latter category included also those extracts for which an IC50
value was not available.
Results
Extracts from 13 test biomasses were evaluated as well as
those from two reference materials (Nostoc M1 and let-
tuce). Among the test biomasses, only for P. purpureum
F&M-M46 calculation of the IC50 was not possible due to
lack of toxicity in the tested range (Table 3). For
C. vulgaris Roquette, C. vulgaris Allma, and T. suecica,
as well as for the negative reference lettuce, it was possi-
ble, for at least one of the extracts, to estimate the IC50,
which value, however, was always higher than 15 g L−1
(Table 3). These three biomasses as well as that of
P. purpureum were considered as non-toxic (Fig. 1).
The remaining nine test biomasses and the positive reference
NostocM1 showed an IC50 below 15 g L
−1 (hence toxicity) for
at least one extract and one model (NHDF or A. salina). Only
Klamath powder showed an IC50 below 15 g L
−1 for all the
extracts with both models. The IC50 value of the water extract
of Klamath powder against NHDF was in the range that we
classified as medium toxicity (Table 3, Fig. 1), whereas both
water and methanolic extracts showed an IC50 against A. salina
in the range that we considered of high toxicity (Table 3, Fig. 1).
It is to note that the toxicity of the Klamath powder aqueous
extract against A. salina was much higher after 48 h of expo-
sure, while the methanolic extract acted almost at its full poten-
cy already after 24 h. A similar behavior was observed for the
positive reference Nostoc M1 (Table 3, Fig. 1). The main dif-
ference was that the methanolic extract of NostocM1 behaved
like the aqueous one in terms of toxicity increase with exposure
time. In fact, after 24 h, the IC50 value of the methanolic extract
was 8.2 g L−1 and decreased to 0.4 g L−1 after 48 h; the aqueous
extract was not toxic after 24 h and showed an IC50 of 7.2 g L
−1
after 48 h (Table 3).
For C. sorokiniana F&M-M49 grown in BG11,
C. sorokiniana IAM C-212, and T. lutea F&M-M36, an
IC50 below 15 g L
−1 could be calculated for both models,
although in the case of A. salina only for the methanolic
extracts. IC50 values for T. lutea F&M-M36 extracts were
in the range considered of medium toxicity (Table 3,
Fig. 1), as well as the methanolic extract from
C. sorokiniana IAM-C212, which aqueous extract showed
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instead an IC50 in the range of high toxicity against
NHDF (Table 3, Fig. 1). IC50 values were in the range
of low toxicity for both extracts from C. sorokiniana
F&M-M49 grown in BG11 (Table 3, Fig. 1).
The remaining five biomasses were active only against
NHDF. A. platensis F&M-C256 and N. oceanica F&M-
M24 extracts showed an IC50 higher than 11 g L
−1 and
laid in the low toxicity range; the IC50 of N. sphaeroides
F&M-C117 was in the range of medium toxicity, whereas
extracts from C. sorokiniana F&M-M49 grown in F me-
dium and P. tricornutum F&M-M40 showed an IC50 low-
er than 3 g L−1 and were considered of high toxicity
(Fig. 1, Table 3).
To assess the contribution of artificial seawater salt to
the cytotoxic effects observed, also considering the results
obtained with C. sorokiniana F&M-M49 grown in BG11
and F medium, we tested a range of salt concentrations
(from 30 to 0.6 g L−1) on NHDF. All the hypertonic con-
centrations (30, 15, 12 g L−1) strongly reduced cell survival
as expected, 6 g L−1 caused a modest reduction, whereas 3
and 0.6 g L−1 did not show any cytotoxicity (data not
shown). An IC50 of 11.2 ± 0.6 g L
−1 was calculated. We
can exclude toxicity of artificial seawater salt in our trials
since the maximum salt concentration in microalgal ex-
tracts was estimated to be <3 g L−1.
Discussion
Although the number of microalgal species worldwide is vast,
only few have been isolated and studied with regard to bio-
chemistry and physiology, and even less are exploited for
commercial applications (Tredici et al. 2009). Less than a
dozen microalgal species are presently accepted in the EU as
food or food ingredients (EuropeanUnion 1997), and a similar
situation is recorded also in the USA and Australia. To in-
crease this number, it is necessary to go through the novel
food approval regulations that require the assessment of the
safety of the candidate food ingredient (European Union
2015; FDA 2014; FSANZ Proposal P1024). Starting from this
perspective, this research aimed to evaluate, as preliminary
step, the toxicity of microalgal biomasses of interest as food
sources due to their nutritional qualities, using A. salina and
human dermal fibroblasts as models.
As far as toxicity on cells is concerned, most of the litera-
ture deals with tests against cancer cell lines (Jaki et al. 1999;
Carballo et al. 2002; Bechelli et al. 2011; Hisem et al. 2011),
and only few studies, to our knowledge, focus on the cytotoxic
effects of microalgae on non-cancerous cells (Prestegard et al.
2009; Lopes et al. 2011; Goh et al. 2014). In vitro cytotoxicity
tests are performed to determine the intrinsic ability of a com-
pound to cause cell death as a consequence of damage to the
Table 3 IC50 values calculated or
estimated for microalgal aqueous
or methanolic extracts (expressed
as g of extracted biomass per liter)
on human fibroblasts (NHDF)
and A. salina after 24 and 48 h of
exposure; data are reported as
mean ± SD
Strain IC50 value (g L
−1)
Fibroblasts Artemia salina
H2O extract H2O extract MeOH extract
24 h 24 h 48 h 24 h 48 h
Nostoc sp. M1 (positive reference) 9.3 ± 2.9 nc 7.2 ± 0.2 8.2 ± 2.3 0.4 ± 0.1
Lettuce (negative reference) nc >15* >15* nc nc
A. platensis F&M-C256 11.5 ± 5.7 >15* >15* nc nc
Klamath powder 8.8 ± 0.4 >15* 4.7 ± 1.9 1.7 ± 0.0 1.6 ± 0.1
N. sphaeroides F&M-C117 7.8 ± 1.3 >15* >15* nc nc
C. sorokiniana F&M-M49 BG11 12.6 ± 4.0* nc >15* 13.6 ± 2.9* 13.4 ± 2.3*
C. sorokiniana F&M-M49 F 2.7 ± 1.0 – – – –
C. sorokiniana IAM C-212 3.7 ± 0.09 nc nc 6.0 ± 0.6 5.6 ± 0.6
C. vulgaris Roquette >15* nc >15* nc nc
C. vulgaris Allma nc >15* >15* nc nc
T. suecica F&M-M33 >15* nc >15* >15* >15*
P. purpureum F&M-M46 nc nc nc nc nc
P. tricornutum F&M-M40 2.3 ± 0.4 nc >15* >15* >15*
T. lutea (T-ISO) F&M-M36 6.0 ± 2.2 >15* >15* 6.0 ± 0.5 5.6 ± 0.9
N. oceanica F&M-M24 11.2 ± 2.1 nc nc nc nc
*Estimated value
nc not calculable due to absence of toxicity in the tested range; − not tested
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basic cellular functions. The use of normal human cell lines,
that present a non-aberrant phenotype, is an added value with
respect to the use of cancerous cells that more typically show
chromosome and phenotype aberrations (Jallepalli and
Lengauer 2001; Fackental and Godley 2008). It is worth not-
ing that there is little literature on toxicity of eukaryotic
microalgae on cell lines and A. salina, while a larger number
of papers deal with cyanobacteria.
Six of the tested algal biomasses (T. lutea F&M-M36,
K l ama th powde r , N. sphae ro i d e s F&M-C117 ,
C. sorokin iana F&M-M49 grown in F medium,
C. sorokiniana IAM C-212, and P. tricornutum F&M-M40)
showed a similar or even higher cytotoxicity on fibroblasts
compared to the positive reference Nostoc M1, while only
Klamath powder showed a toxicity similar to Nostoc M1 on
A. salina. The toxic effects on fibroblasts of Nostoc M1, a
cyanobacterium containing cryptophycin, a powerful antimi-
totic agent (Panda et al. 1997), were lower than expected from
our previous data on antifungal activity of this strain
(unpublished) and on cytotoxicity of other cryptophycin-
containing Nostoc strains (Piccardi et al. 2001). On
A. salina, the toxic action of the aqueous extract was observed
only after 48 h of exposure, whereas with the methanolic
extract, the effect was more marked and present already after
24 h. This behavior, in both models, can be explained by the
low solubility of cryptophycin (a cyclic depsipeptide) in wa-
ter, and to the low division rate of fibroblasts compared to
tumor cell lines and of nauplii cells that might slow the action
of the antimitotic venom. The IC50 value shown by Nostoc
M1 on human fibroblasts in this study (9.3 g L−1) is much
higher than that reported by Hrouzek et al. (2016) for the most
cytotoxic Nostoc strain against murine fibroblasts (2.8 g L−1).
Nostoc is one of the cyanobacterial genera with the highest
frequency of cytotoxic metabolites. Among 81 Nostoc strains
tested, cytotoxicity frequency to different target cells was
found to vary for the same extracts from 26 to 76 %
(Hrouzek et al. 2016). Biondi et al. (2008) found five out of
six Antarctic Nostoc isolates to be cytotoxic to HeLa cells.
Fig. 1 Grouping of microalgal extracts according to their toxicity level, based on IC50 values. Aqueous extracts on NHDF after 24 h, and aqueous and
methanolic extracts on A. salina after 48 h are reported. The toxicity levels are displayed in decreasing order (from darker to lighter color)
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Cytotoxicity against murine tumor cell lines was found in 33
(Hrouzek et al. 2011), 60 (Hrouzek et al. 2016), and 65 %
(Hisem et al. 2011) of the Nostoc strains tested. On
A. salina, Piccardi et al. (2000) found toxicity in 24 % of 50
Nostoc extracts, mainly aqueous. The same frequency of tox-
icity was found by Hisem et al. (2011) in 29 methanolic ex-
tracts. It is worth noting that the genus Nostoc includes, be-
sides highly toxic strains, edible species (as N. sphaeroides
and Nostoc flagelliforme) and that, in this study, the edible
N. sphaeroides F&M-C117 showed medium toxicity to fibro-
blasts and no toxicity to A. salina. A similar toxicity pattern
was shown by the aqueous extract from P. tricornutum F&M-
M40. Toxicity of aqueous extracts from this algal species is
reported by Prestegard et al. (2009) on rat hepatocytes (>30 %
death at 4 g L−1 of extracted biomass after 1 h of exposure)
and IPC leukemia cells (>30 % death at 1.5 g L−1 after 18 h).
No literature data are available on toxicity of this alga to
A. salina.
Among the algae approved as food in the EU, the two
commercial C. vulgaris strains were found not toxic (neither
to fibroblasts nor to A. salina). Arthrospira platensis (the so-
called spirulina), that on the basis of its longtime history
(centuries) of human consumption is considered a safe food,
in our work showed a low toxic effect on fibroblasts and no
toxicity to A. salina. Bechelli et al. (2011) found toxicity at
2 g L−1 of extracted biomass with ethanolic extracts of
A. platensis on leukemia cells and no toxicity to normal bone
marrow cells. One of the microalgae approved as food in the
EU is A. flos-aquae from Klamath Lake (European Union,
Novel Food catalogue). In our study, medium toxicity to fi-
broblasts was observed with the aqueous extract from the
biomass harvested from the natural bloom dominated by this
alga in Klamath Lake, whereas high toxicity to A. salina was
found in both aqueous and methanolic extracts. Our results
confirm the findings from Bechelli et al. (2011) who observed
a high toxicity of the ethanolic extract of this bloom against
both leukemia and normal bone marrow cells at concentra-
tions lower than those found toxic in our work. It is necessary
to point out that, although some strains of Aphanizomenon are
known to produce saxitoxin and neosaxitoxin (Ferreira et al.
2001; Ballot et al. 2010a, b), as well as mueggelone, respon-
sible for neurotoxic and ichthyotoxic activity (Papendorf et al.
1997), so far A. flos-aquae fromKlamath Lake has never been
found to produce these toxins (Carmichael 1992; Heussner
et al. 2012). Up to now, this cyanobacterium from Upper
Klamath Lake (OR, USA) has not been stably isolated; thus,
the only way to test its biomass is to harvest blooms from this
lake. The toxicity of the bloom observed in our work could be
due to: (i) compounds produced by A. flos-aquae; (ii) com-
pounds produced by other microalgae present in the popula-
tion, as for exampleMicrocystis spp., often occurring in these
blooms (Gilroy et al. 2000), although the microcystins would
have affected A. salina (Vezie et al. 1996) but not fibroblasts
(Matsushima et al. 1990); and (iii) compounds from biogenic
contaminants (derived from plants, animals, and other micro-
organisms) or non-biogenic sources (Chamorro-Cevallos et al.
2007).
Among the other algae tested, only in few cases it is pos-
sible to compare our data with literature. We found toxicity of
N. oceanica F&M-M24 aqueous extracts to fibroblasts at the
highest concentrations (low toxicity). Goh et al. (2014) found
no cytotoxicity of Nannochloropsis oculata extracts to mouse
fibroblasts. In our study, P. purpureum F&M-M46 did not
exert toxic effects at the concentrations tested. Gardeva et al.
(2012) found that the polysaccharide from P. purpureum re-
duced the viability of MCF7, HeLa, and Graffi tumor cells.
The methanolic extract of T. suecica F&M-M33 showed no
toxicity to A. salina (our work), while the methanolic extracts
of T. suecica CCAP 66/22D caused a 100 % mortality on
Artemia nauplii (Lincoln et al. 1996).
The different toxicity patterns often observed inmethanolic
and aqueous extracts may derive from different molecules
being extracted by the different solvents (Piccardi et al.
2000) or from the same component that is extracted by the
solvents with a different efficiency (see the case of Nostoc sp.
M1).
In general, our results show that the sensitivity of fibro-
blasts towards microalgal aqueous extracts is higher compared
to that of A. salina, and only the extract from Klamath powder
is toxic with both models. With all the extracts, a higher tox-
icity on A. salina was observed after 48 h of exposure, thus
further confirming the lower sensitivity of this model com-
pared to fibroblasts. This is not necessarily a drawback. In
accordance with our study, Hisem et al. (2011) report a lower
sensitivity of A. salina compared to the cell model. The results
obtained in our work with aqueous extracts on fibroblasts are
more coherent with those obtained with methanolic extracts
on A. salina, although the fibroblasts higher sensitivity
allowed to detect a larger number of potentially toxic
biomasses.
Tests on cell lines appear more adequate when the objective
is to determine cytotoxic activity, as also stated by Hisem et al.
(2011). These authors attribute the higher sensitivity of cells
with respect to A. salina to the fact that cyanobacterial metab-
olites generally affect basal metabolic pathways present in the
eukaryotic cell rather than systems in complex multi-cellular
organisms. However, fibroblasts appear too sensitive for use
in general toxicity screenings, while A. salina lethality test, in
particular using a universal solvent (e.g., methanol) and an
exposure time of at least 48 h, appears far more reliable.
Considering its easiness of realization and low cost, our work
confirms the validity of this test in pre-screenings.
In conclusion, this work presents an in vitro analysis of the
toxicity of 11 microalgal strains and one natural bloom of
potential interest for food applications. Taken together, these
data indicate that extracts from microalgae have a different
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pattern of inhibition (and thus toxicity) on A. salina and fibro-
blasts. Although these two models are useful and widely
employed tools to screen the potential toxic effect, the attain-
ment of results not fully in accordance, probably due to the
different sensitivity and complexity of the models, should be
taken into serious consideration. Clearly, results obtained from
in vitro models or invertebrate bioassays are preliminary and
must be confirmed by in vivo studies on mammals performed
on the whole algal biomass and not only on extracts. These
pre-screenings allow reducing the number of candidate strains
to be selected for further in vivo studies on mammals that are
necessary, in most cases, to fulfill the mandatory requirement
of subchronic toxicity data for novel food applications, at least
in the EU. In conclusion, from this study, the two commercial
C. vulgaris strains, T. suecica F&M-M33, and P. purpureum
F&M-M46 emerged as non-toxic and other two strains,
A. platensis F&M-C256 and N. oceanica F&M-M24, as sub-
stantially non-toxic. T. lutea F&M-M36, the two
C. sorokiniana strains, N. sphaeroides F&M-C117, and
P. tricornutum F&M-M40 showed some toxicity and need
further investigation. Finally, Klamath powder was found to
be the most toxic among the biomasses tested, inhibiting both
models.
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